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This thesis documents the contributions made to four projects. Three of these projects 
explore the synthesis and reactivity of 1,2-bis(boronic esters), whereas the final project 
attempts to expand the scope of the Aggarwal group’s lithiation–borylation methodology. 
Project 1: Synthesis of Atorvastatin derivative 223 
The Aggarwal group has shown that enantioenriched 1,2-bis(boronic esters) can be 
homologated selectively at the primary boronic ester with lithiated carbamates or 
benzoates to generate 1,3-bis(boronic esters), which can be oxidised to the corresponding 
1,3-diols, in high diastereomeric excess.1 This reagent-controlled process is able to access 
any stereochemical permutation of the 1,3-diol products without any matched or 
mismatched effects. The first project aimed to use this methodology to achieve a concise 
synthesis of compound 223, which is a derivative of the blockbuster statin, atorvastatin. 
 
Project 2: Studies towards the total synthesis of bahamaolide A 
1,3-Poly(boronic esters) can be obtained through an iterative diboration–homologation 
sequence when the homologation phase utilises a carbenoid with a pendent alkene. In the 
second project, we proposed to demonstrate the power of this methodology through the 
synthesis of the newly isolated oxopolyene macrolide, bahamaolide A.2,3 The C2 
symmetric nature of the polyol portion of bahamaolide A led us to consider an iterative 
bi-directional strategy for its construction, where eight of the nine stereodefined hydroxyl 
groups would be revealed through the stereospecific oxidation of a carbon–boron bond. 
Our retrosynthetic analysis revealed C2 symmetric octaboronic ester 444 as the key 






Project 3: Studies towards a novel boronic ester protecting group 
The third project was concerned with reversing the innate reactivity of a 1,2-bis(boronic 
ester) with a lithiated carbamate or benzoate by affording a regioselective homologation 
through the more hindered secondary boronic ester moiety. We rationalised that this could 
be achieved by lowering the Lewis acidity of the primary boronic ester relative to the 
secondary boronic ester by installing a suitable protecting group. Literature known 
protecting groups for boronic esters are incompatible with lithiation–borylation reactions 
and so a novel group was sought. 
 
Project 4: Studies towards a new leaving group in lithiation–borylation reactions 
The final project aimed to increase the scope of the lithiation–borylation reaction to 
include reaction partners that contain a strongly electronegative group, such as alkyl 
fluorides. Boronate complexes derived from a lithiated carbamate/benzoate with a 
boronic ester containing a strongly electron withdrawing substituent do not undergo the 
desired 1,2-metallate shift, but instead fragment to regenerate the boronic ester and 
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This section has been adapted from a book chapter written by the author, which is to be 
published in an upcoming edition of PATAI’S Chemistry of Functional Groups. 
The 1,2-metallate rearrangement of boronate complexes involves the migration of a boron 
bound R1 group to an α-carbon atom with concomitant loss of an α-carbon bound 
nucleofuge, thus forming a new carbon–carbon or carbon–heteroatom bond (Scheme 1). 
This process requires anti-periplanar orientation of the migrating- and leaving groups, 
which renders the operation stereospecific, occurring with inversion of configuration at 
the α-carbon centre.4 Of the metals and semimetals that can facilitate this transformation, 
boron is unique in its ability to execute this operation with exquisite levels of 
stereochemical fidelity.  
 
Scheme 1 1,2-Metallate rearrangement of a boronate complex 
The 1,2-metallate rearrangement is especially useful for making C─C bonds, which leads 
to a new boronic ester. Indeed, the new boronic ester can be homologated again and again, 
in an iterative manner, essentially growing the carbon chain one atom at a time. The 
homologation can be performed in an enantioselective fashion by incorporating a chiral 
ligand into the boronic ester component (substrate-control), or by utilizing an 
enantioenriched carbenoid species (reagent-control) (Scheme 2). 
 
Scheme 2 Substrate- and reagent-controlled homologation of boronic esters 
Substrate-controlled homologation of boronic esters 
The Matteson Reaction 
The Matteson reaction is the displacement of a leaving group from the α-carbon atom of 





performed in an iterative two-step sequence, which begins with formation of α-chloro 
boronic ester 3 through homologation of alkylboronic ester 2 with 
(dichloromethyl)lithium (1), followed by invertive substitution of the α-halide through 
addition of a nucleophile to afford homologated boronic ester 4 (Scheme 3).6 The product 
can be obtained with exquisite levels of diastereoselectivity (up to >99:1 dr) through the 
use of chiral diol ligands on boron and ZnCl2 as an additive, where the diastereoselectivity 
is controlled by the stereochemical environment imparted by the chiral ligand.7  
 
Scheme 3 The Matteson reaction 
Corey proposed a model to account for the diastereoselectivity.7 Addition of 
(dichloromethyl)lithium to alkylboronic ester 2 afforded boronate complex 5. In the 
favoured case (transition state 6), ZnCl2 coordinated to the less hindered oxygen atom of 
the boronic ester moiety and to the pro-R chloride. There was also a further stabilising 
interaction between a chloride bound to ZnCl2 and the proton at the α-boryl carbon centre. 
The coordination of ZnCl2 placed the pro-R chloride anti-periplanar to the migrating R1 
group, thus facilitating migration. In the disfavoured case (transition state 7), ZnCl2 
coordinated to the less hindered oxygen atom of the boronic ester and the pro-S chloride; 
however, the favourable chloride-proton interaction was replaced by an unfavourable 
steric interaction between two chlorides. Midland has shown through calculation that the 
difference in energy between transition states 6 and 7 is 12.6 kcal mol–1.8 Reaction of 
α-halo boronic ester 3 with a Grignard reagent gave boronate complex 8, which 
underwent stereospecific 1,2-metallate rearrangement to afford secondary boronic ester 
4 with inversion of stereochemistry at the α-carbon atom (Scheme 4).  
 





Several features of the reaction are worthy of note; 
1) Boronate complex 5 was stable at –100 °C and did not undergo 1,2-metallate 
rearrangement until warmed to ambient temperature. (Dichloromethyl)lithium 
was unstable at temperatures above –100 °C and decomposed before 
1,2-rearrangement occurred, thus preventing over homologation. 
2) Upon addition of a Grignard reagent to α-chloroboronic ester 3, boronate complex 
formation occurred exclusively. β-Elimination of the α-chloride was not observed.   
3) α-Chloro boronic esters can undergo epimerization by chloride ions.9 The 
epimerization event was found to have a 0.75-order dependence on lithium 
chloride, and was accelerated by water and DMSO. Therefore, quenching of the 
reaction with water prior to extraction led to a reduction in diastereoselectivity. 
Despite this, epimerization was avoided by quenching with a saturated solution of 
ammonium chloride, which was postulated to keep the boronic ester and LiCl in 
separate phases (Scheme 5).10 
 
Scheme 5 Racemization of α-chloro boronic esters with LiCl 
Sequential double stereodifferentiation with DIPED and DICHED  
Matteson showed that diisopropylethanediol (DIPED)11 and 1,2-dicyclohexylethane-1,2-
diol (DICHED)12 performed superbly in the asymmetric homologation of boronic esters, 
routinely giving superior diastereoselectivity to the corresponding pinanediol ligated 
boronic esters.13 The reason for this enhanced stereoselectivity is that in certain cases C2 
symmetric boronic esters undergo sequential double stereodifferentiation, where the 
contra-kinetic diastereoisomer is discriminated against twice within the reaction sequence 






Scheme 6 Sequential double stereodifferentiation 
 
The conversion of α-chloroboronic ester 9 to boronic ester 10 was accompanied by an 
enrichment in diastereomeric ratio value (97:3 to 99.8:0.2 dr). In the case of the directed 
diastereoisomer, the 1,2-metallate rearrangement occurred efficiently through the 
expected transition state; however, the contra-kinetic diastereoisomer underwent contra-
thermodynamic O-migration to afford a borinic ester, which decomposed upon 
isolation.14 The contra-kinetic diastereoisomer was present in too small an amount to 
study so boronic ester 11 was synthesized through conversion of (R,R)-DIPED to (S,S)-
DIPED. For this diastereoisomer, the interaction between the Lewis acid and the α-carbon 
bound proton is replaced with an unfavorable steric clash between the Lewis acid and the 
propyl group. Reorientation of the boronate complex to place one of the boronic ester 
oxygen atoms anti-periplanar to the departing chloride ion restored the stabilizing 
interaction between the Lewis acid and the α-carbon bound proton and alleviated the 
steric clash between the Lewis acid and propyl group, and resulted in O-migration 
(Scheme 7).14 This phenomenon resulted in matched case homologations yielding 
products with very high diastereomeric ratio values. 
 





Migration of N-centred nucleophiles 
The synthesis of tertiary α-amino boronic ester 13 from the reaction of dimethylamine 
with (iodomethyl)boronic ester 12 furnished 13 in 85% yield after transesterification with 
catechol.15 Piperidine was also competent in this reaction, giving the corresponding 
tertiary α-amino boronic ester 14 in 50% yield. However, the reaction could not be 
expanded to the synthesis of primary or secondary α-amino boronic esters due to the 
instability of the products, which decomposed through a protodeboronation pathway 
(Scheme 8). 
 
Scheme 8 Formation of α-amino boronic esters 13 and 14 
Synthesis of stable α-amino boronic ester derivatives was achieved by treatment of 
α-haloboronic esters with LiHMDS.16,17,18 In this instance, 1,2-metallate rearrangement 
yielded silyl protected α-amino boronic ester 15, which was isolated by distillation. 
Unprotected α-amino boronic ester 19 was accessed through silyl deprotection of 18 with 
methanol; however, 19 was unstable. Instead, the acetylated derivative 16 was targeted 
by treatment of 15 with acetic anhydride in acetic acid. Destructive removal of pinanediol 
with BCl3 yielded optically pure (R)-α-amino boronic acid 17 (Scheme 9).17 The (S)-
enantiomer (ent-17) was prepared using the same sequence with (R)-pinanediol. Both 
(R)- and (S)-enantiomers were potent inhibitors of the serine protease chymotrypsin, with 
the (R)-enantiomer being more active than the (S)-enantiomer.17  
 
Scheme 9 Synthesis of stable α-amino boronic ester derivatives 
This methodology was used by Adams in the first synthesis of the serine protease inhibitor 
bortezomib,19 which is marketed as Valcade® by Takeda Oncology for the treatment of 





L-phenylalanine (22) and L-boronoleucine (21), which was assembled from isobutyl 
boronic ester 20 using Mattson’s homologation methodology.23 An efficient deprotection 
of pinanediol boronic ester 24 by transesterification with isobutyl boronic acid gave 
bortezomib and regenerated boronic ester 20 (Scheme 10). 
 
Scheme 10 Synthesis of bortezomib 
Azides are also competent nucleophiles in the displacement of α-boryl chloride ions. 
Treatment of α-chloroboronic ester 25 with sodium azide generated the stable 
α-azoboronic ester 26.10 Despite its stability, 26 was especially susceptible to LiCl 
mediated epimerization. To prevent unwanted epimerization, boronic ester 25 was added 
to a ten-equivalent excess of sodium azide in dichloromethane/water with a 
tetrabutylammonium phase transfer catalyst, which permitted the isolation of α-
azoboronic ester 26 with >99:1 dr. Homologation of 26 with (dichloromethyl)lithium 
proceeded smoothly to yield α-chloroboronic ester 27; however, subsequent addition of 
butyl magnesium chloride resulted in β-elimination leading to butyl boronic ester 29 and 
material characterized as having an alkene, which would presumably have the structure 
of 28. The desired product was obtained through the addition of excess ZnCl2, which 
promoted 1,2-migration over elimination. Oxidation of boronic ester 30 at pH 7.6 and 







Scheme 11 Azides as nucleophiles in the Matteson reaction 
The displacement reaction of α-chloroboronic esters has also been applied to the synthesis 
of amino acids.24 A facile 1 step oxidation of α-chloroboronic ester 32 to carboxylic acid 
33 was achieved by treatment with NaClO2. Subsequent reduction of 33 by hydrogenation 
over a Pt catalyst yielded enantiopure (S)-amino acid 34 (Scheme 12).24 Using this 
methodology, Matteson was able to synthesise phenylalanine, valine, serine and glutamic 
acid. The synthesis of α-amino derivates with sodium azide proved to be superior than 
when using LiHMDS, due to the instability of the β-silylamino α-chloro boronic ester 35, 
which was formed after a further homologation with (dichloromethyl)lithium.24  
 
Scheme 12 Synthesis of amino acids using the Matteson reaction 
Migration of O-centred nucleophiles 
Matteson has shown that O-centred nucleophiles participate in 1,2-metallate 
rearrangement reactions to yield protected α-hydroxy boronic esters.10 The rate and 





ZnCl2 to the oxygen atom of the migrating group.25 To overcome this limitation a slight 
excess of ZnCl2 is required,10 although addition of superfluous amounts of ZnCl2 resulted 
in enhanced epimerization of the products by ZnCl2 and LiZnCl3.9 The optimum loading 
of ZnCl2 was found to be 1.0 equiv for each alkoxy substituent and an additional 0.7 equiv 
for catalysis. The limit of iterative installation of contiguous benzyloxy substituents was 
realized during the synthesis of (L)-ribose (Scheme 13).25  
 
Scheme 13 Synthesis of (L)-ribose 
In this case, the use of α-bromoboronic esters, such as 37, resulted in superior yields and 
diastereomeric ratios than the corresponding α-chloroboronic esters. Advanced 
intermediate 38 was obtained in six iterative steps from benzyloxy boronic ester 36. 
Homologation of boronic ester 38 with both (dibromomethyl)lithium and 
(dichloromethyl)lithium gave an intractable mixture; however, peroxide–aldehyde adduct 
39 was observed in poor yield after oxidation with hydrogen peroxide following 
homologation with (dichloromethyl)lithium. Hydrogenation with palladium over carbon 
yielded (L)-ribose. The difficulties in installing the final carbon atom were attributed to 
the steric bulk of the system; however, more recently Hirschhäuser and coworkers have 
suggested that formation of six-membered intramolecular boronate complex 40 impedes 






Recent applications of the Matteson reaction in total synthesis 
Kazmeier reported the synthesis of polyketide fragment 50 as an advanced intermediate 
in the synthesis of lagunamide A using six sequential Matteson homologation steps 
followed by oxidation (Scheme 14).28 Synthesis of intermediate 52 from methyl boronic 
ester 51 proceeded smoothly; however, homologation of 52 with LiCH2Cl failed to 
generate boronic ester 53. The solution to this problem was to employ LiCH2Br as the 
homologating agent and to ensure that the reaction temperature was strictly maintained at 
–60 °C, which permitted the formation of 53 in 89% yield. A further homologation gave 
α-chloro boronic ester 54, which was transformed to aldehyde 50 in high yield. The chiral 
ligand was recovered in quantitative yield through addition of methyl boronic acid to 
regenerate methyl boronic ester 51. 
 
Scheme 14 Synthesis of aldehyde 50 as an intermediate in the synthesis of lagunamide A 
Armstrong applied the Matteson homologation reaction to the synthesis of intermediate 





tautomycin (Scheme 15).29,30 Compound 55 was obtained after three iterative Matteson 
homologation steps, a further homologation with (dichloromethyl)lithium, 
de-chlorination of the resulting α-chloro boronic ester with sodium 
trimethoxyborohydride and oxidation. 
 
Scheme 15 Synthesis of alkene 55 as an intermediate in the synthesis of the C1–C21 fragment of tautomycin 
Davoli showed the convergent synthesis of (–)-microcarpalide in which fragments 57 and 
58 were both prepared using substrate-controlled homologations of boronic esters 
(Scheme 16).33,34 Homoallylic alcohol 57 was obtained from boronic ester 56 following 
two homologation steps and oxidation. Allylic alcohol 58 was obtained through a similar 
sequence from boronic ester 59. The synthesis of (–)-microcarpalide was completed in a 












Reagent-controlled homologation of boronic esters 
Reagent-controlled homologation has the advantage over substrate-controlled 
homologation in that either enantiomer/diastereoisomer of the product can be obtained by 
selecting the appropriate enantiomorph of the chiral reagent, whereas in a substrate-
controlled process a two-step sequence to exchange the enantiomer of chiral ligand must 
be performed prior to homologation. For a reagent-controlled homologation of boronic 
esters to be successful a number of criteria must be fulfilled: (i) the chiral reagent must 
be chemically and configurationally stable under the reaction conditions (ii) the formation 
of the boronate complex and the subsequent 1,2-metallate rearrangement must be 
stereospecific (iii) any excess carbenoid must decompose prior to 1,2-metallate 
rearrangement to prevent over-homologation (iv) the stereoselectivity of the reaction 
should not be influenced by stereogenic centres already present in either the carbenoid or 
the boronic ester. 
Homologation of Boronic Esters with Lithiated Carbamates and Benzoates 
Enantioselective deprotonation of Hoppe-type carbamates33 and Beak-type 
triisopropylbenzoates34 gives dipole stabilized carbanions. These intermediates fulfil the 
criteria required for reagent-controlled homologation. Specifically, when treated with 
s-BuLi and (–)-sparteine, O-alkylcarbamates and triisopropylbenzoates undergo reagent-
controlled deprotonation of the pro-S-proton. The resulting lithium carbenoid is 
chemically and configurationally stable at –78 ˚C and can be trapped with electrophiles 
with retention of stereochemistry (Scheme 17).  
 
Scheme 17 Asymmetric deprotonation of an O-alkyl carbamate with s-BuLi and (+)-sparteine. 
Hoppe showed the first example of a reagent-controlled homologation of boronic esters 
with the conversion of primary O-alkylcarbamates to enantioenriched secondary alcohols 
in a two-step process. Specifically, deprotonation of carbamate 62 with 
s-BuLi/(–)-sparteine generated lithiated carbamate 63. Treatment of 63 with triisopropyl 
borate resulted in electrophilic trapping with retention of configuration to yield boronic 





to 64 at –78 ˚C formed boronate complex 65, which underwent stereospecific 
1,2-metallate rearrangement with inversion of configuration upon warming the reaction 
mixture to room temperature, yielding secondary alcohol 66 after oxidation (Scheme 18).  
 
Scheme 18 Hoppe's reagent-controlled homologation of boronic esters 
The Lithiation–Borylation Reaction 
Lithiation–borylation is the colloquial description of the homologation of boronic esters 
with lithiated carbamates and benzoates, which has been extensively developed by the 
Aggarwal group.36 The reaction consists of three phases; (i) the generation of a lithiated 
carbenoid through the enantioselective or enantiospecific deprotonation of a suitable 
carbamate or benzoate, or through the stereospecific tin–lithium exchange of an 
enantioenriched α-stannyl benzoate, (ii) the stereoretentive formation of a boronate 
complex, (iii) the stereoinvertive 1,2-metallate rearrangement of the boronate complex to 
yield a homologated boronic ester with concomitant expulsion of the carbamate or 






Scheme 19 The lithiation–borylation reaction 
The rates of lithiation, borylation and migration are impacted by the identity of the 
directing group, the solvent, the diamine and steric hinderance at the β-position of the 
carbamate/benzoate.37 Lithiation of benzoates with s-BuLi and (+)-sparteine occurred two 
to three times faster than the corresponding carbamates due to a parasitic interaction 
between the carbamate, s-BuLi and (+)-sparteine, which was observable through in situ 
IR spectroscopy.37 No such interaction was detected upon lithiation of a benzoate; 
however, borylation of a lithiated carbamate occurred more rapidly than the 
corresponding lithiated benzoate, which was attributed to a steric effect.37 The rate of 
1,2-migration was faster in the case of benzoates than carbamates, which permitted 
challenging migrating groups, such as methyl, to be tolerated in lithiation–borylation 
reactions.38 Specifically, when carbamate derived boronate complex 67 was reacted at 
35 °C for 16 h the expected boronic ester was obtained in less than 10% yield. The 
addition of MgBr2∙Et2O improved the yield to 50%; however, employing benzoate 
derived boronate complex 68 furnished boronic ester 69 in 76% yield after 2 h at 35 °C 






Scheme 20 Differences between carbamates and benzoates in the lithiation–borylation reaction 
Synthesis of tertiary boronic esters 
Aggarwal has shown the synthesis of tertiary benzylic,47,48 allylic,41 propargylic,42 and 
dialkyl43 boronic esters through lithiation–borylation reactions with suitable 
enantioenriched secondary carbamates or benzoates. The reaction proceeded by initial 
deprotonation of the enantioenriched carbenoid precursor 70 and subsequent addition of 
a boronic ester, which generated boronate complex 71. The reaction was then warmed to 
ambient temperature to permit 1,2-metallate rearrangement; however, due to the hindered 
nature of the boronate complex and the relatively low nucleofugality of carbamates, the 
1,2-migration was slow.40 As a result, when the carbamate contained an arene, alkene or 
alkyne in the α-position, a competing process occurred where boronate complex 71 
reversibly fragmented at elevated temperature and regenerated stabilized organolithium 
species 72, which was not configurationally stable above –70 °C.40 Partial racemization 
of 72 occurred before recombination with the boronic ester, which afforded a boronate 
complex of undesired configuration, which subsequently migrated to yield the 






Scheme 21 Reversible fragmentation of boronate complexes leads to products with diminished ee values 
This issue was resolved through the addition of a second electrophile—which reacts with 
the carbenoid irreversibly—before warming to ambient temperature. The optimal 
electrophile was MgBr2∙MeOH,40 which permitted the formation of tertiary alcohols in 
high yield and enantiomeric excess, even when using sterically hindered or electron 
withdrawing reaction partners. The role of MgBr2∙MeOH is two-fold; firstly, coordination 
of MgBr2 to the carbamate makes it a better leaving group, which promotes the desired 
1,2-migration over fragmentation. Additionally, any lithiated species generated by the 
reversible fragmentation of the boronate complex is immediately quenched by MeOH, 
thus preventing recombination with the boronic ester.40 
1,2-Rearrangement of boronate complexes can be applied to the enantiodivergent 
synthesis of tertiary alcohols from enantioenriched secondary alcohols.39 Secondary 
benzylic carbamates—derived from the corresponding enantiopure secondary benzylic 
alcohol—can be lithiated with s-BuLi to generate a benzylic carbenoid that is 
configurationally stable at –78 ˚C. Retentive trapping of a boronic ester, 
1,2-rearrangement and subsequent oxidation yields an enantioenriched tertiary alcohol. 
Interestingly, if the same benzylic carbenoid is treated with a trialkyl borane, electrophilic 
trapping occurs with inversion of configuration to yield the enantiomeric tertiary alcohol. 
This reactivity is in stark contrast to carbenoids derived from alkyl carbamates, which 
trapped both boronic esters and trialkyl boranes with retention of configuration.39 In the 
case of secondary benzylic carbamates, mesomeric stabilization of the anion into the 
aromatic ring causes the sp3 centre to become partly planarized, which results in the build-
up of electron density on the opposite face of the lithium ion.47,48 When a carbenoid was 
quenched with a boronic ester, it was proposed that an oxygen atom of the boronic ester 
coordinated to the lithium ion of the carbenoid prior to nucleophilic attack, which resulted 





boranes, no such coordination is possible and the trialkyl borane approacheed from the 
bottom face of the carbenoid, which is less hindered and has sufficient electron density, 
resulting in inversion of configuration at the sp3 centre. Through judicious choice of 
organoboron species it was therefore possible to obtain either enantiomer of tertiary 
alcohol from the same enantioenriched secondary alcohol (Scheme 22). Primary boronic 
ester and trialkyl borane derivatives were well tolerated, with ethyl boronic ester and 
triethyl borane giving tertiary alcohols 73 and ent-73 in 95% and 91% yield, respectively, 
and both with complete—but opposite—enantiospecificity. The more sterically hindered 
isopropyl boron derivatives both gave the respective products 74 and ent-74 in high yield; 
however, a slight erosion of the enantiomeric ratio was observed for both the alcohol 
derived from the boronic ester (74, 96:4 er) and the borane (ent-74, 2:98 er). 
Incorporating electron deficient aryl groups also yielded products with a reduced 
enantiomeric ratio value, as exemplified by examples 75 and ent-75. Phenyl substituted 
boranes could not be used as the products decomposed through a protodeboronation 
pathway during the oxidation phase; however, phenyl boronic esters were competent 
substrates, as demonstrated by alcohol 76, which was obtained in 89% yield and with 
96:4 er (Scheme 22). 
 
Scheme 22 Enantiodivergnt synthesis of tertiary alcohols 
The erosion of enantiomeric excess occurred when the reaction was warmed to ambient 
temperature to facilitate 1,2-migration of the boronate complex.40 Upon warming, the 
boronate complex underwent reversible fragmentation and reformed the stabilized 
benzylic carbenoid and boronic ester. Partial racemization of the carbenoid occurred at 
elevated temperature before recombination with the boronic ester yielded a boronate 





generate the tertiary alcohol of undesired configuration. As discussed previously, 
complete enantiospecificity could be restored through addition of MgBr2∙MeOH prior to 
warming the reaction mixture to permit 1,2-migration. Under these conditions a wide 
range of electron rich, electron deficient and sterically hindered tertiary boronic esters 
were synthesized in high yield and with perfect enantiospecificity; notable examples 
being substrates 77, 78, and 79, which were obtained with diminished enantiomeric ratio 
values in the absence of MgBr2∙MeOH. The reaction also tolerated pyridyl boronic 
esters,44 which generated α-pyridyl tertiary alcohols 81 and 82 after oxidation with 
NaOH/H2O2 (Scheme 23). 
 
Scheme 23 Complete enantiospecificity in the synthesis of tertiary boronic esters 
The synthesis of tertiary allylic boronic esters was achieved through lithiation–borylation 
reactions with suitable enantioenriched allylic carbamates.41 Hoppe has shown that 
treatment of lithiated secondary allylic carbamates with electrophiles such as Me3SnCl or 
methyl chloroformate leads to a mixture of products derived from α- and γ-attack of the 
organolithium,45 while aldehydes react through a Zimmerman–Traxler type transition 
state to yield γ-substituted products.46 Boronic esters primarily undergo α-attack of the 
organolithium due to coordination of a pinacol oxygen atom to the lithium (Scheme 24).41 
Primary and secondary boronic esters yielded products of α-addition exclusively, with 
102 being obtained in 75% yield and 98:2 er and 103 being obtained in 76% yield and 
99:1 er following the addition of MgBr2∙MeOH at –78 ºC. In the case of secondary 
boronic esters, lower enantiomeric ratio values were obtained in the absence of 
MgBr2∙MeOH, as the hindered boronate complex reversibly regenerated the stabilized 
allylic lithiated species, which partially racemized and recombined with the boronic ester. 
The reaction tolerated aryl boronic esters; however, small amounts of γ-addition were 
observed, with product 104 obtained in 84% yield and with 98:2 er together with 7% of 





substituents on the carbamate. Increasing the steric bulk at the γ-position reinforced the 
regioselectivity for borylation at the α-position, with alcohol 105 being obtained 
exclusively as the α-addition product. Conversely, increasing the steric bulk at the α-
position resulted in increased formation of γ-addition products, as exemplified by 
substrate 106. Increasing the steric bulk of the R2 position of the carbamate did not result 
in the formation of γ-addition products but did contribute to a reduction in the 
enantiospecificity of the reaction, with compound 107 being obtained in 94:6 er with the 
addition of MgBr2∙MeOH following the formation of boronate complex (Scheme 24). 
 
Scheme 24 Synthesis of tertiary allylic alcohols 
The synthesis of tertiary propargylic alcohols was achieved through lithiation–borylation 
reactions with suitable enantioenriched propargylic carbamates.42 Hoppe has shown that 
lithiated propargylic carbamates are only configurationally stable at –78 °C when there is 
a bulky substituent in the terminal position of the alkyne,47 and so the scope of the reaction 
was limited to t-butyl substituted alkynes. Propargylic carbamate 108 was lithiated with 
n-BuLi and the resulting carbenoid quenched with isopropyl pinacolato boronic ester, 
which yielded propargylic alcohol 109 after oxidation with no regiomeric products from 
γ-addition to the alkyne; however, 109 was racemic (Scheme 25, entry 1). The 
enantiospecificity of the reaction was improved by using the less sterically hindered 
neopentyl boronic ester, with 109 being obtained in 38% es when using two equivalents 
of the boronic ester (Scheme 25, entry 3). A further increase in the enantiospecificity was 
observed when using three equivalents of boronic ester (81% es, Scheme 25, entry 4); 
however, utilization of isopropyl ethylene glycolato boronic ester resulted in the 






Scheme 25 Effect of boronic ester ligand on enantiospecificity in the homologation of secondary propargylic 
carbamates 
The dependence of the es value on both the equivalents of the boronic ester used and on 
the boronic ester ligand suggests that the erosion in enantioenrichment is caused by 
reversibility of the boronate complex, racemization of the carbenoid upon warming and 
recombination with the boronic ester. In the case of hindered pinacolato boronic esters 
reversibility is much faster than 1,2-rearrangement, which results in the complete 
fragmentation of the boronate complex and isolation of a racemic alcohol. The boronate 
complex derived from a neopentyl boronic ester is less hindered and so less prone to 
reversible fragmentation, while increasing the number of equivalents of the boronic ester 
increases the likelihood that the carbenoid will recombine with the boronic ester before 
extensive racemization occurs. Ethylene glycol boronic esters are less hindered than 
neopentyl boronic esters and promote 1,2-migration over reversibility, permitting the 
isolation of propargylic alcohols with high to perfect enantiospecificity. Under the 
optimized conditions primary, secondary, allylic and benzylic boronic esters all 
participated in the reaction to yield propargylic alcohols 110, 111, 112, and 113, 
respectively, with high levels of enantiospecificity (Scheme 26). Phenyl boronic ester also 
participated in the reaction, but the tertiary alcohol could not be isolated as the 







Scheme 26 Synthesis of tertiary propargylic alcohols 
The generation of tertiary trialkyl boronic esters using lithiation–borylation methodology 
is challenging because secondary dialkylbenzoates48 and carbamates49 are normally 
resistant to deprotonation. Despite this, Aggarwal has shown that stereospecific lithiation 
of secondary dialkylbenzoates can be achieved under modified conditions:43 treatment of 
a secondary dialkylbenzoate with s-BuLi/TMEDA (1.6/6.0 equiv) in CPME at –60 ºC for 
2 h, which resulted in up to 90% lithiation. Quenching the lithiated species derived from 
4-phenylbutan-2-yl benzoate with ethyl pinacolato boronic ester, followed by oxidation, 
generated alcohol 115 in 71% yield and 97:3 er; however, utilizing the less hindered 
neopentyl boronic gave 115 in 80% yield and with complete enantiospecificity (Scheme 
27). Using these conditions secondary (116), aryl (117 and 118) and allylic (119) boronic 
esters were tolerated. Increasing the steric bulk of the starting benzoate gave the desired 
products (119) but in lower yield because of the more challenging lithiation (Scheme 27). 
 






Aggarwal has shown that the homologation of boronic esters using lithiated carbamates 
can be performed iteratively to generate complex molecules with exquisite control of 
stereochemistry.50 In this vein, all four diastereoisomers of alcohol 124 were prepared 
through two sequential homologations of carbamate 120 by varying the enantiomer of 
chiral reagent used in each step (Scheme 28).50 The lithiation of carbamate 120 with 
s-BuLi and (–)-sparteine yielded lithiated species 121, which was quenched with ethyl 
boronic ester to afford secondary boronic ester 122 in 78% yield and 98:2 er after 
1,2-metallate rearrangement. The enantiomeric ratio corresponds to the selectivity of the 
lithiation step, which is faithfully transferred through the enantiospecific formation of the 
boronate complex and subsequent 1,2-migration. Homologation of 122 with (–)-sparteine 
ligated carbenoid 123 and oxidation gave secondary alcohol 124 in 96:4 dr and >98:2 er. 
The diastereoisomer (125) was obtained by homologating 122 with (+)-sparteine 
surrogate coordinated carbenoid ent-123, again with high diastereo- (94:6 dr) and 
enantiomeric ratios (>98:2 er). The use of the O’Brien (+)-sparteine surrogate51 was 
required due to the commercial unavailability of (+)-sparteine at the time. Ent-124 and 
ent-125, were obtained with high enantiomeric ratio values and with 94:6 dr and 9:1 dr, 
respectively, through homologation with the opposite enantiomer of chiral reagents at 
each step, thus showing that each step is operating under reagent control (Scheme 28). 
 
Scheme 28 Synthesis of all four stereoisomers of alcohol 124 
In 2014, the Aggarwal group published the synthesis of a molecule containing 10 





homologation of boronic esters.52 This feat is particularly impressive as both the 
diastereoselectivity and the amount of over- and under-homologation must be controlled. 
For example, if each homologation proceeded to 98% completion, with 1% over-
homologation and 1% under-homologation, after 10 homologation steps the desired 
product would be only 82% pure. If each homologation proceeded in 98:2 er, the final 
product would again only be 82% pure after 10 homologations, with the mass balance 
being made up with diastereoisomers that could prove difficult to separate. Controlling 
the enantioselectivity of each step is particularly challenging because the lithiation of 
ethyl benzoate 126 with a combination of s-BuLi and (+) or (–)-sparteine provides 
lithiated species 127 in only 95:5 er. This was overcome by synthesizing α-stannyl 
benzoate 128, which could be recrystallized to >99.9:0.1 er. Stereospecific tin–lithium 
exchange was achieved through the addition of n-BuLi to stannane 128 to obtain 
carbenoid 127 with retention of configuration and as a single enantiomer (Scheme 29).52 
 
Scheme 29 Homologation of a boronic ester with enantiopure carbenoid 127 
128 was used in excess with respect to the boronic ester to ensure complete conversion 
to boronate complex 129 and thus prevent under-homologation. To prevent over-
homologation, the excess carbenoid was decomposed at –40 °C for one hour before the 
reaction mixture was warmed to ambient temperature to facilitate 1,2-migration. The 
reaction mixture was then filtered to remove the insoluble LiOTIB salt and concentrated 
to yield the homologated boronic ester for use in the next iteration. Although seven 
homologations could be performed without any additional purification steps, the authors 
elected to perform an aqueous work up after every third homologation. With the 
optimized homologation conditions in hand, the authors synthesized the all-anti 
diastereoisomer 131 by subjecting boronic ester 130 to nine iterative homologations with 





This sequence was repeated to generate the all-syn diastereoisomer 132 by altering the 
enantiomer of lithiated species used in each homologation, and the syn–anti 
diastereoisomer 133 was synthesized by alternating the enantiomer of lithiated species in 
every other homologation. Poly-methyl substituted alkyl chains often adopt specific 
conformations to avoid syn-pentane interactions along the chain. Although the all-anti 
diastereoisomer 131 exhibited no conformational preference, the all-syn diastereoisomer 
132 adopted a helical conformation and the syn–anti diastereoisomer 133 adopted a linear 
conformation (Scheme 30). 
 
Scheme 30 Assembly-line synthesis of molecules 131, 132, and 133 
As a further demonstration of the power of Aggarwal’s assembly-line synthesis, the 
natural products (+)-kalkitoxin and (+)-hydroxyphthioceranic acid were synthesized with 
exceptional efficiency and stereocontrol.53 (+)-Kalkitoxin was assembled from fragments 
134, 135, and 136. The synthesis of fragment 135 could be further simplified to 
PMB-substituted boronic ester 137 through an assembly-line sequence using the requisite 
stannane-derived lithiated benzoate or (chloromethyl)lithium and subsequent amination 
of boronic ester 138. In the event, homologated boronic ester 138 was achieved following 
six assembly–line manipulations. The only purification that was required between each 
homologation was a simple filtration to remove LiOTIB. The conversion of boronic ester 
138 to amine 135 proceeded as described by Morken and coworkers,54 and was followed 
by an aqueous extraction and an amide coupling with fragment 136, which furnished 
amide 139 in 52% yield from boronic ester 137, and with >95:5 dr and >99:1 er. 





step! The completion of the synthesis was achieved in a further five linear steps (Scheme 
31). 
 
Scheme 31 Synthesis of (+)-kalkitoxin 
(+)-Hydroxyphthioceranic acid is a component of sulfolipid-1, which itself is a 
constituent of the cell wall of Mycobacterium tuberculosis.55 Retrosynthetic analysis of 
(+)-hydroxyphthioceranic acid revealed aryl boronic ester 140 as a suitable starting point 
for synthesis by alternating homologations with lithiated benzoate ent-127 and 
(chloromethyl)lithium followed by a final homologation with lithiated carbamate 141 and 
oxidative cleavage of the PMP group. This synthetic route required sixteen iterative 
homologation reactions. Upon launching the assembly-line sequence, it was found that 
adventitious impurities limited the efficiency of the process, and so column 
chromatography was performed after every fourth homologation. Under these conditions, 
boronic ester 142 was achieved after fifteen homologation reactions and only four 
chromatographic purifications. Homologation of 142 with carbamate 143 was impeded 
by the insolubility of the carbamate in Et2O and TBME at –78 °C, which prevented 
lithiation. Hoppe has shown that to achieve lithiation in a related substrate, an excess of 
s-BuLi and (–)-sparteine (4.0 equiv) was required.56 Such an excess of s-BuLi is 
inappropriate in this case as it would form an irreversible boronate complex with the 
boronic ester and significantly reduce the yield. Instead, stannane 144 was prepared in 
32% yield by lithiating 143 in a mixture of TBME and PhMe at –60 °C. 144 showed 
improved solubility in TMBE, and the lithiated species was liberated through the addition 
of an equimolar quantity of n-BuLi. Fragment 145 was obtained in 85% yield and 





removal of the PMP group completed the synthesis. Impressively, the entire synthesis 
was achieved in only one month and with a total of seven purification steps (Scheme 32). 
 
Scheme 32 Synthesis of (+)-hydroxyphthioceranic acid 
Assembly-line synthesis has been applied to the synthesis of additional natural products, 
such as (–)-baulamycin A and B57 and the mycolactone core58 (Scheme 33). The 
modularity of assembly-line synthesis was an essential feature in the synthesis of 
(–)-baulamycin A and B as the authors were required to synthesize several 
diastereisomers to determine the correct structure.57 
 
Scheme 33 Baulamycins A and B and the mycolactone core 
Sulfoxides as Carbenoid Precursors  
Homologation of boronic esters with carbenoids derived from α-chlorosulfoxides 
Blakemore has shown that reagent-controlled homologation of boronic esters can also be 
achieved using α-chloro organolithium/Grignard reagents, which can be derived in 
enantioenriched form from the corresponding enantiopure Hoffmann 





with EtMgCl generated the corresponding magnesium carbenoid (147), which after 
addition of a boronic ester and heating to reflux gave the homologated boronic ester which 
was subsequently oxidised. Using this approach, alcohols 148–152 were obtained; 
however, the enantiomeric ratio values were not synthetically useful (Scheme 34). The 
low er values are presumably due to partial racemization of the carbenoid prior to 
boronate complex formation. 
 
Scheme 34 Homologation of boronic esters using magnesium carbenoids derived from the corresponding α-chloro 
sulfoxide by sulfoxide–magnesium exchange 
α-Chloro lithium carbenoids can be generated by addition of t-BuLi, to 
α-chlorosulfoxides. In contrast to the corresponding magnesium carbenoids, α-chloro 
lithiated species are chemically unstable and must be liberated in the presence of a boronic 
ester (in situ lithiation) to prevent decomposition.61 Under these conditions, 
sulfoxide–lithium exchange is faster than direct addition of butyllithium to the boronic 
ester; moreover, the formation of a boronate complex is faster than decomposition of the 
carbenoid. The lithium carbenoid was superior to the magnesium carbenoid in terms of 
both yield and enantiospecificity and could accommodate the use of pinacolato boronic 
esters. Primary and secondary pinacolato boronic esters participated and gave 153 and 
154, respectively, in good yield but with slightly reduced enantiomeric excess values 
(92% and 82% ee, respectively). While the alcohol derived from isobutyl sulfoxide (155) 
was obtained with good levels of enantiospecificity, generally, modification of the 
sulfoxide component resulted in much lower enantiomeric excess values, as shown by 






Scheme 35 Homologation of boronic esters using lithium carbenoids derived from the corresponding α-chloro 
sulfoxide by sulfoxide–lithium exchange 
Blakemore sought to showcase this methodology through the synthesis of all four 
stereoisomers of alcohol 159, which were constructed through a three-step iterative 
sequence of homologations followed by terminal oxidation.61 In each case the desired 
alcohol was obtained with an excellent enantiomeric ratio value; however, the 
diastereomeric ratio values were comparatively low. The low diastereoselectivity values 
are caused by a chiral amplification phenomenon, whereby the minor enantiomer from 
the first homologation is transferred into a different diastereomeric series in the second 
homologation.62 This process is a limitation of iterative reagent-controlled homologation 
processes that do not use enantiopure reagents (Scheme 36).  
 
Scheme 36 Synthesis of all four diastereoisomers of alcohol 159 
Homologation of boronic esters with carbenoids derived from α-sulfinyl carbamates 
O'Brien reported the synthesis of α-sulfinyl carbamates as precursors to α-metallated 
carbamates and showed their application to boron homologation reactions with a single 
example utilizing isobutyl pinacolato boronic ester.63 The synthesis of either enantiomer 
of α-sulfinyl carbamate 161 was achieved in 99:1 er through asymmetric lithiation of the 
parent carbamate 120 and subsequent trapping with Andersen's chiral sulfonate64 (160). 
The high enantiomeric ratio value observed in the synthesis of 161 was general to all 
α sulfinyl carbamates synthesised in this way, as the minor enantiomer after lithiation was 
delivered into a different diastereomeric series upon trapping with sulfonate 160 and was 





revealed the magnesium or lithium carbenoid, respectively, which were quenched with 
isobutyl pinacolato boronic ester. Both the magnesium and lithium carbenoids afforded 
alcohol 163 in high yield; however, the lithium carbenoid proved superior in terms of 
enantiospecificity and generated 163 without erosion of enantiomeric ratio (Scheme 37).  
 
Scheme 37 Homologation of i-BuBpin with carbenoids derived from α-sulfinyl carbamate 161 
Homologation of boronic esters with carbenoids derived from α-sulfinyl benzoates 
The utility of α-sulfinyl benzoates as precursors to α-lithiated benzoates was investigated 
by Aggarwal as an alternative to α-stannyl benzoates.65 In contrast to α-stannyl benzoates, 
α-sulfinyl benzoates are generally non-toxic and are obtained in >99:1 er without 
recrystallization, which permits the use of non-crystalline α-sulfinyl benzoates as 
carbenoid precursors. Metallation of an α-sulfinyl benzoate with t-BuLi (conditions A) or 
i-PrMgCl∙LiCl66 (conditions B) liberated the lithium or magnesium carbenoid, 
respectively, which was quenched with a boronic ester. α-Sulfinyl benzoates containing 
primary alkyl groups performed well under both sets of conditions, as shown by boronic 
ester 164, which was isolated in excellent yield and enantiospecificity. Similarly, the 
α-sulfinyl benzoate substituted with an isopropyl group underwent the homologation 
reaction to yield boronic ester 165 with exquisite enantiospecificity; however, when using 
the magnesium carbenoid the yield was poor due to the enhanced steric demand of the 
substrate. Some common functional groups that are incompatible with lithiation 
chemistry, for example, azides, could be tolerated when using a magnesium carbenoid, 
as shown in example 167. Finally, the reaction showed complete reagent-control, as 
demonstrated by substrate 168, which was obtained in >95:5 dr when using either the 
lithium or magnesium carbenoid; however, steric demand again resulted in a low yield in 






Scheme 38 Homologation of boronic esters with carbenoids derived from α-sulfinyl benzoates 
Having demonstrated the feasibility of using α-sulfinyl benzoates as carbenoid precursors 
in boron homologation reactions, Aggarwal reported the synthesis of contiguously 
substituted alcohol 171 through an iterative sequence with outstanding control of 
selectivity; however, the efficiency of the reaction diminished with increasing steric 
demand.65 Whilst the first two homologation reactions with allylic α-sulfinyl benzoate 
169 proceeded with almost complete conversion of starting material to product, the third 
homologation utilizing methyl α-sulfinyl benzoate 170 required an extra equivalent of 
t-BuLi (3.0 equiv instead of 2.0 equiv) to achieve 85% conversion, which highlights the 
threshold at which steric hindrance inhibits homologation with α-sulfinyl benzoate 
derived lithiated carbenoids. After oxidation, alcohol 171 was achieved in 41% overall 
yield and with >95:5 dr, demonstrating that high diastereoselectivity can be achieved in 
an iterative process as long as the carbenoid is enantiopure and the reaction is entirely 
stereospecific (Scheme 39). 
 






Homologation of Boronic Esters with Cyclic Carbenoids 
Homologation of boronic esters with lithiated epoxides 
Aggarwal has shown that enantioenriched 1,2-diols can be obtained by the reaction of 
boronic esters with lithiated epoxides.67 Treatment of terminal epoxide 172 with LTMP 
in the presence of a boronic ester (in situ lithiation) generated the trans lithiated epoxide 
exclusively, which was immediately quenched by the boronic ester to yield boronate 
complex 173. Stereospecific 1,2-metallate rearrangement then gave β-hydroxy boronic 
ester 174, which was oxidized to the corresponding syn 1,2-diol as a single 
diastereoisomer (Scheme 40). The success of the reaction was influenced by the 
electronics of both the epoxide and the boronic ester. Electron donating groups promoted 
formation of the desired product, whereas electron withdrawing groups promoted 
decomposition of intermediate α-hydroxy boronic ester 174 through a boron-Wittig type 
elimination to yield an alkene, such as 176. Primary and secondary alkyl boronic esters 
were well tolerated, for example, diols 177 and 178 were obtained in high yield and as 
single diastereoisomers. Incorporation of groups with an intermediate electronic profile, 
such as aryl groups, resulted in a reduced yield of the product due to the competing 
elimination pathway; however, syn-diol 179 was still obtained in good yield and as a 
single diastereoisomer. Employing sterically hindered and heteroatom containing 
epoxides delivered 180 and 181 in moderate yields and with perfect diastereocontrol. 
Finally, when an enantioenriched epoxide was used, the desired 1,2-diol was obtained 
with complete enantiospecificity, as shown by example 182.  
 






Further elaboration of intermediate β-hydroxy boronic ester 174 was also possible. 
Specifically, the addition of TESOTf after boronate complex formation generated 
protected β-hydroxyl boronic ester 184, which was re-subjected to the reaction 
conditions. Treatment of 184 and either enantiomer of epoxide 183 with LTMP furnished 
diastereomeric triols 185 and 186, each in good yield and with perfect 
diastereoselectivity. Other transformations of boronic ester 184 were also applied. A 
one-carbon homologation reaction yielded 1,3-diol 187 with an excellent enantiomeric 
ratio value (Scheme 41). 
 
Scheme 41 Elaboration of boronic ester 184 
Florio has shown that styrene oxide can be regiospecifically lithiated at the benzylic 
position by the addition of s-BuLi and TMEDA at –98 ºC. The lithiated species was then 
trapped with electrophiles with retention of stereochemistry and perfect 
enantiospecificity.68 However, when a boronic ester was employed and TESOTf was 
added after boronate complex formation, Aggarwal obtained tertiary alcohol 188 as a 
racemate.67 The enantiospecificity of the reaction could be improved by reducing the 
reaction temperature from –98 to –115 °C and by utilizing the less hindered 
neopentylglycol boronic ester derivatives. Under these conditions, primary and secondary 
alkyl boronic esters performed well, yielding tertiary alcohols 189 and 190 in 87% and 
69% yield respectively and with 99:1 er. The reaction tolerated boronic esters containing 







Scheme 42 Homologation of boronic esters with styrene oxide 
Homologation of boronic esters with lithiated aziridines 
The formation of 1,2-amino alcohols can be achieved through the reaction of a lithiated 
N-protected aziridine with a boronic ester.69 Specifically, trans-lithiation of N-Boc 
protected aziridine 194 with LTMP in the presence of boronic ester 195 generated 
boronate complex 197, which underwent 1,2-metallate rearrangement to yield 
syn-1,2-amino alcohol 199 after oxidation of the boronic ester with basic peroxide.69 
Hodgson has shown that when lithiated aziridine 196 is generated in the absence of a 
suitable electrophile, Boc-group migration occurs to form aziridinyl esters, such as 201, 
after aqueous work up.127,128 To supress this potential side reaction, the reaction was 
performed at the highest reasonable concentration (0.5 M) and with an excess of the 
boronic ester (3.0 equiv). Under these conditions, the desired 1,2-amino alcohols were 
obtained exclusively with complete suppression of the side reaction (Scheme 43). Primary 
and secondary boronic esters were well tolerated, with amino alcohols 202 and 203 
obtained with complete diastereoselectivity and in 75% and 81% yield, respectively, 
when starting from the racemic aziridine. Utilizing an enantiopure aziridine permitted the 
formation of amino alcohols with complete enantio- and diastereocontrol, as shown by 
example 204. In addition, employing an enantioenriched boronic ester gave 
diastereoisomers 205 and 206 with complete enantio- and diastereocontrol, thus showing 






Scheme 43 Homologation of boronic esters with lithiated aziridines 
Florio has shown that lithiation at the benzylic position of 2-phenyl-N-Boc-aziridine with 
s-BuLi results in the exclusive migration of the Boc-group through an aza-Wittig type 
[1,2] rearrangement.72 Aggarwal subsequently found that migration of the N-protecting 
group could be prevented by employing the less labile N-Bus protecting group.69 
Specifically, treatment of 2-phenyl-N-Bus-aziridine with n-BuLi/TMEDA gave lithiated 
species 208, which was quenched with a boronic ester to yield amino alcohols bearing 
quaternary stereogenic centres after oxidation (Scheme 44). 
 
Scheme 44 Homologation of boronic esters with aziridine 207 
Homologation of boronic esters with lithiated azetidinium ions 
The synthesis of γ-amino boronic esters through lithiation–borylation reactions is 
challenging as α-aryl N-Boc azetidines are resistant to deprotonation; however, the 
corresponding azetidinium ions can be deprotonated at the benzylic position with lithium 
amide bases.73 The resulting organolithium—a lithium stabilized carbanion/ylide—is 





to ensure trapping before decomposition. Aggarwal has shown that treatment of 
azetidinium 209 and a boronic ester with LDA at –78 ̊ C in THF formed boronate complex 
210, which underwent 1,2-migration upon warming to room temperature to generate the 
desired tertiary γ-dimethylamino boronic ester (Scheme 45).73 The reaction tolerated 
primary and secondary alkyl boronic esters, as exemplified by 211 and 212, which were 
isolated in 69% and 44% yield, respectively. Electron rich aryl boronic esters also 
performed well, with para-methoxyphenyl boronic ester yielding product 213 in 75% 
yield; however, when more electron poor aryl groups were used, such as phenyl boronic 
ester, the tertiary boronic ester derivatives could not be isolated due to protodeboronation 
of the products. Despite this, tertiary alcohol derivative 214 could be isolated in 70% yield 
after an oxidative work up with NaOH/H2O2 (Scheme 45). 
 
Scheme 45 Homologation of boronic esters with lithiated azetidinium ions 
Employing enantioenriched azetidinium ion 215 did not lead to the formation of 
enantioenriched products, due to the configurational instability of lithiated species 216. 
It was shown that the lithium stabilized carbanion is in equilibrium with the corresponding 
ylide 217, which underwent racemization through carbene intermediate 218, thus 
generating racemic products (Scheme 46).73 
 
Scheme 46 Mechanism of lithiated azetidinium ion racemization 
The process was not expandable to five-membered pyrrolidinium 219, which instead 
underwent Sommelet–Hauser rearrangement to yield benzo-fused 
1,2,3,4,5,8-hexahydroazocine 222 as the only product (Scheme 47).73 The exclusive 
formation of 222 suggested that either; (i) formation of the boronate complex is much 





boronate complex is slow, so the boronate complex instead reverts to the starting boronic 
ester and stabilized carbanion. The origin of the slow migration can be attributed to the 
decreased ring strain in pyrrolidinium 219 when compared to azetidinium 209 (Scheme 
47). 
 






Chapter 1: Synthesis of Atorvastatin Derivative 
223 
Project aim 
It had been shown within our group that diborylmethane (225) can be used as linchpin 
reagent in the synthesis of 1,2- and 1,3-bis(boronic esters) through lithiation–borylation 
reactions with sparteine ligated or diamine free carbenoids, respectively (Scheme 49).74 
To further showcase this methodology we aimed to demonstrate a concise synthesis of 
compound 223, a derivative of the blockbuster statin, atorvastatin (247), by combining 
the reactivity of sparteine ligated and diamine-free carbenoids with diborylmethane 
(Scheme 48). Compound 223 could be transformed into atorvastatin (247) through 
deprotection of the silyl ether and subsequent oxidation of the primary alcohol. 
 
Scheme 48 Transformation of compound 223 into atorvastatin (247) 
 
Introduction 
Homologations of diborylmethane 
Diborylmethane (225) can act as a linchpin reagent in the synthesis of 1,2- and 
1,3-bis(boronic esters),74 where the product obtained is dependent on the nature of the 
carbenoid employed. In the case of (+) or (–)-sparteine ligated carbenoids, 
diborylmethane was homologated at one boronic ester to afford 1,2-bis(boronic esters). 
Formation of single boronate complex 224 was facile; however, the carbenoid was too 
hindered to generate a further boronate complex with the remaining boronic ester within 
the same molecule. Conversely, diamine-free carbenoids are unhindered and can 
homologate diborylmethane (225) twice to afford symmetrical 1,3-bis(boronic esters). In 
this instance, the carbenoid formed bis(boronate complex) 226—from reaction at both 






Scheme 49 Single and double homologation of diborylmethane (225) with lithiated benzoates 
The synthesis of a range of enantioenriched 1,2-bis(boronic esters) was achieved through 
homologation of diborylmethane (225) with primary benzoates. The reaction tolerated 
nitrogen functionality when protected as a pyrrole group, as exemplified by product 227, 
which was isolated in 63% yield and with 97:3 er. The scope of the reaction extended to 
a broad range of substrates, including several that are challenging to make using current 
transition metal catalysed diboration methods,91,92 for example, substrates containing 
alkynes or proximal stereogenic centres. Substrates containing terminal alkynes were 
tolerated when the alkyne was protected in situ as its conjugate base through addition of 
an additional equivalent of s-BuLi and (+)-sparteine, as shown by product 228. The 
reaction operated under reagent control, as exemplified by products 229 and 230, which 
were both isolated in good yields and with excellent diastereomeric ratios (Scheme 50). 
 
Scheme 50 Synthesis of 1,2-bis(boronic esters) through the reaction of diborylmethane (225) with primary benzoates 
The synthesis of primary–tertiary 1,2-bis(boronic esters) through the diboration of 
1,1-disubstituted alkenes does not proceed in useful yield or enantioselectivity;75 
however, homologation of diborylmethane (225) with lithiated secondary benzylic 
carbamates provided primary–tertiary 1,2-bis(boronic esters) 231–234 with complete 
control of enantioselectivity. The reaction was insensitive to the electronic nature of the 





aromatics were also tolerated, albeit with a reduced yield, but with no reduction in 
enantiomeric ratio (Scheme 51).  
 
Scheme 51 Synthesis of 1,2-bis(boronic esters) through the reaction of diborylmethane (225) with secondary benzylic 
carbamates 
The synthesis of symmetrical 1,3-bis(boronic esters) was achieved in one operation 
through the addition of diborylmethane (225) to an excess of diamine-free carbenoid, 
generated from the corresponding α-stannyl benzoate through stereospecific tin–lithium 
exchange using n-BuLi. Primary and secondary alkyl carbenoids participated in the 
reaction, as shown by products 235 and 236, which were both isolated in high yield and 
with excellent diastereomeric ratios. Carbenoids containing alkenes and silyl ethers were 
also well tolerated, yielding products 237 and 238 with high stereoselectivity (Scheme 
52). 
 
Scheme 52 Synthesis of symmetrical 1,3-bis(boronic esters) using diborylmethane (225) as linchpin reagent 
The synthesis of non-symmetrical 1,3-bis(boronic esters) was also achieved in a one-pot 
procedure from diborylmethane (255). Specifically, after formation of mono(boronate 
complex) 239 by reaction of 225 with 1 equiv of sparteine-ligated carbenoid, stannane 
240 was added to the reaction mixture. In situ formation of carbenoid 241 was achieved 
through addition of n-BuLi, which reacted with 239 to give bis(boronate complex) 242. 





non-symmetrical 1,2-bis(boronic esters) 243 to 246, each with perfect diastereocontrol 
(Scheme 53).  
 
Scheme 53 Synthesis of non-symmetrical 1,3-bis(boronic esters) using diborylmethane (225) as linchpin reagent 
Atorvastatin 
As a further display of the utility of this reaction, we aimed to synthesise a derivative of 
atorvastatin (247), which is marketed by Pfizer under the brand name Lipitor (Figure 1). 
Atorvastatin is one of the most commercially successful drug ever developed, earning 
Pfizer $12.7 billion in 2007 alone. Lipitor came off patent in 2011, allowing a host of 
generic versions to enter the market. 
 
Figure 1 Atorvastatin (247)  
Like all statins, atorvastatin is an inhibitor of HMG-CoA-reductase, which is the enzyme 
responsible for the reduction of HMG-CoA to mevalonic acid in the early stages of 
cholesterol biosynthesis (Figure 2). Lipitor is a competitive inhibitor of HMG-CoA but 
does not inhibit binding of the cofactor, NADPH. The protein exists as a tetramer with 
each of the neighbouring monomers contributing to the structure of the active site. The 
binding mode of a number of statins was elucidated in 2001 by Deisenhofer77 who solved 
the crystal structure of the catalytic portion of HMG-CoA-reductase bound to various 
statins (Figure 2). Atorvastatin shares common structural motifs with HMG-CoA and 
mevalonic acid and does indeed bind the enzyme in the same way. The terminal 
carboxylate forms an interaction with Lys735, while the hydroxyl groups bind to Ser684, 





site it can be assumed that not all the interactions are stabilizing. Atorvastatin therefore 
has additional interactions, through a hydrogen bond from its amide to Ser565, as well as 
Van Der Waals interactions with residues Leu562, Val683, Leu853, Ala856 and Leu857. The 
combination of these interactions leads to atorvastatin having an IC50 value of 8nM.77  
 
Figure 2 Binding mode of atorvastatin 
Industrial Synthesis of Atorvastatin 
The industrial synthesis of atorvastatin was achieved by the coupling of the fragments 
248 and 249 in a highly optimised Paal−Knorr reaction (Scheme 54a) using a catalytic 
amount of pivalic acid followed by deprotection of the acetonide and t-butyl ester.78 
Fragment 248 was made in two steps from diketone 250, initially by condensation with 
benzaldehyde to afford intermediate 251. An umpolung 1,4-addition of 
parafluorobenzaldehyde was then achieved through a Stetter reaction to yield the desired 





fragment 249 was achieved in from isoascorbic acid (253) in high yield and 
diastereoselectivity (Scheme 54c).79 A number of functional group interconversions led 
to advanced fragment 254. Syn-selective reduction of the ketone was performed according 
to a procedure described by Narasaka,80 followed by acetonide protection, which 
generated intermediate 255. Finally, the primary amine was revealed through high-
pressure hydrogenation of the nitrile to afford unprotected fragment 249.  
 
Scheme 54 The industrial synthesis of atorvastatin 
Choice of Target and Retrosynthetic Analysis 
We decided that synthesis of acetonide protected amine 256, which differs from fragment 
249 only by carboxylic acid protecting group, would constitute a fragment that could 
easily be transformed into atorvastatin (247). The synthesis of 256 would proceed through 
a one pot, bidirectional, desymmetrising lithiation−borylation reaction between 
diborylmethane (225) and carbenoids 257 and 258. (Scheme 55a). This one-pot process 
would be achieved by mono addition of (–)-sparteine-ligated carbenoid 259 to 
diborylmethane (225) to generate boronate complex 260. Formation of diamine-free 
carbenoid 261 in the presence of 260 would form the second boronate complex (262), 
which after 1,2-metallate rearrangement would afford the desired 1,3-diboronic ester 






Scheme 55 Retrosynthetic analysis of 256 
Results and Discussion 
Selecting the optimal leaving group 
Before attempting this transformation it was necessary to determine which leaving group 
would prove superior, and so both benzoate 268 and carbamate 267 of 
3-dibenzylaminopropanol (264) were prepared (Scheme 56a). Amine 264 was 
bis(protected) with benzyl bromide in reasonable yield to afford amine 265, which was 
converted into benzoate 266 under Mitsunobu conditions, and carbamate 267 by reaction 
with N,N-diisopropylcarbamoyl chloride. The lithiation of both benzoate 266 and 
carbamate 267 was then evaluated in a lithiation−deuteration study by deprotonation with 
s-BuLi in the presence of TMEDA followed by quenching with deuterated methanol 
(Scheme 56b). Gratifyingly, both benzoate 266 and carbamate 267 displayed full 
deuterium incorporation when quenched with CD3OD after a lithiation period of 3 h, as 
determined by 1H NMR analysis. With this positive result the diboration of carbenoid 
precursors 266 and 267 with diborylmethane (225) was attempted (Scheme 56c). 266 and 
267 were lithiated with s-BuLi and (+)-sp for a period of 3 h. Diborylmethane (225) was 
added and the resulting mixture stirred at −78 °C for 1 h. The benzoate was then stirred 
overnight at room temperature to permit 1,2-migration, whereas the carbamate was heated 
at 35 °C for the same period. Disappointingly, no product was obtained under these 
conditions for either the benzoate or the carbamate. As lithiation has been proven to occur, 
this result must either be due to inefficient boronate complex formation, the formation of 
a reversible boronate complex that decomposes upon warming to diborylmethane (225) 
and the respective carbenoid or slow 1,2-migration. 11B NMR analysis of the reaction 





occurring, which may be due to stabilisation of the carbenoid by coordination of the 
nitrogen atom lone pair to the lithium ion, thus reducing its nucleophilicity. 
 
Scheme 56 Evaluation of leaving group in the lithiation–borylation reaction of 266 and 267 with 225 
As a result, we sought an alternative protecting group where the nitrogen lone pair is not 
available for donation. On evaluation of our target, we decided that a pyrrole would be 
perfectly suited to this role as the nitrogen lone pair would be implicated in the aromaticity 
of the ring and would allow us to alter our target to compound 223, which includes the 
substituted pyrrole of atorvastatin (Scheme 57). 
 
Scheme 57 Retrosynthetic analysis of 223 
The presence of an acidic amide proton added a complication to our proposed key step; 
however, there is literature precedence for performing lithiation reactions in the presence 
of unprotected amides when using an excess of s-BuLi to protect the amide in situ as its 
conjugate base (Scheme 58). Beak has shown that benzylic lithiation can be achieved in 





When deprotonation occurs in the presence of (−)-sparteine the pro-(S) proton is removed 
selectively to afford an anion that can be intercepted by electrophiles. Although Beak 
reported good-to-high yields in all cases, the enantioselectivity was shown to vary 
substantially depending on the electrophile used. 
 
Scheme 58 Lithiation of a substrate containing an unprotected secondary amide 
Development of a Pyrrole Protecting Group 
Before investigating the reactivity of carbenoid 272, it was decided to test the previously 
problematic lithiation−borylation reaction using a pyrrole with no acidic protons. 
2,5-Dimethylpyrroles 278 and 279 were chosen for this role and were synthesised as 
shown in Scheme 59a from 3-aminopropanol (264). Formation of the pyrrole moiety was 
achieved through a Paal-Knorr reaction with acetonylacetone to generate alcohol 277, 
which was transformed into benzoate 278 and carbamate 279 in high yields using 
procedures previously described for the synthesis of 266 and 267. The lithiation of 
pyrroles 278 and 279 were evaluated in a lithiation−deuteration study (Scheme 59b). 
Pleasingly, full deuterium incorporation was observed for both benzoate 278 and 
carbamate 279 after a lithiation period of 3 h, as determined by 1H NMR analysis. 
 





The diboration of carbenoid precursors 278 and 279 was then attempted (Scheme 60). 
Gratifyingly, 11B NMR analysis showed that boronate complex formation occurred for 
both benzoate 278 and carbamate 279. In the case of carbamate 279, migration was 
afforded by heating the reaction mixture overnight at 35 °C; whereas the reaction mixture 
was stirred overnight at ambient temperature for the benzoate. Crude GCMS analysis 
suggested the exclusive formation of the desired product (227) in the benzoate reaction, 
which was isolated in 63% yield and with 97:3 er (Scheme 60a). However, in the 
carbamate reaction 227 was contaminated with another species with a mass that 
corresponded with compound 282. Formation of 282 could plausibly occur through 
decomposition of boronate complex 283 to generate stabilised α-boryl anion 284. Given 
this result, benzoate 278 was taken forward for further studies. 
 
Scheme 60 Lithiation–borylation of benzoate 278 and carbamate 279 with diborylmethane, with proposed 
degradation pathway for the carbamate 
Key Step 
With the benzoate established as the optimum leaving group, the key coupling between 
pyrrole 278, diborylmethane (225) and α-stannyl benzoate 288 was then investigated. The 
synthesis of α-stannyl benzoate 288 was achieved in three steps from 1,3-propane diol 
(285). Deprotonation of 285 with one equivalent of sodium hydride and quenching with 
TBSCl afforded monoprotected alcohol 286 in quantitative yield. Conversion into 
benzoate 287 was achieved under Mitsunobu conditions in high yield. Finally, stannane 





(+)-sparteine followed by trapping of the organolithium with Me3SnCl with retention of 
stereochemistry (Scheme 61). 
 
Scheme 61 Synthesis of stannane 288 
Practically, the coupling of fragments 278, 225 and 288 is challenging because the 
corresponding carbenoids must be formed separately and then combined at −78 °C to 
prevent decomposition that is observed above −40 °C. Owing to this constraint it would 
be difficult to add carbenoid 273 via a syringe or cannula, and so our group’s own custom 
glassware was used for this purpose (Scheme 62b). The lithiation of pyrrole 278 required 
the use of precious (–)-sparteine to obtain the correct diastereomer of atorvastatin 
derivative 223; however, to not waste (–)-sparteine anti-diastereomer 291 was selected as 
the model compound for this coupling. Lithiation of benzoate 278 and formation of 
boronate complex 289 was achieved in the A side of the vessel at –78 °C. Concurrently, 
in the B side, tin−lithium exchange of stannane 288 afforded carbenoid 290. Following 
the requisite time, 290 was tipped into the compartment containing the first boronate 
complex 289 while still at −78 °C. After a further hour at −78 °C, the reaction mixture 
was heated at 35 °C for 16 h. Gratifyingly, on the first attempt, the product (291) was 
isolated in 24% yield (Scheme 62a). 
 





Because the formation of compound 227 proceeds in good yield (64%) the logical place 
to aim our efforts at optimisation was the formation of the second boronate complex. 
Upon formation of boronate complex 289, the (+)-sparteine that was coordinated to the 
carbenoid derived from benzoate 278 becomes free within the reaction mixture. If 
formation of the second boronate complex is indeed slow, this adventitious (+)-sparteine 
may coordinate to carbenoid 290, reducing its nucleophilicity. By performing the 
tin−lithium exchange in THF (a better coordinator than Et2O but similar to (+)-sparteine), 
the putative coordination of (+)-sparteine to carbenoid 290 may be retarded and thus 
allow for a greater amount of boronate complex formation (Scheme 63). Unfortunately, 
under these conditions no product was observed. After purification, 1,2-bis(boronic ester) 
227 and rearranged carbenoid 292 were obtained. Formation of 1,2-bis(boronic ester) 227 
suggests that formation of the initial ate complex occurred as expected. The presence of 
rearranged carbenoid 292 suggests that THF is a competent solvent for tin−lithium 
exchange; however, the carbenoid furnished is not sufficiently nucleophilic to form a 
boronate complex or the boronate complex formed is reversible in THF. As a result, the 
carbenoid decomposed, forming α-hydroxy ketone 292, upon warming to room 
temperature. Because compound 291 was obtained when using Et2O as solvent, albeit in 
low yield, it was decided to move on to optimising the reaction to obtain target 223. 
 
 
Scheme 63 Reaction of diborylmethane with carbenoid precusors 278 and 288 using THF as solvent for the tin–
lithium exchange 
Application of model studies to the real system 
Synthesis of benzoate 294 was achieved in two steps from 3-aminopropanol and 
commercially available diketone 248. Emulation of the highly specific Paal−Knorr 
reaction described by Roth,74,75 yielded advanced pyrrole 293, which was subjected to a 







Scheme 64 Synthesis of benzoate 294 
We then evaluated the lithiation of benzoate 294 through lithiation−deuteration studies 
(Table 1). Beak has shown that asymmetric benzylic lithiation in the presence of 
unprotected secondary amides is possible when using an excess of s-BuLi and sparteine.81 
We sought to utilise this approach to protect the secondary amide of 115 in situ as its 
conjugate base. Benzoate 294 proved to be completely insoluble in ethereal solvents at 
the usual concentration for the lithiation of primary benzoates (0.33 M); however, this 
problem was overcome by performing the reaction at 0.1 M. Treatment of 294 with 
2.0 equiv of s-BuLi and (+)-sparteine for 3 h at −78 C resulted in 55% deuterium 
incorporation after quenching with CD3OD, as determined by 1H NMR analysis (Table 
1, entry 1). Increasing the lithiation time to 5 h had a positive influence and resulted in 
60% deuterium incorporation (Table 1, entry 2). It has been shown that the level of 
lithiation can be improved by utilizing CPME or TBME as solvent;43,53,82 however, in this 
case these solvents had no effect, with deuterium incorporation remaining at 60% (Table 
1, entries 3 and 4). Increasing the number of equivalents of s-BuLi and (+)-sparteine to 
2.5 resulted in 74% deuteration (Table 1, entry 5), whereas 85% deuterium incorporation 
was achieved when using 3.0 equivalents of s-BuLi and (+)-sparteine (Table 1, entry 6). 
Although it stands to reason that higher levels of deuterium incorporation could be 
achieved by further increasing the equivalents of s-BuLi and (+)-sparteine, the excess 
s-BuLi would presumably be able to attack the free boronic ester in the boronate complex 
derived from the addition of diborylmethane to lithiated 294. We therefore decided to 







Table 1 Lithiation deuteration studies of benzoate 294 
We next investigated the homologation of diborylmethane 225 with benzoate 294 (Table 
2). 294 was treated with 2.0 equiv of s-BuLi and (+)-sparteine for a lithiation period of 5 
h. A solution of 225 in Et2O was then added and stirred for a borylation period of 1 h. 
Following this borylation period, the reaction mixture was warmed to ambient 
temperature and stirred overnight. The desired product 296 was obtained in 12% yield 
and 18% of the starting material 294 was recovered; however, the rest of the mass balance 
could not be accounted for (Table 2, entry 1). Increasing the equivalents of s-BuLi, 
(+)-sparteine and diborylmethane had a negative influence on the reaction, resulting in 
just 4% yield of 296 (Table 2, entry 2). A slight increase in yield (13%) could be obtained 
by heating the reaction to reflux overnight (Table 2, entry 3); however, this result is no 
better than the original conditions described in entry 1. Finally, increasing the borylation 
period from 1 to 2 h also gave no increase in yield (Table 2, entry 4). We did not expect 
quantitative yield of 1,2-bis(boronic ester) 296 as the lithiation–deuteration studies in 
Table 1 showed that the maximum level of lithiation that could be achieved when using 
2.5 equiv of s-BuLi and (+)-sparteine was 74%; however, the observed yields of 296 were 
not acceptable. The combination of the poor yields of 296 and the failure to be able to 
account for the mass balance of the reaction suggested that decomposition of a species on 
the reaction pathway was occurring. As there was no clear way to improve this reaction, 
we opted to construct 296 using another methodology that was being developed in the 
group, that merges asymmetric diboration reactions with lithiation–borylation to generate 






Table 2 Homologation of benzoate 294 with diborylmethane 
Synthesis of 1,3-diols through a diboration/lithiation–borylation sequence 
Aggarwal has shown that the reaction of a 1,2-bis(boronic ester)—derived in 
enantioenriched form through Morken’s asymmetric diboration reaction75,76 of a terminal 
alkene—with a (+) or (–)-sparteine coordinated lithiated benzoate or carbamate resulted 
in a regioselective reaction at the less hindered primary boronic ester to form a single 
boronate complex at –78 ºC.83 While the selectivity of this transformation may seem 
unremarkable—the less hindered primary boronic ester reacts over the more hindered 
secondary boronic ester—the choice of carbenoid was crucial for the success of the 
reaction. Employing an unhindered TMEDA ligated- or diamine free-carbenoid resulted 
in the non-selective formation of a mixture of both boronate complexes resulting from 
reaction at the primary boronic ester and from reaction at both boronic esters (Scheme 
65). Since the enantiomer of 1,2-bis(boronic ester) can be controlled by selection of the 
appropriate enantiomer of phosphonite ligand 297 and the enantiomer of lithiated 
carbenoid can be controlled by selection of the appropriate enantiomer of sparteine, it was 
possible to synthesize all four stereoisomers of diol 298 with good yield and uniformly 
high diastereo- and enantioselectivities, which demonstrated that the process operated 
under complete reagent control. Under the standard conditions, primary carbamates and 
benzoates could be utilized to obtain 1,3-diols, such as 299, in good yield and with perfect 
stereoselectivity. Significantly, employing a secondary benzylic or allylic carbamate, or 
a secondary dialkyl benzoate, permitted the formation of molecules containing adjacent 
secondary–tertiary 1,3-diols, 300 to 303. A method for the formation of any 
diastereomeric permutation of secondary–tertiary 1,3-diols with complete stereocontrol 






Scheme 65 Synthesis of 1,3-diols through a diboration/lithiation–borylation sequence 
Pyrrole 304 was synthesized through a Paal–Knorr reaction between allyl amine and 
commercially available 1,4-diketone 248 in 45% yield. Diboration of the terminal alkene 
of 304 under Morken’s conditions generated the required bis(boronic ester) (ent-296) in 
62% yield; however, despite multiple attempts we were unable to determine the 
enantiomeric excess of ent-296 as we could not identify conditions that permitted 
separation of the enantiomers by chiral HPLC or SFC analysis. Subjecting ent-296 to the 
final homologation furnished diol 223 as a single diastereomer after oxidation with basic 
peroxide and completed our synthesis of an atorvastatin derivative. The high dr of 223 
shows that the er of 1,2-bis(boronic ester) ent-296 must have been >95:5 as it is known 
that the homologation of a 1,2-bis(boronic ester) with a lithiated benzoate occurs with 
complete enantiospecificity of the bis(boronic ester) and operates under complete reagent 
control. If the er of ent-296 were any lower this would therefore be faithfully reproduced 






Scheme 66 Synthesis of atorvastatin derivative 223 
Conclusion 
The synthesis of atorvastatin derivative 223 has been achieved in three steps by 
combining Morken’s asymmetric diboration reaction with lithiation–borylation. This 
procedure operated under complete reagent-control during the lithiation–borylation phase 
and provided the target molecule with excellent levels of stereoselectivity. It was not 
possible to synthesise 223 using diborylmethane as linchpin reagent because benzoate 
294 was resistant to both lithiation and borylation. While trying to optimize this approach 
it was shown that 2,5-dimethylpyrrole can be used as a primary amine protecting group 
that is compatible with lithiation–borylation reactions, thus expanding the scope of this 






Chapter 2: Studies Towards the Total Synthesis of 
Bahamaolide A 
Project aim 
It has been shown in our group that stereodefined poly(boronic esters) can be accessed in 
an iterative manner by combining asymmetric diboration reactions and 
lithiation–borylation reactions, which employ a chiral carbenoid that contains a homoallyl 
group. Specifically, reaction of an enantioenriched 1,2-bis(boronic ester)—which is 
derived from a terminal alkene through Morken’s asymmetric diboration reaction—with 
homoallylic sulfoxide 305 generates a 1,3-bis(boronic ester), such as 306, with a pendent 
alkene that is primed to undergo a further asymmetric diboration reaction. We aimed to 
utilise this process to achieve the first total synthesis of the oxopolyene macrolide 
bahamaolide A (Scheme 67).2,3 
 
Scheme 67 Iterative synthesis of 1,3-poly(boronic esters) and bahamaolide A 
Introduction to the oxopolyene macrolides 
The oxopolyene macrolides are a subset of the polyene macrolide family of compounds, 
which contains over 200 members.90 The first polyene macrolide to have its absolute 
configuration deduced was amphotericin B. In 1970, Schaffner showed that the polyol 
array of amphotericin B had an all-syn configuration through crystallisation of the 
N-iodoacetyl derivative 30791 (Figure 3). By analogy, it was incorrectly assumed that 
other polyene macrolides also contained all-syn polyols,92 which led to the publication of 






Figure 3 N-iodoacetyl amphotericin B used by Schaffner to determine the absolute configuration of amphotericin B 
One such method was proposed by Lipshutz, who showed an iterative procedure whereby 
a chiral epoxide was opened by a high order vinyl cuprate to form a homoallylic alcohol, 
which was subsequently epoxidised.93 Addition of high order cuprate 309 to 
enantioenriched epoxide 308 resulted in the formation of homoallylic alcohol 310 in high 
yield. Conversion of 310 to epoxide 312 was achieved through a Cardillo epoxidation;94 
specifically, carbonate formation followed by substrate directed attack of the alkene, after 
activation with iodine, to afford intermediate 311. Treatment of 311 with base resulted in 
cleavage of the carbonate and subsequent ring closing yielded epoxide 312, which is 
primed for re-entry into the iterative cycle. Homoallylic alcohol 316 was obtained 
following a further iteration with this methodology (Scheme 68). 
 
Scheme 68 Lipshutz's literative synthesis of enantiopure syn-1,3 polyols 
Lipshutz sought to showcase this methodology in the synthesis of all-syn roflamycoin.95 
Retrosynthetic analysis revealed polyol containing fragments 318 and 320, which were 
to be coupled together using dithiane 319 as a one-carbon linchpin. Fragments 317 and 
321 were also to be installed through alkylation chemistry with the corresponding 
dithianes (Scheme 69a). Synthesis of dithiane 317 was achieved in seven steps from 





which was subjected to Sharpless epoxidation conditions to yield epoxide 325 in high 
yield and as a single enantiomer. Opening of the epoxide with dithiane 319 furnished diol 
326, which was converted to 317 through elimination of the primary alcohol (Scheme 
69b). Polyol 328 is a common intermediate in the synthesis of fragments 330 and 332, 
and was constructed using the iterative strategy shown in Scheme 68. 330 was achieved 
in a further four steps from 328 through protection of the 1,3-diol, reductive removal of 
the benzyl ether, activation of the hydroxyl group and a Finkelstein reaction. 332 was 
achieved through Sharpless epoxidation of the homoallyl group and subsequent ring 
opening with dithiane 319 (Scheme 69c). The final fragment was made by opening 
epoxide 333 with high order cuprate 334 to afford elaborated homoallylic alcohol 335, 
which could be used as a functional handle to install the polyene moiety. 336 was then 
achieved through protection of the 1,3-diol as the acetonide (Scheme 69d). Despite 
successfully synthesising fragments 317, 330, 332 and 336, Lipshutz did not publish the 







Scheme 69 Lipshutz’s synthesis of fragments 317, 318, 320 and 321 en route to all-syn roflamycoin 
The correct configurations of mycoticin, roxaticin and roflamycoin were later deduced by 
Schreiber7,8 Maehr98 and Rychnovsky,99 respectively.  
Schreiber’s synthesis of (+)-mycoticin 
The first oxopolyene macrolide to succumb to total synthesis was mycoticin, which was 
achieved by Schreiber.100 Schreiber’s retrosynthetic analysis revealed fragment 339 as the 
key component, which contained the stereodefined hydroxyl array. The unsaturation at 
C-29 would be installed through a Julia olefination reaction with sulfone 337 and the 
polyene region would be installed through a HWE reaction with polyene containing 





containing fragment 339 could be obtained from Weinreb amide 340, which contains a 
protected C2-symmetric polyol array, and vinyl bromide 341. Weinreb amide 340 could 
be achieved in enantioenriched form through a bi-directional chain extension strategy 
from diketone 342 (Scheme 70). 
 
Scheme 70 Schreiber's retrosynthetic analysis of mycoticin A 
Diketone 342 was achieved from sulfone 343 through acylation with mixed anhydride 
344 followed by reductive desulfuration with zinc. Asymmetric ketone reduction using 
Noyori’s method and protection as the methyl ketal afforded protected diol 347 as a single 
stereoisomer. Conversion of the meta-methoxylphenyl groups to β-ketoesters was 
achieved through a dissolving metal reduction of the aromatic groups and subsequent 
ozonolysis in 60% yield. Reduction of the β-ketoesters using Noyori’s method and 
acetonide protection afforded diester 349, which was reduced to the dialdehyde without 
isolation and subsequently vinylated and protected to yield hexaol 350 in 30% yield over 






Scheme 71 Schreiber's synthesis of compound 350 
Hexaol 350 was converted to Weinreb amide 340 in 6 steps. Ozonolysis of 350 afforded 
dialdehyde 351. The two final stereocentres of 240 were set by base catalysed 
epimerisation of 351 that favoured the C2 symmetric adduct 352. Reduction of both 
aldehydes with NaBH4 preceded a desymmetrising mono-protection of one terminal 
alcohol, which proceeded in statistical yield. Oxidation of the remaining hydroxyl group 
using Ley’s conditions and amide formation yielded Weinreb amide 340. Acylation of 
the vinyl anion derived from fragment 341, Luche reduction, ozonolysis and mesylation 
resulted in compound 353 in 86% yield. Simultaneous removal of the mesylate and PMB 
ether, and reduction of the ketone with >15:1 syn:anti selectivity with lithium in buffered 
ammonia resulted in a 1,3-diol that was protected as the acetonide to yield 354 in 58% 
yield over two steps. Deprotection of both silyl ethers, reprotection of the less hindered 
primary hydroxyl group and oxidation of the remaining alcohol furnished aldehyde 355 
in 39% yield over three steps. Installation of fragment 337 was achieved through a Julia 
olefination reaction, which installed the C-29 unsaturation, to give 356 in 30% yield over 
three steps. 356 was converted to 357 through a series of oxidation level changes and 





338, saponified and subjected to macrolactonisation conditions described by Yamaguchi 
to afford acetonide protected mycoticin A, 358, in 20% yield over four steps. Global 
deprotection of the acetonides with dowex resin afforded (+)-mycoticin in a total of 35 
steps as the longest linear sequence (Scheme 72). 
 





Leighton’s formal synthesis of (+)-mycoticin A 
Leighton achieved a formal synthesis of (+)-mycoticin A by synthesising the Schreiber 
intermediate 356 using a diastereoselective aldol reaction to join fragments 359 and 360 
(Scheme 73).101 
 
Scheme 73 Leighton's retrosynthetic analysis of the Schrieber intermediate, 356 
Fragment 359 was synthesised from known alcohol 361102 in eight steps. Cross metathesis 
of 361 with diethoxyacrolein followed by protection of the alcohol as the PMB ether gave 
alkene 362 with > 20:1 E:Z selectivity. Hydrolysis of the acetal with PPTS in acetone 
furnished aldehyde 363, which was subjected to Brown’s asymmetric allylation 
conditions to yield homoallylic alcohol 364 in 71% yield over four steps and with 10:1 dr. 
Substrate directed Leighton oxymercuration yielded syn-acetonide 365 with no erosion 
of diastereomeric ratio. Rhodium catalysed formylation of 365 proceeded through 
oxidative addition of rhodium into the carbon–mercury bond, insertion of CO and 
reductive elimination to generate aldehyde 366. Conversion of the aldehyde to the methyl 
ketone was achieved through addition of a Grignard and subsequent oxidation to yield 







Scheme 74 Synthesis of fragment 359 
Aldehyde 360 was synthesised from known aldehyde 366103 in seven steps. Asymmetric 
crotylation of 366 using Brown’s protocol yielded homoallylic alcohol 367, which was 
converted to diallylsilylane 368. Rhodium catalysed silylformylation and subsequent 
oxidation of the silyl group afforded tetraol 369 in 55% over four steps and with >10:1 dr. 
The silylformylation proceeded through oxidative addition of rhodium into the Si–H 
bond, insertion to the alkene, formylation and reductive elimination of a hydride to 
generate 372, which underwent a spontaneous syn-allylsilylation reaction to generate 
homoallylic alcohol 373.104 Stereospecific Tamao oxidation then yielded the desired 
tetraol. Installation of an acetonide furnished homoallylic alcohol 370, which underwent 
a syn-Leighton oxymercuration reaction and subsequent formylation to yield fragment 







Scheme 75 Synthesis of aldehyde 360 
Synthesis of the Schreiber intermediate was completed by coupling fragments 356 and 
360 with a Mukaiyama aldol reaction, which is known to furnish the 1,3-anti products 
when using methyl ketones and β-alkoxy aldehydes.15,16 In the event, treatment of 359 
and 360 with TMSOTf, Hünig’s base and BF3∙OEt2 yielded aldol product 374 as an 
inseparable mixture of diastereomers. Anti-selective reduction of the ketone using 
tetramethylammonium triacetoxyborohydride afforded compound 375, also as an 
inseparable mixture of diastereoisomers. Installation of an acetonide and deprotection of 
the terminal silyl ether completed the synthesis and yielded the Schreiber intermediate 






Scheme 76 Completion of the synthesis of the Schreiber intermediate 356  
Evans’ synthesis of (+)-roxaticin 
Evans’ retrosynthetic analysis of (+)-roxaticin107 revealed advanced polyol containing 
fragment 377, which underwent HWE reaction and macrolactonisation with polyene 
containing phosphonate 376 to arrive at the natural product. Further disconnection of 377 
led to compounds 378, 379 and 380, which were coupled together using a Julia olefination 
and a diastereoselective 1,3-anti aldol reaction (Scheme 77). 
 





Fragment 380 was synthesised from propionyl oxazolidinone 381 in 11 steps. An 
alkylation reaction between 381 and ((chloromethoxy)methyl)benzene afforded 
oxazolidinone 383 in quantitative yield and > 200:1 dr. Reductive removal of the chiral 
auxiliary and Parikh-Doering oxidation yielded aldehyde 383, which was subjected to an 
allylation reaction using tributylallyl stannane to afford homoallylic alcohol 384 in 
35:1 dr. Protection of the hydroxyl group, oxidation of the alkene and subsequent Wittig 
reaction generated homoallylic alcohol 386 in 86% yield. Addition of benzaldehyde 
resulted in the formation of alkoxy intermediate 387, which underwent substrate directed 
conjugate addition to afford protected 1,3-diol 388 with >95:5 dr. Installation of a 
cyclopentyl ketal protecting group and methylation of the Weinreb amide furnished 
fragment 380 as a single diastereoisomer (Scheme 78). Cyclopentyl ketals were superior 
to the corresponding acetonides in this case as acetonide deprotection was low yielding. 
 





The synthesis of sulfone 378 began with an Evans auxiliary directed aldol reaction with 
isobutraldehyde to furnish alcohol 392 with > 200:1 dr. 378 was generated as a single 
diastereomer through a further sequence of reductive removal of the oxazolidinone group, 
selective PMB protection of the secondary alcohol, sulfuration and oxidation to the 
sulfone (Scheme 79). 
 
Scheme 79 Synthesis of sulfone 378 
The synthesis of fragment 379 was achieved in six steps from aldehyde 395. An Aldol 
reaction between 395 and Chan’s diene analogue 396 occurred under the chiral influence 
of the copper-pybox complex 397 to afford β-ketoester 398 in > 99% ee after demasking 
of the silyl ethers with PPTS. Selective syn reduction of 398 occurred upon treatment 
with Et2BOMe and NaBH4 to afford the syn-diol, which was bis-protected with TSBCl 
to give 399. Reductive removal of the benzyl ether and oxidation of the alcohol with 
Dess-Martin periodinane afforded aldehyde 379 in almost quantitative yield (Scheme 80). 
 
Scheme 80 Synthesis of aldehyde 397 
The coupling of fragments 378 and 379 was achieved using a Julia olefination to afford 





cyclopentyl ketal was required for high selectivity in the 1,3-anti aldol reaction between 
aldehyde 402 and silyl enol ether 400 as β-siloxyaldehydes give poor diastereofacial 
control.106 In the event, the 1,3-anti aldol reaction proceeded to yield ketal 403 as an 
inseparable mixture of diastereomers after protection as the silyl ether. Reduction of 403 
with DiBAlH yielded aldehyde 404, which was subjected to a 1,5-anti boron aldol 
reaction with 380 to generate aldol adduct 405. Kinetic resolution of the diastereoisomers 
of 405 occurred during the reaction to yield the desired adduct as a single diastereomer. 
Anti-selective reduction of the ketone, installation of the cyclopentyl ketal, reductive 
removal of the benzyl ether, oxidation to the aldehyde and oxidative removal of the PMB 
group furnished aldehyde 406. HWE reaction with polyene containing phosphonate 376 
afforded open chain compound 407, which was saponified, subjected to Yamaguchi 
macrolactonisation conditions and globally deprotected to afford (+)-roxaticin with 35 
steps in the longest linear sequence and with 55 total steps and an overall yield of 0.18%. 
To prevent decomposition during the macrolactonisation reaction, the mixed anhydride 
had to be isolated prior to the addition of DMAP and NEt3. Utilizing cyclopenylketals 
resulted in superior yields upon deprotection than the corresponding acetonides, which 






Scheme 81 Completion of (+)-roxaticin 
 
Paterson’s synthesis of the polyol region of (+)-roxaticin 
Paterson reported the convergent synthesis of fragment 408, which represents the polyol 
region of (+)-roxaticin.108 Retrosynthetic analysis of 408 revealed aldehyde 409 and 
ketone 410, which were merged using a diastereoselective 1,5-anti boron aldol 
reaction.109,110 409 and 410 were also made using diastereoslective aldol reactions; 
specifically, a 1,5-anti boron aldol reaction between aldehyde 411 and ketone 412 was 
used to generate 409, whereas a 1,3-syn aldol reaction between acetone and aldehyde 413 






Scheme 82 Paterson's retrosynthetic analysis of the polyol region of (+)-roxaticin (408) 
The 1,5-anti boron aldol reaction between 411 and 412 and subsequent diastereoselective 
reduction of the carbonyl proceeded in high yield and diastereospecificity. Acetonide 
protection, selective cleavage of the primary silyl ether and Swern oxidation yielded 
aldehyde 409. 1,3-syn aldol reaction between acetone and aldehyde 413 generated 410 
after PMB protection of the secondary alcohol. The key 1,5-anti boron aldol reaction 
between aldehyde 409 and 410 and subsequent hydroxyl directed anti reduction of the 
carbonyl using Me4NBH(OAc)3 generated the desired 1,3-polyol, which was acetonide 
protected to afford the target compound 408 in 35% overall yield (Scheme 83). 
 
Scheme 83 Paterson's synthesis of compound 408 
Rychnovsky’s synthesis of (–)-roxaticin 
Rychnovsky achieved the total synthesis of the unnatural enantiomer (–)-roxaticin,111 





Rychnovsky suggested a convergent strategy to synthesise the polyol motif through the 
alkylation of cyanohydrin acetonide moieties 417 and 419 with C2 symmetric 
dibromoacetonide 418. The polyene was installed through a series of alkylation reactions 
using vinyl Grignard fragments, such as 415, and the macrocycle was formed through a 
ring closing HWE reaction (Scheme 84). 
 
Scheme 84 Rychnovsky's retrosynthetic analysis of (–)-roxaticin 
Desymmetrisation of dibromoacetonide 418 with the anion from cyanohydrin acetonide 
419 afforded tris(acetonide) compound 420. This reaction occurred with high selectivity 
to generate the syn-acetonide,112 as the nitrile was put in the axial position due to its low 
A-value following deprotonation. To avoid over-homologation of bis(functionalised) 
linchpin 418, a 2.0 equiv excess was used. A second alkylation utilising cyanohydrin 417 
generated intermediate 421 in 91% yield, which underwent reductive decyanation with 
LiDBB to afford polyol containing fragment 422 in 63% yield. Oxidative opening of the 
terminal acetonide, TES protection of the primary alcohol and protection of the secondary 
alcohol as the 1,3-benzodithiolan-2-yl ether (BDT) furnished polyol intermediate 423. 
The BDT ether was the optimal protecting group as it was not possible to cleave other 
groups, such as PMB or an enol ether, without destruction of the polyene. Esterification 
of 423 was achieved through removal of the silyl ethers and treatment with 424, BOP and 
DMAP. The primary alcohol was oxidised to the aldehyde and the polyene installed using 
a modification of Wollenburg’s protocol, which afforded conjugated aldehyde 426 after 
two cycles of Grignard addition. The synthesis was completed with an overall yield of 
5x10–4% following a ring closing HWE reaction using Roush–Masamune conditions and 






Scheme 85 Completion of (–)-roxaticin 
Rychnovsky was able to expand this methodology to the synthesis of dermostatin A, 
roflamycoin, 17-deoxyroflamycoin and filipin III by altering the acetonide protected 






Scheme 86 Rychnovsky's retrosynthetic analysis of dermostatin A, roflamycoin, 17-deoxyroflamycoin and filipin III 
Krische’s synthesis of (+)-roxaticin 
Krische reported the synthesis of (+)-roxaticin, which uses a C–C bond forming transfer 
hydrogenation reaction as the key step113 and represents the current state of the art of 
oxopolyene macrolide syntheses. Notably, the synthesis of the polyol region proceeded 
with excellent levels of enantio- and diastereoselectivity without the use of chiral 
auxiliaries. Retrosynthetic disconnections revealed polyol 430 as the key fragment, which 
was accessed from C2 symmetric polyol 431, which in turn was made from 
1,3-propanediol (285) through a series of iterative, bi-directional allylation reactions 
directly from the alcohol oxidation level. Installation of the western hemisphere of the 
molecule and the unsaturation at C-28 was achieved through a cross metathesis reaction 
with alkene 427, while the polyene region was incorporated through cross metathesis with 






Scheme 87 Krische's retrosynthetic analysis of (+)-roxaticin 
The synthesis started with double allylation of 1,3-propanediol (285), which proceeded 
using ortho-cyclometallated iridium C,O-benzoate, which was generated in situ from 
[Ir(cod)Cl]2, (R)-Cl-3-NO2BzOH and allyl acetate, to generate diol 432 with > 99% ee 
and 30:1 dr. The mechanism of this reaction involves initial oxidation of the reactant 
alcohol to an aldehyde followed by stereoselective allylation of said aldehyde. 
Remarkably, the ortho-cyclometallated iridium C,O-benzoate catalyses both the 
oxidation and allylation phases of the reaction, and does so with near perfect enantio- and 
diastereoinduction. Protection of diol 432 as an acetonide and ozonolysis with a reductive 
workup of the resulting aldehyde yielded tetraol 433 in 86%. The iterative cycle of double 
allylation, protection, oxidation and reduction was then repeated a further two times to 
yield C2 symmetric octaol 431 with exquisite levels of enatio- and diastereoselectivity. 
Desymmetrisation of 431 using a Greico primary alcohol dehydration reaction furnished 
intermediate 434, which was primed to undergo cross metathesis with alkene 427 to yield 
435 in 53% yield with complete (E)-selectivity. Asymmetric crotylation of 435 directly 
from the alcohol oxidation level gave advanced fragment 436 in high yield and 14:1 dr, 
which underwent subsequent cross metathesis with acrolein, silyl ether protection and 
PMB deprotection to yield aldehyde 437. Protection of the C-14 hydroxyl group was vital 
to permit macrolactonisation; however, cross-metathesis with acrolein did not occur when 
the alcohol was protected as the silyl ether, presumably due to steric demand. This 
limitation was easily overcome by performing the cross-metathesis reaction prior to the 





polyene fragment 428, saponification of the ester, Yamaguchi macrolactonisation and 
global deprotection to give (+)-roxaticin with an overall yield of 0.74% (Scheme 88). 
 





Critical appraisal of the presented literature methods to make oxopolyene macrolides 
Commonly, the strategies employed in the synthesis of the 1,3-polyol motif are variations 
of two approaches; specifically, an asymmetric allylation–oxidation approach (Scheme 
89a) or an acetate aldol–diastereoselective ketone reduction strategy (Scheme 89b). The 
first strategy consists of asymmetric allylation of an aldehyde to give an enantioenriched 
homoallylic alcohol, which is subsequently oxidised at the alkene to generate a new 
aldehyde that is ready to engage in a further allylation reaction. The second strategy 
involves performing a diastereoselective aldol reaction using a methyl ketone enolate to 
afford a β-hydroxy ketone, which is subsequently reduced to afford a 1,3-syn or 1,3-anti 
diol by using either a boron based Lewis acid and sodium borohydride or 
NMe4BH(OMe)2, respectively. 
 
Scheme 89 Common approaches in the synthesis of 1,3-polyols 
Leighton presented two variations of the asymmetric allylation–oxidation approach in his 
formal synthesis of (+)-mycoticin. In the first variation, the oxidation phase was 
conducted using a substrate directed oxymercuration reaction followed by a rhodium 
catalysed formylation of the resulting Hg–C bond, which generated a diastereomerically 
pure syn 3,5-dihydroxy aldehyde in two steps from the homoallylic alcohol. (Scheme 
90a). This process represented a rapid method to generate β-formyl syn 1,3-polyols from 
homoallylic alcohols in high dr, although the use of mercury limits the attractiveness of 
this methodology. In the second variation, a substrate directed tandem silylformylation–
allylation sequence of a homoallylic alcohol, which afforded direct access to a 
homoallylic syn 1,3,5-triol after oxidation of the silyl group (Scheme 90b). The main 
disadvantage of both strategies was that they operated under substrate control and thus 
only syn 1,3-polyols could be accessed. Moreover, in the allylation phase Leighton 
utilised Brown’s asymmetric allylboration reaction, which is known to be sensitive to 
stereocentres already present within the molecule and generates isopinocampheol as a 







Scheme 90 Leighton's allylation–oxidation sequence 
A more attractive process would operate entirely under reagent control so that either 
enantiomer/diastereomer of the product could be obtained from the same starting material 
simply by selecting the appropriate enantiomer of chiral reagent. Krische reported the 
synthesis of (+)-roxaticin using an iridium catalysed allylation reaction which fulfilled 
this criteria and represents the current state of the art of oxopolyene macrolide synthesis 
(Scheme 91). The power of Krische’s methodology was that either enantiomer of the 
homoallylic alcohol product could be accessed directly from the corresponding primary 
alcohol without having to oxidise to the aldehyde prior to functionalisation, thus saving a 
non-skeletal bond forming manipulation. This was possible because the iridium catalyst 
was bifunctional; specifically, the catalyst facilitated the in situ oxidation of the alcohol 
to an aldehyde and also catalysed the asymmetric allylation reaction. Nevertheless, 
oxidation of the alkene moiety of the homoallylic product was still required to obtain a 
new primary alcohol for re-entry into the iterative cycle. Using this iterative procedure, 
Krische was able to synthesise C2 symmetric polyol 431 in a bidirectional manner in just 
three iterative cycles without the use of premetallated nucleophiles with very high 
enantio- and diastereocontrol and went on to complete the synthesis of (+)-roxaticin in 
significantly fewer steps than previously described. 
 
Scheme 91 Krische's allylation–oxidation sequence 
Using aldol chemistry to construct the 1,3-polyol motif is challenging because Evans’ 
oxazolidinone auxiliary does not facilitate the aldol reaction between aldehydes and 
methyl enolates with high levels of diastereocontrol, which is postulated to be due to loss 





controlled diasteroselective aldol reactions have been developed that can achieve this 
transformation, for example the 1,3-anti and 1,5-anti boron aldol reactions. In the 1,3-anti 
aldol reaction a methyl silyl enol ether reacts with a chiral β-hydroxy aldehyde to give 
1,3-anti products (Scheme 92). Evans proposed that the reaction proceeded through an 
open transition state under Felkin–Anh control, where the carbonyl and hydroxyl C–O 
bonds in the electrophile point in opposite directions in the transition state to limit dipole 
repulsion. In the 1,5-anti boron aldol reaction a chiral β-hydroxy ketone reacts with an 
aldehyde using a boron based Lewis acid to give 1,5-anti products (Scheme 92b). In this 
case, the reaction proceeded through a closed 6-membered transition state, where the 
β-hydroxyl group of the enolate interacted with the aldehyde to afford the 1,5-anti 
products.  
 
Scheme 92 Substrate controlled diastereoselective aldol reactions 
The reduction of β-hydroxy ketones can be used to afford either 1,3-syn or 1,3-anti diols 
depending on the conditions employed (Scheme 93). 1,3-Syn diols can be accessed 
through addition of a Lewis acid and a reducing agent. In this case the Lewis acid chelates 
the ketone and hydroxyl group to form a 6-membered transition state that the hydride 
attacks selectively to afford the 1,3-diol (Scheme 93a). 1,3-anti diols can be afforded 
through reduction with Me4NBH(OAc)3, whereby delivery of the hydride occurred from 






Scheme 93 diastereoselective reduction of β-hydroxy ketones 
Paterson utilised three convergent diastereoselective aldol reactions and subsequent 
diastereoselective ketone reductions in his synthesis of the polyol region of (+)-roxaticin; 
specifically, two 1,5-anti boron aldol reactions and a 1,3-syn aldol reaction (Scheme 82). 
This strategy was very efficient both in terms of step count and overall yield and because 
the key steps proceeded under substrate control, very high dr values were obtained 
without the use of chiral auxiliaries. 
The strategies used by Schreiber and Rychnovsky differed from the others dramatically. 
Schreiber reported the efficient bidirectional synthesis of compound 350 using Noyori’s 
asymmetric ketone reduction as the stereodetermining reaction (Scheme 71). A key 
feature of this strategy was the genius use of the PMP group as a masked β-keto ester, 
which permitted the selective reduction of each pair of carbonyl groups in sequence, thus 
ensuring the product would be C2 symmetric. Nevertheless, the synthetic sequence 
became less efficient after the synthesis of 350 had been achieved, with a significant 
number of steps being dedicated to protecting group and redox level manipulations that 
did not form skeletal bonds.  
Rychnovsky presented a convergent strategy where the polyol motif of (–)-roxaticin was 
constructed through the alkylation of cyanohydrin acetonide moieties 417 and 419 with 
C2 symmetric dibromoacetonide 418 (Scheme 84). This methodology generated the 
desired products in high dr, but more significantly it could be adapted to generate other 
members of the oxopolyene macrolide family, which was demonstrated by Rychnovsky 
in the syntheses of dermostatin A, roflamycoin, 17-deoxyroflamycoin and filipin III 
(Scheme 86). A disadvantage of this approach was that the syntheses of 417 and 419 were 





constructed a further 13 steps were required to complete the synthesis, which contributed 
to an overall yield of only 0.0005%. 
Studies Towards the Total Synthesis of Bahamaolide A 
Bahamaolide A 
Bahamaolide A was isolated alongside bahamaolide B from a Streptomyces species, 
cultured from a sediment sample from North Cat Cay in the Bahamas.2 Bahamaolides A 
and B differ only in the geometry of the C-13 double bond (Figure 4). Both bahamaolides 
A and B are 36-membered macrocyclic lactones, which contain a conjugated hexaene and 
11 stereocentres, 9 of which form a contiguous 1,3-polyol. Bahamaolide A is an inhibitor 
of Candida albicans isocitrate lyase with an IC50 value of 10.8 μM;3 however, 
bahamaolide B was completely inactive in the tested biological assays. Currently, neither 
bahamaolide A nor B have succumbed to total synthesis. 
 
Figure 4 Bahamaolides A and B 
The relative configuration of the polyol portion of bahamaolide A was deduced through 
13C NMR acetonide analysis (Scheme 94).2,114 Specifically, treatment of bahamaolide A 
with an excess of 2,2-dimethoxypropane and PPTS resulted in the formation of the five 
acetonide protected compounds (Scheme 94a). Analysis of the 13C NMR spectrum of the 
compound with a free hydroxyl group at the C-15 position suggested the presence of two 
syn acetonides and two anti acetonides. The protons at C-17 and C-19 displayed a 
common ROSEY correlation with the methyl group at C-41, which had a 13C NMR 
chemical shift of 19.4 ppm which is indicative of the acetonide being in the chair 
conformation and the C-17 and C-19 hydroxyl groups being syn to one another (Scheme 
94b). By the same analysis the hydroxyl groups at C-31 and C-29 were also assigned as 
syn. The protons at C-21 and C-23 displayed ROSEY correlations with the methyl groups 
at C-44 and C-45, respectively, which had 13C NMR chemical shifts of 24.7 ppm and 25.1 
ppm, respectively. A HMBC correlation between C-44 and C-45 to C-43 confirmed that 
the hydroxyl groups at C-21 and C-23 were anti to one another. Through the same 





also assigned as anti. The same analysis was performed on the compound with a free 
hydroxyl group at C-31, which showed a syn relationship between the hydroxyl groups at 
C-27 and C-29 and between C-19 and C-21, and an anti relationship between the hydroxyl 
groups at C-23 and C-25 and between C-15 and C-17. Interestingly, the hydroxyl group 
at C-15 was determined to have the opposite stereochemistry to the hydroxyl group in the 
same position of the structurally related compound dermostatin A and others, such as 
roxaticin, and mycoticin (Scheme 94c). This variation highlights the need for the 
proposed structure to be either confirmed or challenged through total synthesis. The 
absolute configuration of bahamaolide A was deduced from the compound with a free 







Scheme 94 Bahamaolide A structural elucidation 
Retrosynthetic analysis 
The C2-symmetric nature of the 1,3-polyol section of bahamaolide A led us to consider 
an iterative, bi-directional strategy for its construction. Disconnection of the polyene 
moiety led to poly(boronic ester) containing fragment 441, from which each of the 





carbon–boron bonds. The polyene unit would be installed through a series of iterative 
Suzuki reactions using MIDA-protected boronates 440 and 439 and bromide 438 before 
macrolactonisation would form the macrocycle. Fragment 441 can be simplified to 
fragment 442 through a diboration reaction, which in turn can be simplified to our key C2 
symmetric octaboronic ester 444 through sequential homologation reactions with 
carbenoid precursors such as 443 and 445. Octaboronic ester 444 would be obtained from 
1,4-pentadiene (448) through an iterative, bi-directional diboration–homologation–
diboration sequence going through intermediates 447 and 446, thus setting six stereogenic 
centres in just three operations (Scheme 95). 
 
Scheme 95 Retrosynthetic analysis of bahamaolide A 
Results and discussion 
Previous work 
When I accepted to take on this project it had already been worked on by two previous 
group members – Dr Alexander Fawcett and Dr Teerawut Bootwicha. Dr Fawcett showed 
the optimisation of the double diboration of 1,4-pentadiene to afford tetraboronic ester 





using the diboration conditions described by Morken (Scheme 96).22,23 He was also the 
first person to synthesise octaboronic ester 444. 
  
Scheme 96 Synthesis of tetraboronic ester 447 
Dr Bootwicha showed the optimisation of the double homologation of tetraboronic ester 
447 to afford doubly homoallylic tetraboronic ester 446 and successfully optimised 
conditions for its purification on a small scale (Scheme 97). Specifically, Dr Bootwicha 
showed that 3.2 equiv of homoallylic sulfoxide 305—1.6 equiv per terminal boronic 
ester—were required, with fewer equivalents giving inferior yields while higher 
equivalents led to over homologation. As homoallylic sulfoxide 305 co-eluted with 
homologated tetraboronic ester 446 a slight excess of i-PrMgCl·LiCl with respect to 305 
was used to ensure complete consumption. Utilization of the corresponding lithium 
carbenoid—derived through sulfoxide–lithium exchange with t-BuLi—gave inferior 
yields. Purification of 446 was achieved using column chromatography with a mobile 
phase containing mixtures of hexane, PhMe, DCM and EtOAc and high silica loading. 
Whilst this method of purification worked well on small scale (ca 50 mg), it proved to be 
unreliable and non-time efficient with scales in excess of 100 mg. 
 
Scheme 97 Synthesis of tetraboronic ester 447 
Dr Bootwicha also showed the optimisation of the double diboration reaction to achieve 
octaboronic ester 444. Using the conditions described by Morken, 444 was achieved as a 
mixture with compound 449, which arises from a diboration–hydroboration event. 444 
and 449 co-elute; however, performing a very difficult column using a mobile phase 
containing mixtures of hexane, PhMe, DCM, Et2O and acetone with very high silica 
loading permitted the isolation of 444 and 449 in 38% and 27% yield, respectively. The 
amount of 449 formed in the reaction was reduced by performing the reaction at high 





ester 444 and only 7% of diboration–hydroboration product 449 (Scheme 98). 
Unfortunately, the dr of 444 could not be determined at this stage by 1H or 13C NMR 
analysis due to overlapping resonances. 
 
Scheme 98 Synthesis of octaboronic ester 444 
Optimisation of the synthesis of octaboronic ester 444 
Although Dr. Bootwicha developed a method to obtain small quantities of very pure 
octaboronic ester 444, this required two very challenging and irreproducible columns, 
which could not supply a sufficient amount of 444 to support a total synthesis project. My 
first task upon accepting to work on this project was to develop a scalable route to 444 
that permitted the formation and isolation of significant quantities of material in a single 
pass. A thorough re-investigation of TLC solvent conditions for the crude reaction 
mixture of 446 revealed three spots: the desired product and two impurities, which could 
not be fully characterised due to overlapping aliphatic resonances in the 1H NMR 
spectrum (Scheme 99). Impurity 1 overlapped with the top of the spot corresponding to 
446, whereas impurity 2 was clearly separated below 446. Acetone/hexane was the only 
solvent system identified that could separate all three components. Flash column 
chromatography using a 5% acetone/hexane mobile phase permitted the separation of 
impurity 2; however, it was not possible to remove impurity 1 in this way. Fortunately, 
NMR analysis showed that impurity 1 did not contain alkenes and so would not interfere 
in the following asymmetric diboration reaction. The mixture of 446 and impurity 1 was 
taken forward to the double diboration reaction. As predicted, impurity 1 did not 
influence the reaction and was easily separated from octaboronic ester 444. The removal 
of hydroboration product 449 proved to be more of a challenge and could only be 





solvent systems. A mobile phase of 4% acetone/hexane proved to be optimal to separate 
444 and 449 using flash column chromatography and allowed 700 mg of octaboronic 
ester 444 to be isolated following a single purification when the double diboration 
reaction was performed on a 1.21 mmol scale. The purification of 444 is still a major 
challenge—each purification takes 6–8 hours to complete and deviating from the standard 
protocol results in mixed fractions—however, using this method enough material to 
investigate later stages in the synthesis could be obtained. 
 
Scheme 99 Synthesis of octaboronic ester 444 
Desymmetrisation of 444 using α–sulfinyl benzoate 305 
With a method to access octaboronic ester 444 rapidly and on a reasonable scale 
established, we turned our attention to its desymmetrisation with homoallylic sulfoxide 
305. The desymmetrisation was first attempted by reacting 444 with half the number of 
equivalents of homoallylic sulfoxide 305 and i-PrMgCl∙LiCl that were used to 
homologate tetraboronic ester 447 bi-directionally; specifically, 1.6 equiv of 305 and 
1.7 equiv of i-PrMgCl∙LiCl (Table 3, entry 1). These conditions afforded 23% of the 
desired desymmetrised product (450) along with 14% of over homologated product 451, 
with the mass balance being made up with unreacted octaboronic ester 444. Increasing 
the number of equivalents of sulfoxide 305 and i-PrMgCl∙LiCl to 2.0 and 2.1, 
respectively, gave a modest increase in the yield of 450, which was afforded in 28% yield 
along with 14% yield of the over homologated product 451 and returned 52% of 
octaboronic ester 444 (Table 3, entry 2). Increasing the equivalents further to 2.5 equiv 





octaboronic ester 450, 31% of over homologated boronic ester 451 and 20% of unreacted 
octaboronic ester 444 (Table 3, entry 3). The rough 1:2:1 ratio of 451:450:444 represents 
a statistical yield for the transformation and was judged to be the maximum yield of 450 
that could be obtained when using octaboronic ester 444 as the limiting reagent. We next 
sought to lower the equivalents of homoallylic sulfoxide 305 by using t-BuLi and the 
sterically demanding triamine PMDTA to perform the metallation, to afford the more 
reactive lithium carbenoid. Applying the optimal conditions for the homologation of a 
simple 1,2-bis(boronic ester); specifically, 1.2 equiv of 305, 1.5 equiv of t-BuLi and 1.5 
equiv of PMDTA, consumed octaboronic ester 444 but did not afford any of the desired 
product, and instead showed only a baseline spot by TLC analysis (Table 3, entry 4). This 
baseline spot could plausibly be caused by direct attack of t-BuLi to any one of the 
boronic ester moieties of 444 to form a non-productive, irreversible t-butyl boronate 
complex, which would sequester 444. The equivalents of t-BuLi with respect to sulfoxide 
305 were then adjusted to an equimolar ratio, which permitted the formation of a small 
amount of the desired desymmetrised product 450 (9%); however, full consumption of 
444 was again observed (Table 3, entry 5). Increasing the equivalents of sulfoxide 305 
and t-BuLi to 1.1 did not positively impact the reaction (Table 3, entry 6) and so entry 3 
was selected as the optimal conditions. Presumably, a higher yield of 450 could be 
obtained by using sulfoxide 305 as limiting reagent and employing a 3–5 equivalent 
excess of octaboronic ester 444; however, this was not viewed as an appropriate course 
of action due to the challenge of accessing 444 and was not investigated. As in the case 
of octaboronic ester 444, the purification of desymmetrised octaboronic ester 450 was 
highly challenging, with the product, 451 and 444 running very close to one another by 
TLC analysis. After some optimisation it was found that the optimal mobile phase was 
acetone/PhMe; however, when attempting to purify more than 200 mg of material the 
purification had to be performed multiple times to recover material from the resulting 
mixed fractions. Inspection of the allylic resonances in the 1H and 13C NMR spectra 
suggested that 450 had a dr value of >95:5; however, it is plausible that other 
diastereomers could be concealed by the overlapping resonances in the aliphatic region 






Table 3 Desymmetrisation of octaboronic ester 444 with homoallylic sulfoxide 305 
While investigating conditions for the desymmetrisation of octaboronic ester 444, model 
studies towards the construction of the polyene moiety were conducted concurrently and 
will be discussed in the next section. 
Investigation of an iterative Suzuki-coupling strategy for the synthesis of the polyene 
To install the polyene moiety, we aimed to use an iterative Suzuki coupling strategy using 
MIDA boronates, which was pioneered by Burke (Scheme 100).116 Specifically, Suzuki 
coupling reactions between a vinyl pinacol boronic ester, such as 452, and a bi-functional 
coupling partner 453 containing a MIDA boronate proceeded to give a single product 
when performed under anhydrous conditions using Buchwald’s second generation XPhos 
Pd cycle precatalyst,117 Cs2CO3 and DMSO. Deprotection of MIDA boronate 454 under 
basic conditions in the presence of pinacol generated a reactive pinacol boronic ester, 
which was primed to undergo a further Suzuki coupling reaction. This procedure was 







Scheme 100 Burke's iterative Suzuki approach utilizing MIDA boronates 
Morken has shown that 1,2-bis(boronic esters) undergo selective Suzuki coupling 
reactions at the primary boronic ester with aryl bromide or vinyl chloride electrophiles in 
yields typically greater than 90% when using Pd(OAc)2, RuPhos and KOH as base 
(Scheme 101).118 Interestingly, simple primary boronic esters do not react under these 
conditions and it was proposed that internal chelation of the primary boronic ester pinacol 
group to the secondary boron centre increases the Lewis acidity of the terminal boronic 
ester and thus accelerates transmetallation at this position. 
 
Scheme 101 Morken's primary selective Suzuki coupling of 1,2-bis(boronic esters) with aryl bromides 
Unfortunately, Morken and Burke’s methodologies are incompatible as the strong 
aqueous base required for Morken’s coupling would prematurely deprotect MIDA 
boronate 455 to reveal boronic acid 456, which would react non-selectively to generate a 






Scheme 102 Incompatibility between Morken and Burke's cross-coupling methodologies 
The Watson group have shown that weaker aqueous bases; specifically, K3PO4, can be 
used in Suzuki reactions employing MIDA-protected building blocks without the 
formation of oligomeric products (Scheme 103a).119–122 Termed ‘boron speciation’, 
Watson’s methodology relies on a rapid coupling event—that typically occurs within the 
first hour of the reaction—to generate a homologated MIDA boronate, such as 457. The 
aqueous K3PO4 then slowly hydrolyses the MIDA boronate to liberate the corresponding 
boronic acid (458), which is esterified with pinacol present in the reaction mixture to 
generate boronic ester 459. Burke and Lloyd-Jones have shown that hydrolysis of MIDA 
boronates occurs through different mechanisms depending on whether NaOH or K3PO4 
is used as the base (Scheme 103b).123 When using NaOH fast hydrolysis occurred, where 
the rate determining step is attack by a single hydroxide. Typically, these fast processes 
take minutes to unveil the boronic acids at ambient temperature. Conversely, utilisation 







Scheme 103 Watson's boron speciation and hydrolysis mechanisms of MIDA boronates 
We sought to merge the methodologies of Morken, Burke and Watson to install the 
polyene moiety of bahamaolide A. Interestingly, Morken reported that whilst aryl 
bromide electrophiles reacted in high yields in cross-coupling reactions with 
1,2-bis(boronic esters), vinyl bromides and iodides were poor reaction partners and that 
vinyl chlorides had to be utilised for high yields. The synthesis of MIDA boronate 
containing vinyl chloride 462 was achieved as shown in Table 4. Radical stannylation of 
alkynyl MIDA boronate 460 proceeded to furnish MIDA boronate 461. Conversion of 
461 to vinyl chloride 462 did not proceed upon stirring with NCS overnight (Table 4, 
entry 1); however, using Cu(II)Cl as the chlorinating agent resulted in clean formation of 
462, albeit in low yield (Table 4, entry 2). Compound 462 proved to be highly hydrophilic 
and modification of the work up procedure to remove the aqueous work up resulted in a 






Table 4 Synthesis of vinyl chloride 462 
With the required vinyl chloride in hand, we next investigated the cross coupling reaction 
with model 1,2-bis(boronic ester) 463. It was anticipated that either 464 or 465, or a 
mixture of both would be obtained depending on the efficiency of MIDA boronate 
hydrolysis. As expected, subjection of 462 and 463 to the conditions described by 
Morken; specifically, 70 °C overnight using NaOH as base, resulted in a complex 
mixture, presumably through premature deprotection of the MIDA boronate and 
subsequent oligomerisation (Table 5, entry 1). A modest screen of bases was then 
performed. Using K3PO4 alleviated the putative oligomerisation of MIDA boronate 463 
but no reactivity was observed, as determined by LCMS analysis, and both 462 and 463 
were recovered (Table 5, entry 2). Performing the reaction with Cs2CO3, K2CO3 or NEt3 
(Table 5, entries 3 – 5) provided no improvement – again no reactivity was observed by 
LCMS analysis and the starting materials were recovered. The solvent was then changed 
to DMSO to be in line with Burke’s procedure (Table 5, entries 6 – 9); however, the same 
result was observed. Furthermore, the lack of reactivity could not be improved by 
performing the reaction at 90 °C in either THF or DMSO (Table 5, entries 10 – 17), which 






Table 5 Attempted cross-coupling reaction between vinyl chloride 462 and 1,2-bis(boronic ester) 463 
Due to the lack of reactivity between vinyl chloride 462 and bis(boronic ester) 463 under 
the tested reaction conditions, the iterative Suzuki strategy was abandoned in favour of a 
more promising approach. 
Sammakia’s strategy for the synthesis of the polyene portion of RK397 and 
dermostatin A 
As an alternative method to synthesise the polyene region of bahamaolide A, we were 
drawn to a strategy pioneered by Sammakia in his syntheses of RK397124 and dermostatin 
A,125 which utilised a cross metathesis reaction between advanced polyol containing 
fragment 466 and conjugated aldehyde 467 to afford trienal 468. The remaining alkenes 
were installed through a Horner-Wadsworth-Emmons (HWE) reaction with phosphonate 
469 to yield an advanced intermediate that was converted to dermostatin A in a further 







Scheme 104 Sammakia's approach towards the synthesis of the polyene region of dermostatin A 
Retrosynthetic analysis version 2.0 
The advantage of this method was that the required homoallylic alkene could potentially 
be accessed through a primary selective vinylation reaction of poly(boronic ester) 
containing intermediate 441. The retrosynthetic analysis of bahamaolide A was therefore 
altered to install the polyene moiety using Sammakia’s strategy (Scheme 105). 
Disconnection of the polyene moiety revealed advanced poly(boronic ester) containing 
intermediate 471, which would be accessed from 441 through a selective vinylation 
reaction of the primary boronic ester. 441 would be accessed in the same manner 
previously described from octaboronic ester 44 through sequential homologation 
reactions with carbenoid precursors such as 443 and 445 to generate 442, which would 






Scheme 105 Second generation retrosynthetic analysis of bahamaolide A 
Development of a primary selective vinylation of 1,2-bis(boronic esters) 
We next turned our attention to identifying a selective vinylation reaction of the primary 
boron moiety of a 1,2-bis(boronic ester). Morken has shown a palladium catalysed 
cross-coupling reaction between the primary boronic ester of a 1,2-bis(boronic ester) and 
vinyl chloride,118 which was generated in situ through elimination of dichloroethane with 
KOt-Bu (Scheme 106a). When applying these conditions to poly(boronic ester) 472 the 
desired product 473 was not obtained (Scheme 106b). Instead, complete conversion of 
the starting materials to a baseline spot was observed by TLC analysis, which suggested 
decomposition. It is hard to rationalise why decomposition of 472 would occur; however, 
after obtaining the same result after multiple repeats of the reaction, this approach was 
abandoned. 
 
Scheme 106 Morken's primary selective vinylation of a 1,2-bis(boronic ester) and our attempt to emulate it using 





Aggarwal has shown that 1,2-bis(boronic esters) react in a Zweifel olefination reaction at 
both boron centres to generate bis(functionalised) products when an excess of reagents 
are used (Scheme 107).126 Specifically, addition of vinyllithium—generated from the tin–
lithium exchange of tetravinyl tin with n-BuLi—to both boron centres of bis(boronic 
ester) 474 afforded bis(vinyl boronate complex) 475. Treatment of 475 with I2 furnished 
bis(iodonium) 476, which underwent 1,2-metallate rearrangement to give homologated 
bis(boronic ester) 477. Anti-elimination of 477 after the addition of NaOMe/MeOH 
ensued to furnish bis(alkene) 478 in high yield. 
 
Scheme 107 Bis(vinylation) of a 1,2-bis(boronic ester) 
We sought to adapt these conditions to enable a primary selective vinylation reaction of 
1,2-bis(boronic esters) using the mechanistic manifold of the Zweifel olefination reaction. 
We envisaged that exclusive formation of a boronate complex at the primary boronic ester 
could be achieved by carefully controlling the stoichiometry of the reaction as well as 
employing sterically hindered di- or tri-amine ligands to sequester the reactivity of vinyl 
lithium. Because this procedure would ultimately be used on a substrate that contains 9 
secondary boronic esters, the threshold for what was considered to be an acceptable level 
of bis(functionalisation) in a simple bis(boronic ester) was set to 0%. In an initial attempt, 
model bis(boronic ester) 479 was reacted with 1.0 equiv of vinyl lithium in the presence 
of 1.1 equiv of PMDTA at –78 °C. The putative boronate complex was then treated 
successively with I2 and NaOMe. These conditions led to 13% yield of the desired product 
480; however, the major species obtained was bis(functionalised) product 481, which was 
isolated in 45% yield (Table 6, entry 1). The predominance of 481 led us to search for a 
less reactive vinyl nucleophile. Aggarwal has shown that vinyl boronate complexes can 
be achieved by adding vinylmagnesium chloride to boronic esters using a 1:1 mixture of 





complex, which arises through displacement of the pinacol group by 3.0 equiv of 
vinylmagnesium chloride, was observed exclusively. The trivinylboronate complex was 
a productive intermediate in the transformation; however, it was preferable to use 
1.0 equiv of vinylMgCl in order to reduce waste and avoid potential functional group 
incompatibility (Scheme 108b). 
 
Scheme 108 Aggarwal's modified Zweifel olefination 
Utilization of 1.2 equiv of vinylmagnesium chloride in a 1:1 mixture of THF/DMSO at 
0 °C with 479 afforded only 10% of the desired product 480, with the mass balance being 
made up with unreacted starting material and a trace amount of bis(functionalised) 
product 481 (Table 6, entry 2). Instead of increasing the equivalents of vinylmagnesium 
chloride, which would presumably also increase the amount of over-homologation, we 
initially opted to increase the reactivity of the vinyl nucleophile. Knochel has shown that 
the reactivity of Grignard reagents towards magnesium–halogen exchange reactions 
increases in the presence of LiCl.128 Moreover, Morken has shown that formation of 
boronate complexes with vinylmagnesium chloride was enhanced when using LiCl as an 
additive.129 The reaction was then repeated using 1.6 equiv of vinylmagnesium chloride 
and a 0.5 M solution of LiCl in THF in a 1:1 mixture with DMSO as solvent (Table 6, 
entry 3). Under these conditions poor consumption of the starting material was still 
observed and bis(functionalised) product 481 was isolated in 24% yield while the desired 
product 480 was only obtained in 7.5% yield. We then investigated the effect of changing 
the equivalents of vinylmagnesium chloride; however, performing the reaction with 2.0 
and 3.0 equiv of vinylmagnesium chloride only served to increase the amount of 
bis(functionalisation), as expected (43% and 65% yield, respectively, Table 6, entries 4 
and 5). Performing the reaction at –78 °C in THF with 1.5 equiv of vinylmagnesium 
chloride afforded similar yields of 480 and 481, with the mass balance being made up 
with unreacted starting material. Finally, we attempted to use bulky amine ligands to 





moiety. Surprisingly, this resulted in the complete arrest of the reaction and permitted the 
recovery of 80% of 479 in the case of PMDTA and 78% of 479 in the case of (+)-sparteine 
(Table 6, entries 7 and 8). Due to the unfavourable results from this model study, we 
abandoned this approach to pursue a more promising one using lithiation–borylation 
reactions. 
 
Table 6 Vinylation of 1,2-bis(boronic ester) 479 
As it is known that (+)-sparteine coordinated lithiated benzoates react selectively at the 
primary position of a 1,2-bis(boronic ester),83 we next attempted to develop a primary 
selective vinylation reaction of a 1,2-bis(boronic ester) by employing a lithiated benzoate 
with a β-leaving group, such as 482 (Scheme 109). Treatment of a 1,2-bis(boronic ester) 
with 482 would lead to an intermediate such as 483, which could undergo an elimination 





are known to be chemically unstable and eliminate prematurely to furnish vinyl benzoate 
(485). To avoid this premature elimination reaction, a masked leaving group would have 
to be used, i.e. one that cannot leave before being activated with a suitable reagent. With 
these criteria established, we selected benzoates 486, 488 and 490 as viable candidates. 
In the case of benzoate 486, reaction with bis(boronic ester) 479 would deliver 
intermediate 1,3-bis(boronic ester) 487, which should undergo anti-elimination after 
addition of a base. Lithiation of hydroxyl benzoate 488 with two equivalents of s-BuLi 
should form a dianion, where the hydroxyl group has been protected as its conjugate base, 
which will react with 479 to generate intermediate 489. Optimally, a spontaneous 
syn-elimination would furnish homoallylic boronic ester 484; however, if this operation 
does not occur a dehydrating agent could be added to promote the elimination. Finally, 
formation of a boronate complex between the carbenoid derived from benzoate 490 and 
479 would generate a 1,3-bis(boronic ester) such as 491. The tertiary amine of 491 could 
be activated with a chloroformate to afford an activated carbamate, which could undergo 
elimination upon addition of a base.130 
 
Scheme 109 Proposed primary selective vinylation reaction of 1,2-bis(boronic esters) using lithiated benzoates with 
β-leaving groups 
The efficiency of the lithiation of 486, 488, and 490 was first evaluated using a 





s-BuLi and TMEDA for 3 h followed by quenching with CD3OD did not give deuterium 
incorporation at the desired position, but gave complete conversion to vinyl benzoate 
(485), thus confirming that 486 is not a suitable carbenoid precursor (Table 7, entry 1). 
Lithiation of hydroxyl benzoate 488 for 3 h using 2.3 equiv of s-BuLi and TMEDA 
followed by quenching with CD3OD afforded 100% deuterium incorporation of the 
hydroxy group but no deuterium incorporation at the desired position (Table 7, entry 2). 
Performing the reaction with (+)-sparteine in place of TMEDA also did not permit 
deuterium incorporation at the position α to the benzoate (Table 7, entry 3). Aggarwal has 
shown that the recalcitrant lithiation of secondary dialkylbenzoates can be achieved when 
using an excess of TMEDA with respect to s-BuLi and by using CPME as solvent;43 
however, subjection of 488 to 2.3 equiv of s-BuLi and 8.6 equiv of TMEDA in CPME at 
–78 °C resulted in only 20% deuterium incorporation at the desired position after addition 
of CD3OD (Table 7, entry 4). Our attention then turned to tertiary amine containing 
benzoate 490. Beak has shown that deuterated 490 can be obtained in 82% yield from 
490 by lithiating with s-BuLi/TMEDA at −78 °C in THF.131 In our hands, subjecting 490 
to 1.3 equiv of s-BuLi and TMEDA for 1 h at −78 °C resulted in 100% deuterium 
incorporation after quenching with CD3OD; however, only 72% yield was isolated due 
to non-specific decomposition of 490 under the reaction conditions (Table 7, entry 5). It 
has been shown that using THF as solvent leads to poor ee values in sparteine mediated 
enantioselective deprotonation reactions;132 moreover, THF is an inferior solvent to Et2O 
in the stereospecific deprotonation of secondary dialkylbenzoates.130 Both of these 
observations suggest deleterious attributes surrounding the use of THF and so the reaction 
was repeated using Et2O as solvent. Treatment of 490 with 1.3 equiv of s-BuLi and 
(+)-sparteine at −78 °C for 3 h in Et2O again afforded 100% deuterium incorporation after 
addition of CD3OD, but only 56% of the deuterated compound was isolated (Table 7, 
entry 6). To reduce the amount of decomposition the lithiation time was reduced. 
Performing the reaction for 30 min furnished 87% deuterium incorporation but 
decomposition was prevalent when inspecting the crude 1H NMR spectrum (Table 7, 
entry 7). Further decreasing the lithiation period to 10 min resulted in a comparable 
deuterium incorporation value (84%) but decomposition was persistent (Table 7, entry 
8). Finally, the lithiation was performed at −100 °C for 1 h, which did not improve 
deuterium incorporation or suppress decomposition as determined by crude 1H NMR 





a new approach to install the homoallyl group through a lithiation−borylation reaction 
using carbenoid precursor 495 (Scheme 111). 
 
Table 7 Lithiation–deuteration studies of benzoates 486, 488 and 490 
Retrosynthetic analysis version 3.0 
The difficulty that we experienced in developing a primary selective vinylation of 
1,2-bis(boronic esters) led us to consider installing the homoallyl group through a 
lithiation−borylation reaction with carbenoid precursor 495 (Scheme 111). We also 
decided to perform the oxidation of the boronic esters before the installation of the 
polyene because Cossy has shown that the polyene moiety of 492 is unstable to oxidising 
conditions (Scheme 110).133 
 





The retrosynthetic analysis was altered to reveal acetonide protected polyol 493, which 
would be obtained from polyol 494 through a metathesis reaction with trienal 470 and a 
HWE reaction with phosphonate 469. 494 leads back to octaboronic ester 444 through 
sequential homologation reactions with carbenoid precursors 495 and 496 and oxidation 
of the resulting (poly)boronic ester containing compound (Scheme 111). 
 
Scheme 111 Retrosynthetic analysis of bahamaolide A 
Proposed forward synthesis of bahamaolide A 
As described previously, the forward synthesis would commence with the synthesis of 
octaboronic ester 444 through the diboration–homologation–diboration sequence from 
1,4-pentadiene (448) (Scheme 112). Desymmetrisation of 444 would now be performed 
with sulfoxide 497 to afford homologated poly(boronic ester) 498. Installation of the 
pendant alkene required for the metathesis reaction with trienal 470 would be achieved 
through homologation of the primary boronic ester moiety of 498 with sulfoxide 499 to 
generate 500. Stereospecific oxidation of all eight boronic esters would yield a 
poly(alcohol), which would be protected as the poly(acetonide) to yield 501. The use of 
different silyl ether protecting groups in sulfoxides 497 and 499 is necessary because 
Krische has shown that the hydroxy group at C-21 must be protected for 
macrolactonisation to be successful;113 whereas, Sammakia reported the metathesis–
HWE–macrolactonisation sequence when the hydroxyl group at C-1 was 





position in the presence of the TBS silyl ether at the C-21 position would afford alcohol 
494, which is primed to undergo the methathesis–HWE–macrolactonisation sequence to 
generate protected bahamaolide A (502). Global deprotection under acidic conditions 
would afford the desired natural product and conclude the total synthesis (Scheme 112). 
 





Synthesis of sulfoxides 497 and 499 
Sulfoxide 497 was synthesised from allylbenzoate (503) in four steps (Scheme 113). 
Hydroboration of 503 using pinacol borane and Wilkinson’s catalyst afforded boronic 
ester 504, which was sequentially homologated with carbenoids derived from stannane 
505 and benzoate 507. The resulting secondary boronic ester 508 was then 
stereospecifically oxidised to yield alcohol 509 as a single diastereoisomer as determined 
by 1H NMR. No intermittent isolation or purifications were performed, thus providing 
509 in one pot from boronic ester 504. TES protection of 509 proceeded in high yield to 
furnish silyl ether 510, which was converted to sulfoxide 497 through asymmetric 
lithiation and trapping with Andersen’s chiral sulfinate. The whole process could be 
performed on gram scale to afford multigram quantities of sulfoxide 497 as a single 
diastereomer. 
 
Scheme 113 Synthesis of sulfoxide 497 
The synthesis of sulfoxide 499 (Scheme 114) was initiated from alcohol 511, which was 
oxidised to aldehyde 512 and subjected to Brown’s asymmetric allylation reaction using 
((+)-Ipc)2Ballyl to generate homoallylic alcohol 513 as an inseparable mixture with 
(+)-isopinocampheol (514), an expected by-product of the reaction. Protection of both 





which was separated from TBS-protected isopinocampheol by flash column 
chromatography. The enantiomeric ratio of the reaction was found to be 92:8 by chiral 
HPLC analysis. The reason for this low value is that the magnesium salts generated when 
forming ((+)-Ipc)2Ballyl from ((+)-Ipc)2BOMe and vinylMgBr reduce the rate of the 
allylboration reaction and prevent it entirely at temperatures below –78 °C.134 In the 
absence of magnesium salts, allylboration reactions occur instantaneously at –100 °C to 
give products with >99% ee; however, their removal, especially on a large scale, is 
operationally challenging. Fortunately, the disappointing enantiomeric ratio of 515 was 
inconsequential as upon forming sulfoxide 499 the minor enantiomer of 515 was 
transferred to a different diastereomeric series and removed by flash column 
chromatography, thus yielding sulfoxide 499 in 62% yield and as a single diastereomer. 
 
Scheme 114 Synthesis of sulfoxide 499 
Desymmetrisation of octaboronic ester 444 using sulfoxide 497 
The desymmetrisation of octaboronic ester 444 was next performed using sulfoxide 497. 
Replicating the number of equivalents used when desymmetrising 444 with homoallylic 
sulfoxide 305—2.5 equiv of 305, 2.6 equiv of i-PrMgCl∙LiCl—fully consumed 444 and 
furnished 37% yield of the desymmetrised product 498 and 48% yield of over 
homologated octaboronic ester 516 (Table 8, entry 1). This product distribution suggested 
that a superfluous amount of sulfoxide 497 was being used, so the equivalents of 497 and 
i-PrMgCl·LiCl were reduced to 2.0 and 2.1, respectively (Table 8, entry 2). Under these 





desymmetrised product 498, 27% yield of over homologated product 516 and 24% 
recovered octaboronic ester 444—and so these conditions were chosen as optimal. 
Because all the NMR signals of compound 498 appear in the aliphatic region, it was not 
possible to determine the dr of the iterative diboration–homologation sequence at this 
point and so the material was moved forward in the sequence with the view to determine 
the dr at a later stage. 
 
Table 8 Desymmetrisation of octaboronic ester 444 with sulfoxide 497 
Homologation of poly(boronic ester) 498 with sulfoxide 499 
With desymmetrised octaboronic ester 498 in hand, the homologation with sulfoxide 499 
was investigated. Treatment of a mixture of 1.0 equiv of octaboronic ester 498 and 
1.3 equiv of sulfoxide 499 with 1.4 equiv of i-PrMgCl·LiCl in DCM at –78 ˚C for 1 h, 
followed by heating at 50 ˚C for 3 h resulted in 45% yield of the desired homoallyl 
containing octaboronic ester 500. Although low yielding, the reaction was remarkably 
clean, and the yield could be adjusted to 93% when unreacted starting material was 
accounted for (Table 9, entry 1). In order to improve consumption of poly(boronic ester) 
498 , the reaction was repeated using 2.5 equiv of sulfoxide 499 and 2.6 equiv of 
i-PrMgCl·LiCl, which afforded 56% of 500; however, consumption of 498 was still poor 






Table 9 Homologation of poly(boronic ester) 498 with sulfoxide 499 
Lithiation–borylation reactions using poly(boronic ester) containing fragments such as 
498 were hitherto unknown, and so it was not obvious whether fragment 498 or 499 (or 
both) was responsible for the lack of reactivity. To test whether the carbenoid derived 
from sulfoxide 499 was a competent reaction partner in lithiation–borylation reactions, 
499 was reacted with simple bis(boronic ester) 463 (Table 10). Treatment of a mixture of 
463 and sulfoxide 499 with t-BuLi at –78 ̊ C in THF resulted in 17% yield of the expected 
product (517) and 65% recovered 463 with no over homologation (Table 10, entry 1). 
This outcome was remarkable because diamine–free lithium carbenoids are known to 
react with 1,2-bis(boronic esters) non-selectively at both boron centres;83 whereas, in this 
case even attack at the primary boron centre is inefficient, which is evidenced by the poor 
yield and recovery of 65% of 463. Increasing the equivalents of sulfoxide 499 and t-BuLi 
(1.5 equiv of each) resulted in complete consumption of bis(boronic ester) 463 and led to 
a modest increase in the yield of 1,3-bis(boronic ester) 517, but also permitted the 
formation of over homologation product 518 in 17% yield (Table 10, entry 2). The mass 
balance of this reaction was poor (47%), which could be due to direct attack of t-BuLi to 
a boronic ester, which would irreversibly form an unproductive boronate complex and 
thus sequester 463. Further increasing the equivalents of 499 to 2.0 or 2.5 provided a 
small increase in the yield of 517 (32% and 36%, respectively); however, the yield of 
over homologation product 518 also increased (31% and 45% yield, respectively) (Table 
10, entries 3 and 4). Remarkably, even with 2.5 equiv of diamine–free carbenoid complete 
conversion of 463 to 518 was not observed, thus highlighting the poor reactivity of the 
carbenoid derived from sulfoxide 499. Incorporation of either PMDTA or TMEDA 
completely arrested reactivity and permitted the re-isolation of most of the starting 






Table 10 Homologation of bis(boronic ester) 463 with sulfoxide 499 
Desymmetrisation of octaboronic ester 444 using sulfoxide 499 
To overcome the poor reactivity of the carbenoid derived from sulfoxide 499, it was 
decided to perform the desymmetrisation of octaboronic ester 444 with homoallylic 
sulfoxide 499, and then perform the second challenging homologation with sulfoxide 497. 
Desymmetrisation of octaboronic ester 444 with 2.0 equiv of sulfoxide 499 proceeded to 
furnish 36% of desired product 519 and 18% of the over homologated octaboronic ester 
520 with 45% of octaboronic ester 444 remaining (Table 11, entry 1). Increasing the 
number of equivalents of sulfoxide 499 to 2.5 restored the statistical product distribution 
and allowed desymmetrised octaboronic ester 519 to be isolated in 47% yield (Table 11, 
entry 2). As in the case of previous desymmetrisation reactions the purification of 519 
was challenging as 520 and 444 were difficult to separate. In addition to this, 519 showed 
some instability to silica gel chromatography, as determined by 2D TLC analysis, which 
dictated that any chromatographic purification be performed rapidly. Fortunately, fast 
purification using an automated Biotage Isolera one system with a hexane/acetone 
gradient permitted the complete separation of 519 from 520 and 444. Unfortunately, the 
reaction proved to not be readily scalable, and increasing the scale of the reaction to 330 
mg of octaboronic ester 444 resulted in a substantial drop in yield (Table 11, entry 3). 





purification. The expected yield was restored by splitting the crude reaction mixture into 
multiple 50 mg sized batches that were chromatographed separately. 
 
Table 11 Desymmetrisation of octaboronic ester 444 with sulfoxide 499 
Homologation of poly(boronic ester) 498 with sulfoxide 497 
The homologation of desymmetrised octaboronic ester 519 with sulfoxide 497 proved to 
also be challenging but was ultimately solved using a brute force approach. Homologation 
of 519 with 2.0 equiv of sulfoxide 497 gave a very clean reaction, where the crude reaction 
mixture consisted only of product, starting material and the expected by-products of the 
reaction; however, the yield of the reaction was only 54% and consumption of the starting 
material was low (Table 12, entry 1). Drastically increasing the equiv of 497 and 
i-PrMgCl·LiCl to 4.0 and 4.1, respectively, resulted in a similarly clean reaction and a 
higher yield (65%); however, full consumption of the starting material was still not 
achieved (Table 12, entry 2). Finally, complete conversion of the starting material was 
achieved when using 5.0 equiv of 497 and 5.1 equiv of i-PrMgCl·LiCl, which afforded 
poly(boronic ester) 500 in 72% yield (Table 12, entry 3). The low reactivity of the 
carbenoid derived from sulfoxide 497 with poly(boronic ester) 519 was disappointing 





5.0 equiv excess would require access to multi-gram quantities. Fortunately, this 
requirement proved to be feasible because the assembly–line methodology52 used to 
construct 497 could be performed efficiently using 5 g of boronic ester 504 with no loss 
in yield or selectivity.  
 
Table 12 Homologation of poly(boronic ester) 519 with sulfoxide 497 
Oxidation of poly(boronic ester) 500 
The oxidation of tetra(boronic ester) 521 has been shown in our group by Dr Hsuan-Hung 
Liao, who found that whilst basic hydrogen peroxide afforded polyol 522 in 73% yield, 
the urea·H2O2 complex was a superior oxidant for this transformation and generated 522 
in 93% yield (Scheme 115a). Due to this precedent the oxidation of poly(boronic ester) 
500 was investigated using urea·H2O2. In a first reaction, poly(boronic ester) 500 was 
treated with 60 equiv of urea·H2O2 at 50 °C for 16 h. Remarkably, LCMS analysis 
suggested complete conversion to poly(alcohol) 523, where all eight boronic esters had 
been oxidised and the TES silyl ether had been removed. Cleavage of the TES group is a 
fortuitous result as its selective removal was originally planned as a discreet step. Other 
oxidants were also tested in this process—NaOH/H2O2, NaBO3—but did not deliver 
complete conversion of 500 to 523 as judged by LCMS analysis. Cognisant of the 
propensity of hydrogen peroxide to form explosive adducts with acetone, dimethyl sulfide 
(2.0 equiv w.r.t urea·H2O2) was added after the oxidation step to reduce the excess H2O2 
before the addition of dimethoxy propane and CSA. Initially, dimethoxy propane and 
CSA were added directly to the reaction mixture after removal of the volatile components, 
but conversion of 523 to 494 was slow and could not be pushed to completion. It was 





to completion after a filtration through celite; however, the yield was low. Changing the 
filter pad from celite to sand had a positive influence on the yield—presumably because 
the celite was retaining some of the polyol components of the reaction. Poly(acetonide) 
494 was then afforded in 58% yield over 2 steps from 500 and with >95:5 dr. Although 
58% is a good yield for a transformation of this complexity, this step should still be 
considered a bottleneck as the theoretical yield of the transformation is half of the mass 
of the starting material (500) that was engaged in the reaction. This feature greatly 
increased the difficulty associated with accessing sufficient amounts of compound 494 to 
complete the synthesis. Because the steps to convert octaboronic ester 444 to 
poly(acetonide) 494 are known to be stereospecific—homologation of a boronic ester 
with an enantiopure carbenoid, oxidation and acetonide protection—the dr of octaboronic 
ester 444 was assumed to have also been >95:5. 
 





Synthesis of the polyene portion 
With the polyol portion of bahamaolide A successfully constructed, we turned our 
attention to the installation of the polyene and formation of the macrocycle. Sammakia 
has shown that cross metathesis between aldehyde 467 and compound 466 proceeded 
with 88% yield and an E/Z ratio of 5:1 favouring the desired diastereomer at the C-13 
double bond when using Grubbs first generation catalyst (Scheme 116a).125 According to 
Grubbs’ terminology, this represents a selective cross-metathesis reaction between a type 
2 (467) and a type 3 (466) olefin.135 A disadvantage of this process was that the synthesis 
of aldehyde 467 was cumbersome and required six steps, four of which were oxidation 
level changes (Scheme 116b).124 
 
Scheme 116 Sammakia's cross-metathesis of trienal 467 with compound 466 and synthesis of trienal 467 
We envisioned that this process could be improved by utilising trienal 470, which can be 
obtained in one step from commercially available sorbaldehyde (524). The terminal 
alkene of trienal 470 should also be a type 2 olefin and should engage in a selective 
cross-metathesis reaction with compound 494. Moreover, the presence of the terminal 
methyl group should increase the electron density of the terminal olefin with respect to 
467, thus promoting the desired transformation. Synthesis of 470 was first investigated 
using a Wittig reaction between sorbaldehyde (524) and phosphonium salt 525, which 
generated trienal 470 in 51% yield (Scheme 117a). Although 470 appeared to be one spot 
by TLC analysis, the 1H NMR spectrum suggested that there were at least four compounds 





resonances. Unfortunately, the E/Z ratio could not be improved through chromatography 
using SiO2 or AgNO3-doped SiO2 as the stationary phase, or by distillation. Due to time 
pressure the metathesis reaction and subsequent steps were performed using 470 derived 
from the reaction shown in Scheme 117a; however, we later found that 470 was generated 
with an improved E/Z ratio of 8:1 when using a HWE reaction to forge the β-alkene 
(Scheme 117b). Specifically, deprotonation of 526 with NaH and addition of 524 
generated conjugated ester 527 in 52% yield and with an E/Z ratio of 8:1. Conversion of 
527 to trienal 470 through a two-step reduction–oxidation sequence proceeded in high 
yield with no loss of E/Z selectivity.  
 
Scheme 117 Synthesis of trienal 470 
Trienal 470 was then engaged in a metathesis reaction with poly(acetonide) 494. In the 
first instance, the reaction was performed with 4.2 equiv of 470 and 5.0 mol% of Grubbs 
first generation catalyst (528) in DCM at reflux. After 6 h, TLC analysis showed the 
presence of both starting materials, 494 and 470, as well as a single new spot whose MW 
matched that of 529 as judged by TLC-MS analysis. The absence of homodimers of 470 
and 494 suggested that their classification as type 2 and type 3 olefins, respectively, was 
correct. At this point a further 5.0 mol% of 528 was added and the reaction was stirred 
for a further 16 h, at which point TLC analysis showed that 494 had still not been fully 
consumed, but no other species were apparent. The reaction was then stopped, and 
aldehyde 529 was obtained in 65% yield (91% brsm) after purification by flash column 
chromatography (Table 13, entry 1). Although 529 was one spot by TLC analysis, 1H and 
13C NMR analysis showed 529 to be a mixture of double bond isomers; however, the 
diastereomeric ratio could not be determined due to overlapping resonances. The yield of 





and 528 to 10 and 20 mol%, respectively (Table 13, entry 2), although the reactio149n 
still did not go to completion.  
 
Table 13 Cross-metathesis of poly(acetonide) 494 with trienal 470 
The HWE reaction with known phosphonate 469136 proceeded without incident to furnish 
hexaene 493 in 72% yield (Scheme 118). 
 
Scheme 118 Horner-Wadsworth-Emmons reaction with aldehyde 529 and phosphonate 469 
The final steps were performed without isolation of any intermediates (Scheme 119). 
Saponification of ester 493 with LiOH proceeded to deliver carboxylic acid 530, which 
was subjected to Yamaguchi’s macrolactonisation conditions without purification. 
Carboxylic acid 530 was treated with 2,4,6-trichlorobenzoyl chloride and Et3N to 
generate mixed anhydride 531. Evans showed in his synthesis of (+)-roxaticin that 
decomposition occurred if the mixed anhydride was not isolated before being added to a 
solution of DMAP in PhMe.107 In light of this precedent, 531 was filtered through a pad 
of celite before being concentrated and re-dissolved in anhydrous PhMe (0.002 M). The 
solution of 531 was then added to a solution of DMAP in PhMe (0.009 M) over 6 h, which 





intermediate in the synthesis of dermostatin A was unstable to purification125 and so 502 
was only purified using a rudimentary filtration through a small pad of silica gel and was 
characterised only by HRMS. Deprotection of poly(acetonides) to yield oxopolyene 
macrolides is notoriously difficult in the literature. In the most extreme example, Evans 
opted to use the more labile cyclopentyl ketals in his synthesis of (+)-roxaticin due to the 
challenges associated with acetonide removal.107 Despite this, the use of DOWEX resin 
in MeOH100,111,113 or HCl in MeOH124,125 have emerged as standard methods to achieve 
this transformation. We opted to use HCl in MeOH as Sammakia showed these conditions 
were successful in the deprotection of the structurally related dermostatin A.125 Protected 
bahamaolide A (502) was treated with HCl in MeOH at room temperature for 16 h, after 
which LCMS analysis suggested the formation of 3 peaks with the correct mass for 
bahamaolide A, which presumably corresponded to the desired product and double bond 
isomers. Unfortunately, the reaction was not complete, as other species corresponding to 
partial deprotection were also detected. Resubjecting the crude mixture to the reaction 
conditions for a further 16 h afforded complete conversion of the peaks corresponding to 
incomplete deprotection to peaks with the correct mass for bahamaolide A. Regretfully, 
at the time of writing the purification of bahamaolide A had not yet been performed due 
to technical difficulties regarding our group’s reverse phase prepHPLC machines. A 






Scheme 119 Synthesis of a crude sample of bahamaolide A 
 
Conclusion 
The synthesis of the polyol portion of bahamaolide A using an iterative, bi-directional 
homologation–diboration–homologation sequence has been successfully realised 
(Scheme 120). Using this protocol, 8 stereogenic centres were set with complete enantio- 
and diastereocontrol in just 5 steps, thus displaying the power of this methodology. 
However, of the 7 steps to transform 1,4-pentadiene into poly(acetonide) 494, 2 were 
bottleneck steps; specifically, 1) the double diboration of tetraboronic ester 446 to afford 
octaboronic ester 444, which required a very challenging column that took 6–8 h to 
complete and was limited by scale, and 2) the desymmetrisation of octaboronic ester 444 
with sulfoxide 499, which also required a very challenging column that was limited by 
scale and was further complicated by the instability of 519 to silica gel. In addition to this, 
carbenoid precursors 499 and 497 were used in 2.5 and 5.0 equivalents excess, 
respectively. The reality of this was that while the reactions themselves were robust, the 





forward to the later steps. Nevertheless, enough poly(acetonide) 494 was obtained to test 
the literature known steps to construct the polyene and close the macrocycle. The 
metathesis reaction between poly(acetonide) 494 and trienal 470 successfully gave the 
product, but before this project will be ready for publication this step will have to be 
repeated using a trienal with a higher E/Z ratio, be that trienal 470 made according to 
Scheme 117b or trienal 467 as used by Sammakia.124,125 The subsequent steps were also 
shown to work as documented in the literature, which allowed the formation of presumed 
protected bahamaolide A (502) without incident or upset. LCMS proved to be an 
invaluable tool to analyse the deprotection of 502 to bahamaolide A, and we currently 













Chapter 3: Towards a Novel Boronic Ester 
Protecting Group 
Project proposal 
Having developed an efficient process for the homologation of 1,2-bis(boronic esters) 
through the less hindered terminal boron centre using sparteine coordinated lithiated 
benzoates and carbamates,83 we were interested to see whether we could develop a 
complementary procedure to selectively homologate 1,2-bis(boronic esters) through the 
more hindered internal boronic ester (Scheme 121).  
 
Scheme 121 Proposed homologation of 1,2-bis(boronic esters) through the more hindered secondary boronic ester 
moiety 
We rationalised that selectivity for the secondary boronic ester of a 1,2-bis(boronic ester) 
in a lithiation–borylation reaction could be achieved by protecting the primary boronic 
ester with a ligand that lowers its Lewis acidity relative to a pinacol boronic ester by 
filling, or partially filling its vacant p-orbital. On inspection of successful methods from 
the literature, boron protection includes forming a diazaboronic ester, such as in 
Suginome’s diaminonaphthaline (DAN) ligand (532),137 or by having a tethered moiety 
with a lone pair available for direct donation into the empty p-orbital of the boron atom, 
such as in Burke’s N-methyliminodiacetic acid (MIDA) boronate (533) (Figure 5).138 Due 
to the presence of acidic protons, both the DAN (532) and MIDA (533) groups are 
incompatible with lithiation−borylation reactions, as they would quench the lithiated 
carbenoids and prevent formation of boronate complexes. In addition to this, the MIDA 
boronate also contains unprotected carbonyl groups that would be subject to attack from 
organolithiums. We therefore aimed to develop a novel boron protecting group that is 






Figure 5 Suginome's DAN and Burke's MIDA ligands for boronic acids 
Once such a group has been identified the synthesis of primary protected 1,2-bis(boronic 
esters) will be investigated using diboron reagents 534 and 535. It was envisioned that 
that desired compounds could be accessed through diboration of a terminal alkene with 
534 (Scheme 122a), or through a lithiation-borylation reaction between diboron 
compound 535 and a primary benzoate (Scheme 122b). 
 
Scheme 122 Proposed synthesis of differentially protected 1,2-bis(boronic esters) using diboron reagents 534 and 535 
Introduction 
Selective functionalisation of a 1,2-bis(boronic ester) through the secondary boron 
moiety 
Morken has shown that 1,2-bis(boronic esters) which contain a proximal hydroxyl group 
undergo Suzuki coupling reactions through the more hindered secondary boronic ester 
moiety with retention of stereochemistry (Scheme 123).139 The origin of the 
regiochemical outcome of the reaction was a substrate directed transmetallation event, 
whereby the hydroxyl group formed a covalent link with the palladium and thus directed 
it to the internal boronic ester. 
 
Scheme 123 Morken's hydroxyl directed coupling reaction 
Morken has also shown that a tandem diboration/mono-oxidation can be achieved in a 
one-pot process starting from a terminal alkene (Scheme 124).140 Asymmetric 
carbohydrate catalysed diboration141,142 using B2pro2 as the diboron source afforded 





with N-methyl morpholine-N-oxide. The regiochemical preference of the oxidation step 
for the internal boronic ester is due to the 1,2-migration being the rate limiting step when 
using NMO as the oxidant. Because the formation of a boronate complex is reversible 
and the 1,2-migration is slow, the more substituted and electron rich secondary carbon 
atom undergoes metallate rearrangement preferentially. Transesterification of the 
remaining boronic ester with pinacol generated an isolable species. The scope of the 
transformation was broad and tolerated mono- and 1,1-disubstituted alkenes to give the 
corresponding products 537, 538 and 539 in high yield and with excellent er. The 
diboration phase was insensitive to nearby stereogenic centres, as shown by 540 and 541, 
which were isolated in similarly high yield and diastereomeric ratio. 
 
Scheme 124 Morken's secondary selective oxidation of 1,2-bis(boronic esters) 
Literature known boronic ester protecting groups 
Heteroatoms adjacent to boron possessing lone pairs are capable of π overlap into the 
vacant p-orbital of boron.143 Nitrogen is less electronegative than oxygen and so is better 
at donating electron density through induction, as is the case for the DAN ligand. In 
contrast to this, the conformation of the MIDA boronate allows the donation of the 
nitrogen lone pair directly to the empty boron p-orbital. Generally, protecting groups with 
a tethered donating group will reduce the Lewis acidity of boron to a greater extent than 
those functioning through an inductive effect, and indeed it is possible for a tethered group 
to form a full boronate complex. Both the DAN and MIDA groups were designed to be 
used in iterative Suzuki-Miyaura coupling reactions (Scheme 125). To perform iterative 
Suzuki-Miyaura reactions, one of the coupling partners must contain both an electrophilic 
component—a halogen or pseudo-halogen—and a nucleophilic component—a boronic 





Suzuki-Miyaura reaction between 542 and boronic acid 543 would result in the desired 
coupling plus an ‘n’ amount of bis(functionalised) coupling partner (544), and the 
polymerisation of the bis(functionalised) coupling partner (545). To prevent these 
undesired processes, the bis(functionalised) coupling partner should be protected at 
boron. After deprotection of the cross-coupled product, another Suzuki-Miyaura coupling 
could be performed, which would result in an iterative chain extension.  
 
Scheme 125 Method of protection in an iterative SM process 
Suginome has applied an iterative Suzuki-Miyaura strategy to the synthesis of oligoarenes 
using diaminonaphthalene as the boron protecting group.137,144 In one example the 
synthesis of phenol 550 was achieved in excellent yield in 8 steps from dan-protected 
boronic acid 546. Deprotection of 546 under aqueous acidic conditions furnished the 
corresponding boronic acid, which was subjected to a palladium-catalysed cross-coupling 
reaction with aryl bromide 547 to afford DAN-protected boronic ester 548. A further two 
iterative cycles of deprotection and cross-coupling generated DAN-protected boronic 
ester 549, which was deprotected and the resulting boronic acid oxidised to yield phenol 






Scheme 126 Suginome's synthesis of oligoarene 550 
Burke has applied an iterative Suzuki-Miyaura strategy to the synthesis of many polyene 
containing natural products using N-methyliminodiacetic acid as the boron protecting 
group.145 Most notably, Burke’s iterative procedure could be performed in a fully 
automated manner, thus allowing for the rapid synthesis of libraries of polyene and 
polyaryl products.146 In one example, the synthesis of asnipyrone B was achieved in 4 
steps from MIDA-protected boronic ester 551. Suzuki reaction between 551 and 
phenylboronic acid generated MIDA-protected boronic ester 552. Deprotection of the 
MIDA boronate under basic conditions in the presence of pinacol generated the 
corresponding pinacol boronic ester, which underwent a Suzuki reaction under anhydrous 
conditions with vinyl bromide 553. Anhydrous conditions are required to preserve the 
MIDA-protecting group of 553, which would otherwise be deprotected in the basic 
aqueous media required for the Suzuki-Miyaura cross-coupling reaction. Asnipyrone B 







Scheme 127 Burke's synthesis of asnipyrone B 
Literature known differentially protected diboron reagents 
Santos has shown both the synthesis of mixed diboron 556, which was the first example 
of a non-symmetrical sp2–sp3 hybridised diboron compound, and its utility in the 
β-borylation of α, β-unsaturated compounds.147,148 Treatment of 556 and an 
α, β-unsaturated compound with CuCl and MeOH in DCM resulted in efficient β-
borylation (Scheme 128a). The reaction tolerated unsubstituted α, β-unsaturated esters 
557 and 558, as well as substitution at the 3 and 4 positions, as exemplified by examples 
559 and 560, respectively. Other electron withdrawing groups, such as cyano (example 
561) and an amide (example 562) also performed well under the reaction conditions 
(Scheme 128b). Because 556 contains an sp3 hybridized boron moiety, σ-bond metathesis 
with CuCl occurs spontaneously without prior activation of the boron source with a base 
or phosphine ligand to afford the active borylating species 563. This represents an 
advantage over platinum,149–151 rhodium,152 nickel153 and copper154 catalysed borylation 
of α, β-unsaturated esters in that the reaction conditions are milder. Copper species 563 
then transfers the Bpin moiety to the 4-position of α, β-unsaturated species 564 to generate 
565, which is subsequently quenched with a proton to yield the product. A σ-bond 
metathesis reaction between copper species 566 and 556 regenerates 563 and closes the 






Scheme 128 Santos' β-borylation of α,β-unsaturated compounds 
Suginome has shown that diboration of terminal alkynes with the unsymmetrical diboron 
reagent 567 generates unsaturated, differentially protected 1,2-bis(boronic esters).155 
Significantly, the reaction has a strong regiochemical preference, with the less Lewis acid 
DAN-protected boron moiety placed at the terminal position (Scheme 129). The reaction 
tolerated a range of aromatic alkynes, including electron neutral (568), electron rich (569) 
and electron deficient (570) alkynes. Aliphatic alkynes were also competent reaction 
partners, as exemplified by example 571, which was isolated in 73% yield (Scheme 129a). 
Moreover, the products underwent a subsequent Suzuki-Miyaura coupling reaction 
selectively at the more hindered internal pinacol boronic ester to yield products 572–575 





unsaturated 1,2-bis(boronic ester) 576, which engaged in a cross-coupling reaction at the 
less hindered primary boronic ester (Scheme 129c).156 
 
Scheme 129 Regioselective diboration of terminal alkynes with diboron 567 and subsequent cross-coupling reaction 
Fernandez has shown that alkenes can undergo metal free diboration reactions with 
diboron 567 to yield differentially protected 1,2-bis(boronic esters);157 however, in this 
case the major regioisomer has the DAN-protected boronic ester at the internal position 
(Scheme 130). A modest substrate scope of alkyl alkenes was presented, but the 
regiomeric ratio values varied wildly depending of the substate and the isolated yields 
obtained were generally poor, which was attributed to partial decomposition of the 
products upon isolation. Moreover, styrenyl substrates did not furnish the desired 







Scheme 130 Fernandez's metal-free diboration of alkenes with mixed diboron 567 
Aggarwal has shown the asymmetric Markovnikov hydroboration of unactivated terminal 
alkenes, using mixed diboron 577 and chiral rhodium catalyst 578 (Scheme 131a).158 The 
reaction worked well for primary alkenes, yielding the desired products in high yield and 
with excellent rr values; however, the er values were comparatively low (579 and 580). 
Interestingly, incorporation of a carbonyl moiety at the position δ to the alkene resulted 
in increased enantioenrichment, as displayed in compound 581. Secondary alkenes could 
also be employed to yield the resulting boronic esters in high yield and rr values, but at 
the detriment of enantiomeric excess (example 582). Styrenyl alkenes were also excellent 
reaction partners, with styrene itself yielding 583 in 95:5 er (Scheme 131b). The reaction 
operates under the same mechanistic manifold as Nishiyama’s diboration reaction.159 
σ-Bond metathesis between catalyst 578 and diboron 577 generates rhodium-boryl 
species 579, which undergoes an enantioselective migratory insertion process with an 
alkene to generate intermediate 580. Protodemetallation of 580 with H2O furnishes 
hydroboration product 581 and regenerates the active catalyst, thus closing the catalytic 






Scheme 131 Aggarwal's Markovnikov hydroboration of terminal alkenes 
The mixed diboron compounds 582−586 have been synthesised and characterised by 
Kleeberg,160,161 while Yoshida has shown the synthesis of diboron 587;162 however, they 
have not been shown to have synthetic applications and so will not be discussed futher 
(Figure 6).  
 






Results and discussion 
Previous work  
Previous work within the group towards the synthesis of a methylene linked differentially 
protected mixed diboron species targeted compounds 588 and 589 (Figure 7). In the case 
of mixed diboron 588, one boron moiety is protected as the trifluoroborate salt, in which 
the coordination sphere of the boron atom is saturated and is therefore not electrophilic. 
The protecting group in mixed diboron 589 is derived from 1,1'-(methylazanediyl)bis(2-
methylpropan-2-ol) and resembles the MIDA boronate, where the carbonyl groups have 
been replaced with geminal dimethyl groups. This alteration removes both the 
unprotected carbonyl groups and the enolisable protons that prevent the MIDA boronate 
being suitable reagent in lithiation−borylation reactions. Unfortunately, 588 was 
insoluble in ethereal solvents and 589 decomposed upon chromatography, thus rendering 
both unsuitable. 
 
Figure 7 differentially protected diboron reagents that were synthesised by previous group members and shown in to 
unsuitable 
Development of diol ligands 
We started our investigation with diols 590–593 (Figure 8), which bear resemblance to 
the MIDA boronate in that they form a dioxaborylcycle when bound to boron and donate 
electron density via a tethered nitrogen atom. Unlike the MIDA boronate the tethered 
nitrogen atoms are exocyclic to the dioxaboryl ring. 
 
Figure 8 Aminediol ligands 590–593 
For diols 590–593 to be suitable protecting groups their corresponding dioxaborylcycles 
(594–597) must adopt a boat conformation to place the nitrogen atom in the correct 
position to donate to the boron atom (Figure 9). In the chair conformation, the tethered 





group α to nitrogen, as in 591, would be axial in a chair conformation. We rationalised 
that this would destabilise the chair conformation and promote formation of the boat. 
Further modifications could be made by introducing a methylene link between the 
nitrogen atom and dioxaboryl ring, thus potentially placing nitrogen atom in a better 
position to form a dative bond with the boron centre, such as in 596 and 597.  
 
Figure 9 Conformational analysis of aminediol ligands bound to boron 
Synthesis of aminodiols 590, 591 and 593 
The synthesis of diol 590 was achieved in a simple one-step dimethylation of serinol (598) 
(Scheme 132a). The product was obtained in high yield after heating at 80 °C for 10 h, 
without the need for additional purification. Diol 591 was synthesized in two-steps from 
nitroethane (599) (Scheme 132b). The initial step proceeded through the double addition 
of formaldehyde to the enolate of nitroethane to form intermediate 600, which was 
obtained as a white solid. Compound 600 was then subjected to a high-pressure 
hydrogenation with RaNi, followed by in situ dimethylation of the formed amine to afford 
the desired ligand in high yield. Diol 593 was synthesized in one-step in high yield 






Scheme 132 Synthesis of aminodiols 590, 591 and 593 
Attempted synthesis of diol 592 
It was hoped that diol 592 could be synthesized in a two-step procedure from 
diethylmalonate (602) by an initial Mannich reaction to yield intermediate 603, followed 
by reduction of the diester to yield the desired diol. Upon evaluation of the literature, it 
was not possible to find an example of this Mannich reaction using dimethyl amine, 
although the same transformation with dibenzylamine was reported.163 Attempting this 
reaction with dimethylamine resulted in a complex mixture, from which 603 could not be 
isolated (Scheme 133a). In light of this failure the route was altered to use Eschenmoser’s 
salt (504) as this was predicted to be a more direct and facile route to 603 (Scheme 133b). 
Unfortunately, this method also did not yield the product, and again many new spots were 
observed by TLC analysis. Due to the unpredicted difficulty in the synthesis of diol 592 
it was removed as a target. 
 





Complexing diols to phenylboronic acid and evaluation of 11B NMR chemical shift 
values  
Phenylboronic acid was chosen as a model substrate to investigate the properties of 
aminodiols 590–593 when complexed to boron. Complexation was achieved by stirring 
the requisite diol with phenylboronic acid in Et2O overnight in the presence of flame-
dried MgSO4 (Table 14).  
 
Table 14 Transesterification of ligands 590–593 to simple boronic acids 
MgSO4 was present to remove water and drive the equilibrium in favour of products. In 
each case, the expected product was formed, as according to 1H NMR analysis of the 
crude mixture. As 11B NMR chemical shift is controlled by the electron occupancy of the 
vacant boron orbital,164,165 evaluation of the efficiency of protection afforded by each of 
the ligands can be evaluated by considering the 11B NMR chemical shift relative to that 
of a pinacol boronic ester (~33 ppm) (Figure 10). As a reference, MIDA boronate 606 has 
a 11B shift of 10.8 ppm.166 In the case of compound 594, the 11B chemical shift is only 
slightly more upfield than that of a boronic acid pinacol ester. This suggests that the 
nitrogen atom is poor at donating electron density into the vacant boron orbital, which 
suggests that either a high proportion of the population is in the chair conformation, or 





introduction of a methyl group α to the nitrogen atom did indeed lower the 11B chemical 
shift, as shown by compound 595, thus suggesting that destabilisation of the chair 
conformation aids in the formation of a dative bond between nitrogen and boron atoms. 
Introduction of a methylene link between the nitrogen atom and the ring further reduced 
the 11B chemical shift to 3.83 ppm in compound 597, which is analogous to a boronate 
complex. This suggests a formal bond between the boron and nitrogen atoms and shows 
that the presence of a methyl substituent at the tip of the boat and a methylene linker 
between the nitrogen atom and the ring place the nitrogen atom in the optimal position to 
donate electron density. Unfortunately, boronic esters 594 and 595 were not stable to flash 
column chromatography and decomposed upon chromatographic purification to 
phenylboronic acid and the corresponding diol. Interestingly, boronic ester 597 proved to 
be stable but immobile on silica gel. To combat this, the boronic acid coupling partner 
was changed to phenethylboronic acid, which is slightly more lipophilic and should elute 
through silica gel more readily. Boronic ester 605 again showed a 11B NMR chemical 
shift in the region of a boronate complex, suggesting a formal nitrogen to boron dative 
bond. Boronic ester 605 proved to also be immobile on silica gel, even in very polar 
eluents (mobile phases consisting of MeOH/DCM, MeOH/NH3/DCM, THF and 
CH3CN/Et2O were trialled). This immobility is puzzling as the 11B NMR chemical shifts 
suggest a formal N−B bond. The origin of this immobility may be due to breaking of the 
N−B bond in solution, thus allowing coordination of the nitrogen atom to silica gel. 
Alternatively, a strong N−B bond may cause weakening of one of the B−O bonds, 
generating a partial negative charge on the oxygen atom that may interact with silica gel. 
Owing to poor compatibility with silica gel it was decided that these ligands would not 








Figure 10 11B NMR chemical shifts of compounds 594, 595, 597 and 605 
Development of diamine ligands 
Our attention next turned to groups that would protect a boronic ester through inductive 
donation of electron density. These compounds would be related to Suginome’s DAN 
ligand. The diamines 607 and 608 had previously been synthesised in the group and had 
decomposed upon chromatographic purification when coordinated to a boronic ester. 
Diamine 609 was selected as the next candidate to test as a boronic ester protecting group 
(Figure 11). 
 
Figure 11 Diamines 607, 608 and 609 
Synthesis of diamine 609 
On evaluation of the literature it was found that diamine 609 could be accessed through 
reduction of 1,10-phenanthroline (610).161,162 Treatment of 610 with sodium 
cyanoborohydride yielded many spots, as determined by TLC analysis, of which none 
could be identified as the desired product. (Scheme 134a). The route was therefore altered 
to use 50% Ni−Al alloy, which proceeded in almost quantitative yield at ambient 
temperature after stirring for 16 h (Scheme 134b). Mixing aluminium with aqueous 
hydroxide generates a tetra-hydroxy aluminium complex and dihydrogen, which acts as 
the reductant in the presence of RaNi. The reaction is performed by dissolving 





wise addition of Ni−Al alloy. As the alloy is added, the reaction mixture turns from 
colourless to dark green, and starts spontaneously refluxing. Cooling the reaction mixture 
at this point was found to be detrimental to the yield (58%), whereas almost quantitative 
yield was obtained when the reaction refluxed. This procedure allowed 609 to be obtained 
without the need for chromatographic purification. The product (609) was obtained as a 
bright yellow solid, which was not bench stable and decomposed over a few days when 




Scheme 134 Reduction of 1,10-phenanthroline (610) 
Complexing diamine 609 to a simple boronic acid 
We next sought to complex ligand 609 to a simple boronic acid to evaluate its stability to 
silica gel. Unfortunately, this process was not as facile as in the case of diols 590, 591, 
and 593 (Table 15). An initial attempt involved stirring phenethyl boronic acid with 
diamine 609 in Et2O at room temperature overnight in the presence of one equivalent of 
flame–dried MgSO4 (Table 15, entry 1). Unfortunately, TLC analysis showed that no 
reaction had occurred and both starting materials were recovered. It has been shown that 
Fe(III) species can be used to catalyse the ligation of Suginone’s DAN ligand to simple 
boronic acids in the presence of water and imidazole in yields of up to 89%.169 Although 
the DAN ligand contains two primary amines and so should be an easier coupling, we 
attempted to adopt this methodology to diamine 609 (Table 15, entry 2). TLC analysis of 
the reaction mixture again showed that no reaction had occurred and the starting materials 
were recovered. Finally, the product was obtained as a purple solid by refluxing the 





catalytic amount of DBU (Table 15, entry 4). Although the reaction proceeded in the 
absence of DBU (Table 15, entry 5), this was detrimental to the yield. Even more 
gratifyingly, the product was both mobile on, and stable to silica gel chromatography and 
was isolated using a gradient of 5% EtOAc in petroleum ether.  
 
Table 15 Ligation of 609 to phenylboronic acid 
Evaluation of protecting group ability of diamine 609 
As expected the 11B chemical shift of 611 was more downfield than that of protected 
boronic esters 594, 595, 597 and 605, owing to donation of electron density from the 
nitrogen atom through an inductive effect being a more subtle than dative donation 
(Figure 12). Despite this, the difference in chemical shift values (33 versus 26.5 ppm) of 
611 and a pinacol boronic ester should be sufficient for discrimination by a carbenoid and 






Figure 12 11B NMR shifts of compounds 611, 594, 595, 605 and 597 
Competition lithiation−borylation reaction 
To test whether our designed diamine was indeed a boronic ester protecting group, a 
lithiation−borylation competition experiment was attempted using phenethylboronic 
pinacol ester and protected phenylboronic acid 611 (Scheme 135). If diamine 609 is a 
successful protecting group, the reaction should yield compound 613 exclusively. 
Formation of organoboron 614 would indicate that protected boronic acid 611 is 
electrophilic enough to be intercepted with a lithiated carbenoid and so would not be a 
suitable protecting group. The lithiation of secondary benzylic carbamate 612 was 
performed in TBME at –78 °C in the absence of a coordinating diamine. Phenethyl 
boronic ester and 611 were to be added together as a solution in TBME at –78 °C after a 
lithiation period of 2 h. Unfortunately, protected boronic acid 611 was completely 
insoluble in both TBME and Et2O and was only partially soluble in toluene. Owing to 
this poor solubility the reaction was not completed as it was not possible to determine the 






Scheme 135 Competition lithiation−borylation experiment 
The value of the 11B NMR chemical shift of 611 gave us cause to assume that it would be 
a suitable protecting group, and was carried through to the synthesis of the mixed diboron 
compounds 615 and 616 in the hope that they would be soluble in ethereal solvents 
(Figure 13). 
 
Figure 13 Mixed diboron compounds 615 and 616 
Synthesis of mixed diboron 615 
Initial attempts to coordinate diamine 609 to B2(OH)4 by refluxing the mixture in toluene 
with catalytic amounts of DBU were unsuccessful. A more forceful approach was 
therefore attempted where diamine 609 was lithiated with n-BuLi followed by the 
addition of B2neo2 (617). The neopentylglycolato group could then be transesterified with 
pinacol to yield the desired mixed diboron (615). Upon addition of n-BuLi a colour 
change was observed from pale yellow to bright orange, suggesting lithiation had 
occurred; however, the 1H NMR spectrum of the crude reaction mixture showed a 
complex mixture that did not appear to contain product (Scheme 136a). Ken has shown 
that mixed diboron compound 567 could be made by heating diaminonaphthalene with 
B2pin2 in toluene for a prolonged period of time at 100 °C.170 We sought to emulate this 
procedure to afford our desired diboron compound (615). Unfortunately, no reaction 
occurred and both starting materials were recovered after heating at 100 °C in toluene for 
3 d (Scheme 136b). Finally, the synthesis of 615 was achieved using a procedure 
developed by Suginome for the synthesis of 567 (Scheme 136c).155 Freshly distilled 





anhydrous THF in the presence of a catalytic amount of anhydrous HCl. After this time, 
the reaction was basified with K2CO3 and pinacol was added. The reaction mixture was 
then stirred for a further 16 h at 50 °C, where after workup and purification, the desired 
product (615) was obtained in 11% yield as a white solid. Although this yield is low, 
enough material was obtained to investigate the reactivity of 615. Efforts to optimise this 
process were put on hold pending the results of the investigation into the reactivity of 
615.  
 
Scheme 136 Synthesis of mixed diboron componud 615 
Synthesis of mixed diboron 616 
It was envisioned that the synthesis of mixed diboron 616 could be achieved through the 
sequential esterification of 1,1-bis(boronic acid) 620, which was obtained through 
hydrolysis of diborylmethane (225) (Scheme 137). Bis(boronic acid) 620 was first heated 
at 120 °C in toluene with one equivalent of diamine 609 and a catalytic amount of DBU. 
Pinacol was then added and the reaction mixture heated for a further 5 h. Unfortunately, 
none of the desired product could be detected and 609 was re-isolated in almost 
quantitative yield. Diborylmethane (225) was isolated in approximately 22% yield, which 
was presumably generated through the double addition of pinacol to 620. This result could 





620 is inert to esterification with 609. Due to the difficulties in synthesising 616, its 
synthesis was put on hold while the properties of 615 were investigated. 
 
Scheme 137 Attempted synthesis of mixed diboron 616 
Homologation of mixed diboron 615 with sulfoxide 621 
With mixed diboron 615 in hand, it was possible to evaluate its behaviour in a 
lithiation−borylation reaction, the product of such a reaction would be a differentially 
protected 1,1-bis(boronic ester). To our dismay, 615 was insoluble in Et2O, TBME, 
CPME and PhMe; however, it was completely soluble in DCM and so we tested a 
homologation between 615 and the carbenoid derived from sulfoxide 621 when using 
i-PrMgCl·LiCl as the metallating agent. Sulfoxide–magnesium exchange of 621 was 
achieved at –78 °C through addition of i-PrMgCl·LiCl to a mixture of 615 and 621. After 
45 min the reaction was heated to 35 °C for 16 h to promote 1,2-metallate rearrangement. 
Gratifyingly, a new spot was present by TLC analysis and formation of the desired 
product was supported by GCMS analysis; however, owing to the scale this reaction was 
performed on, 622 was not fully characterised (Scheme 138). 
 
Scheme 138 Homologation of mixed diboron 615 with the carbenoid derived from sulfoxide 621 
Despite being in a very promising position, work on this project was stopped at this point. 
The reason for this was not related to the chemistry or a loss of interest in the project but 






Throughout the preceding section efforts towards the design and synthesis of a novel 
boronic ester protecting group that is compatible with lithiation−borylation reactions have 
been discussed. Despite their facile installation, it was shown that the diol ligands 590, 
591 and 593 are not suitable owing to their unfavourable interaction with silica gel when 
coordinated to a simple boronic acids (Figure 14). Evaluation of the 11B NMR chemical 
shift values of 590, 591 and 593 bound to a simple boronic acid showed that each was 
competent at reducing the Lewis acidity of the boron atom to a greater or lesser extent. 
As predicted, diol 593 was a superior protecting group than diol 590, a difference that is 
attributed partly to an axially dispositioned methyl group which destabilises the low 
energy chair conformer and a methylene linker that allows for more efficient lone pair 
donation from the nitrogen atom to the boron atom. 
 
Figure 14 Unsuccessful diol protecting groups 
It was found that reduction of 1,10-phenanthroline afforded diamine 609, which once 
coordinated to a simple boronic acid displayed excellent stability and mobility on silica 
gel. An efficient procedure to coordinate diamine 609 to boronic acids has been shown. 
Synthesis of the mixed diboron 615 has been achieved, albeit in low yield, whereas the 
synthesis of 616 is still challenging. The poor solubility of 615 in ethereal solvents 
prevented its use in standard lithiation–borylation reactions; however, 615 has been 
shown to engage in a reaction with a magnesium carbenoid derived from the 
corresponding α-sulfinyl benzoate in DCM. 
 
Figure 15 Compounds 609, 615 and 616 
In conclusion, the foundations for the project have been laid. Diamine 609 has been 
identified as a suitable group to take forwards in the project and a method for its ligation 





requires further optimisation to become synthetically useful. The next step is to test 
diboron 615 in diboration reactions with terminal alkenes and then to evaluate the 






Chapter 4: Towards a New Leaving Group in 
Lithiation–Borylation Reactions 
Introduction 
Formation of fluorinated boronic esters through boron homologation reactions 
Molander has shown that 2,2,2-diazotrifluoroethane (624)—generated from ammonium 
salt 623 with NaNO2—can be homologated with boronic acids or dihaloboranes to yield 
-CF3 trifluoroborates, such as 625, after quenching the reaction with KHF2 (Scheme 
139).171 The reaction could also be quenched with pinacol to yield the corresponding 
pinacol boronic esters; however, the -CF3 boronic esters were not stable and 
decomposed through auto-oxidation upon isolation. The substrate scope of the reaction 
was broad and tolerated a variety of -CF3 trifluoroborates that contained alkyl (626), 
propargyl (627), electron rich-, electron deficient- and heteroaromatic (628, 629 and 630) 
side chains in excellent yield. The success of the reaction was attributed to the use of a 
very good leaving group (N2), which promoted a rapid 1,2-metallate rearrangement and 
thus suppressed decomposition of the boronate complex. 
 
Scheme 139 Homologation of dihaloboranes with 2,2,2-trifluorodiazoethane 
Interestingly, using the potassium trifluoroborate as limiting reagent did not lead to more 
than trace amounts of over homologation. However, when using a boroxine, such as 631, 
the double homologation product was obtained as the major product (Scheme 140).172 
Using 4.0 equiv of 2,2,2-trifluorodiazoethane (624) proved to be optimum and resulted 
in the formation of bis(homologated) products (632) in good yield and dr. The substrate 
scope was again broad and tolerated substrates containing electron rich- and electron 
deficient aryl groups (633 and 634). The reaction didn’t proceed with ortho-substituted 





One example of a substrate containing a heteroaromatic group was given (637). The 
inclusion of others was limited by the availability of the heteroaromatic boroxines, which 
were unstable and decomposed by protodeboronation upon heating. Evaluation of the 
crystal structure of compound 634 showed the relative configuration to by syn. 
 
Scheme 140 Double homologation of cyclic boroxines with 2,2,2-trifluorodiazoethane 
Dilman has shown that migration of a CF3 or C2F5 group attached directly to boron is 
possible with bromide as a leaving group when forcing conditions are used (Scheme 
141).173 Activation of silyl species 639 with KF afforded a nucleophilic ate complex that 
transfered the RF group to the boron atom of 638, thus forming boronate complex 640. 
Heating the reaction mixture affords migration, which furnished homologated fluorinated 
boronic ester 641. As with Molander’s homologation, the success of this transformation 
is attributed to the use of an excellent leaving group.  
 
Scheme 141 Migration of a perfluoroalkyl group using bromide as a leaving group 
Project Proposal 
A major limitation of lithiation–borylation reactions is that when the boronic ester or 
carbenoid bears an electron withdrawing168,169 or mesomerically stabilising36,37 
substituent, reversible fragmentation of the boronate complex occurs in preference to 
1,2-migration, which results in reduced ee values or decomposition of the sensitive 
organolithium reagents in situ. This phenomenon limits the scope of lithiation–borylation 





relevant substituents—such as (per)fluorinated alkyl groups—with this methodology. We 
envisaged that employing a new leaving group, which is superior to the standard 
carbamate or benzoate, would promote the desired 1,2-migration over reversibility and 
enable (per)fluorinated boronic esters to be accessed with this methodology. However, as 
the nucleofugality of the leaving group is increased the nucleophilicity of the lithiated 
species is reduced, disfavouring boronate complex formation and increasing the 
propensity of reversibility. The ideal moiety would therefore be a very poor leaving 
group—to maximise the nucleophilicity of the carbenoid—until activated with a suitable 
reagent. In addition, the leaving group must be able to coordinate to the s-BuLi/ 
(+)-sparteine complex and direct lithiation. We propose the use of O-alkyl isoureas as 
carbenoid precursors. Treatment of pro-chiral carbenoid precursor 642 with a 
combination of (+)-sparteine and s-BuLi should result in asymmetric deprotonation of the 
pro-R proton through coordination of the nitrogen atom lone pair of the isourea to form 
lithiated species 643, which is predicted to be more nucleophilic than the complementary 
carbamate. Quenching this carbenoid with a boronic ester should result in the formation 
of boronate complex 644. Activation of the isourea with an electrophile should then form 
a very good leaving group, which should trigger migration at a temperature below where 
the boronate complex fragments unproductively to starting material, thus furnishing 
homologated boronic ester 646 and urea derivative 647. The isopropyl group on the 
nitrogen atom of the isourea is designed to block the attack of the sp2 carbon of the isourea 
by s-BuLi (Scheme 142a). This activation strategy has been used previously within our 
group in a metal-free cross-coupling of a boronic ester and pyridine. Upon addition of 
Troc-Cl, boronate 648 was acylated at the nitrogen atom, thus facilitating 1,2-
migration.176 The boronic ester was then oxidised and eliminated to yield the cross-







Scheme 142 The proposed use of isoureas as the leaving group in lithiation–borylation reaction 
Results and Discussion 
Synthesis of isoureas 
We first targeted the synthesis of 5-membered cyclic isourea 656 through an adaption of 
the procedure reported by Jones.177 Cyclic thiourea 654 was accessed in high yield 
through the addition of thiocarbonyldiimidazole (653) to N-isopropyl ethylenediamine 
(652). Refluxing cyclic thiourea 654 in neat iodomethane afforded methyl isothiourea 655 
in almost quantitative yield. Treatment of 655 with sodium ethoxide in EtOH did not 
provide any of the desired isourea (656), instead cyclic urea 657 was isolated exclusively. 
The N-isopropyl group of 656 was designed to be a steric shield to prevent attack of the 
sp2 carbon of the isourea by s-BuLi and so it is plausible that the N-isopropyl group 
effectively shields this position and prevents substitution with EtOH. However, urea 657 
is presumably formed through the attack of 655 by adventitious water. Because the yield 
of urea 657 is poor, an argument could be made that the N-isopropyl group is a good 
enough steric shield to effectively block the attack of EtOH, but is only large enough to 
partially inhibit the attack of water (Scheme 143a). We next sought to promote the desired 
transformation by incorporating a superior leaving group (Scheme 143b). Treatment of 
cyclic urea 657 with triflic anhydride and Et3N gave triflate 659 in 94% yield after stirring 
at ambient temperature for 4 d. Surprisingly, no reaction was observed between 659 and 
the alkoxide derived from alcohol 660, as determined by TLC analysis. This result 
bolstered the idea that the N-isopropyl group is too sterically demanding to allow for 





afford an isourea, such as 661.  
 
Scheme 143 Attempted syntheses of isoureas 656 and 661 
Triflate 663 was formed in situ by addition of triflic anhydride and 2,6-lutidine to 
phenethyl alcohol (662). After 1.5 h complete conversion of alcohol 662 to a new apolar 
spot was observed by TLC analysis. To this was added a solution of urea 657 or 664 and 
triethylamine in DCM. The resulting mixture was heated to 50 C for 18 h. Remarkably, 
triflate 663 was stable under these conditions as neither 663 nor ureas 657 or 664 were 
consumed, as determined by TLC analysis (Scheme 144a). Ureas 657 and 664 were also 
inert under Mitsunobu conditions as no conversion of either was observed after stirring 
in the presence of DIAD and PPh3 for 16 h, as determined by TLC analysis (Scheme 
144b). The origin of this lack of reactivity stems from the low acidity of the urea N-H 
proton. DIAD is known to deprotonate protons with pKa values of up to 15; however, the 
pKa of the urea N-H proton is predicted to be between 19 and 26.178 Instead of DIAD, 
Tsunoda proposes the use of phosphoranes as more reactive Mitsunobu reagents, 
specifically (cyanomethylene)trimethylphosphorane (CMMP) (667) and 
(cyanomethylene)tributylphosphorane (CMBP) (668), which can promote reactivity in 






Scheme 144 Attempted synthesis of isoureas 665 and 666 using urea 657 and 664 as the nucleophile 
The reaction was repeated using Tsunoda’s methodology (Table 16). Urea 657 was first 
reacted with CMMP (667) in benzene in a sealed pressure tube at 100 °C for 18 h, which 
resulted in a complete lack of reactivity and the re-isolation of 657 (Table 16, entry 1). 
The reaction was repeated at 150 °C (Table 16, entry 2); however, these conditions also 
did not promote reactivity. Switching to the more reactive phosphorane (CMBP (668), 
Table 16, entry 3) also resulted in no reactivity and both 657 and 662 were re-isolated. 
Finally, we attempted to utilize 6-membered urea 664 but again no reactivity was 






Table 16 Attempted synthesis of 665 and 666 using phosphoranes 667 and 668 
Our attempts to synthesise isoureas 661 and 671 finally came to fruition when applying a 
copper-catalysed Ullman coupling between triflate 659 or 670 and alcohol 660, as 
described by Buchwald (Table 17).184 Treatment of triflate 659 with CuI, 
3,4,7,8-tetramethyl-1,10-phenathroline and Cs2CO3 in toluene at 110 C for 48 h yielded 
isourea 661 in 17% yield (Table 17, entry 1). An improvement in yield was achieved by 
heating at 200 C under microwave irradiation for 8 hours in xylenes (Table 17, entry 2). 
Complementary results could be achieved when using six-membered triflate 670 under 
the same conditions (Table 17, entry 3). Finally, isourea 671 could be obtained in 49% 
yield by performing the reaction under an atmosphere of air (Table 17, entry 4). With 
desired isoureas 661 and 671 in hand we next sought to test their amenability to 






Table 17 Optimisation of the copper catalysed cross-coupling reaction between triflates 659 and 670 and alcohol 660 
 
Lithiations of isoureas 661 and 671 
The lithiation of isoureas 661 and 671 was next evaluated through lithiation−deuteration 
studies (Table 18). Initially 5-membered cyclic isourea 661 was subjected to 1.1 equiv of 
s-BuLi and 1.1 equiv of TMEDA for 6 hours at −78 C in Et2O. Following this lithiation 
period, the reaction was quenched at −78 C with CD3OD and the mixture warmed to 
ambient temperature (Table 18, entry 1). Crude TLC analysis showed the presence of 3 
spots, which corresponded to starting isourea 661, alcohol 660 and a baseline spot, which 
wasn’t characterised. The presence of alcohol 660 was presumably caused by attack of 
s-BuLi at the sp2-hybridised carbon atom of isourea 661. The baseline spot was therefore 
assumed to be diamine by-products of this process. 1H NMR analysis of the crude reaction 
mixture revealed that no deuteration had occurred. This result was surprising as earlier 
difficulties in synthesising isourea 661 had led us to believe that the isopropyl group 
would be an effective steric block of the sp2-hybridised carbon atom. However, as 
complete conversion of isourea 661 to alcohol 660 had not occurred we continued our 
attempts to optimise the lithiation of this substrate. 6-membered cyclic isourea 671 was 





alcohol 660 was again detected by TLC and 1H NMR analysis and no deuteration was 
observed. Increasing the temperature to −60 C did not allow for deuteration in the case 
of 5-membered cyclic isourea 661 (Table 18, entry 3); however, 38% deuteration of 
6-membered cyclic isourea 671 was observed when also increasing the equivalents of 
s-BuLi and TMEDA (Table 18, entry 4). Unfortunately, elimination of alcohol 660 was 
persistent under these conditions. Changing solvent to CPME had a positive effect for 
6-membered cyclic isourea 571 and gave 50% deuteration; however, 5-membered cyclic 
isourea 661 remained resistant to lithiation (Table 18, entries 5 and 6). It is known that 
increasing the number of equivalents of diamine in relation to s-BuLi is beneficial to the 
lithiation of challenging substrates.185 Attempting the lithiation with 1.5 equivalents of 
s-BuLi and 6.0 equivalents of TMEDA was still not sufficient to afford lithiation of 
5-membered cyclic isourea 661 (Table 18, entry 7). To our surprise, applying these 
conditions to 6-membered cyclic isourea 671 resulted in poorer lithiation than previously 
observed, and when changing the solvent back to Et2O, the level of lithiation was poorer 
still (Table 18, entries 8 and 9). Finally, lithiation was attempted with inverse addition; 
specifically, the addition of 6-membered cyclic isourea 671 to a preformed complex of 
s-BuLi and (+)-sparteine (Table 18, entry 10). As the complex of s-BuLi and (+)-sparteine 
is required to afford lithiation in the corresponding benzoates and carbamates, it was 
predicted that preforming this complex would enhance lithiation and reduce elimination 
of alcohol 660. Unfortunately, this was not the case and complete conversion of 







Table 18 Lithiation–deuteration studies of isoureas 661 and 671 
These results revealed two issues that needed to be addressed. The first is that attack of 
the sp2 carbon atom by s-BuLi is occurring and that a new method of preventing this will 
need to be identified. The second is that lithiation is not occurring. Simply increasing the 
steric bulk of the isopropyl group was predicted to be sufficient to prevent attack of 
s-BuLi and elimination of alcohol 660; however, absence of lithiation was expected to 
persist. As pre-coordination of the s-BuLi/diamine complex with the N atom lone pair of 
the isourea must occur, it was predicted that strengthening this interaction would aid 
lithiation. Both difficulties could plausibly by solved by using an electronic effect rather 
than a steric effect to protect the sp2-hybridised carbon atom of the isourea (Scheme 145). 
Treatment of isourea 674 or 675 with one equivalent of s-BuLi would afford anion 676 
or 677, respectively. This anion would be stabilised through resonance, thus lowering the 
electrophilicity of the sp2 carbon atom. In addition, resonance forms res-676 and res-677 
have a full negative charge at the directing nitrogen atom, thus aiding in formation of a 
pre-coordination complex. Addition of a further equivalent of s-BuLi and a diamine 
should afford lithiation at the desired position, the resulting carbanion then being 
quenched by an electrophile (Scheme 145). Synthesis of ethyl isourea 684 was achieved 





anhydride and triethylamine in DCM afforded triflate 683 in moderate yield. Refluxing 
in ethanol for 4 h afforded desired isourea 684 (Scheme 145). 
 
Scheme 145 Proposed electronic protection of isourea 684 
Lithiation of isourea 684 was first attempted by adding an excess of s-BuLi (Table 19). 
Slow addition of 2.1 equiv of s-BuLi to isourea 684 in the presence of 2.1 equiv of 
TMEDA at −78 C for 5h did not afford deuteration (Table 19, entry 1). Ethanol, a 
potential side product, is volatile and so was not detected after removal of solvent; 
however, only 41% of non-deuterated 684 was recovered, suggesting that decomposition 
of some sort had occurred. To counter this, it was decided to first add one equivalent of a 
non-nucleophilic base to form the desired anion, followed by the addition of s-BuLi 
(Table 19, entry 2). LiHMDS was chosen as the non-nucleophilic base. Following the 
addition of LiHMDS, 2.1 equivalents of s-BuLi were added, the first to deprotonate 
hexamethyldisilylazane and the remaining 1.1 equivalents to afford the desired lithiation. 
Again, no deuteration was observed and only 38% non-deuterated 684 was recovered. 
Following these unsuccessful results, it was decided move away from isoureas and test 
other groups as directing groups in lithiation−borylation reactions. 
 





Isothioureas as a leaving group in lithiation−borylation reactions 
As with benzoates, -lithiation of thioesters followed by trapping of the resulting anion 
with electrophiles is known.186 In contrast to benzoates,187 the carbenoids formed are 
configurationally unstable at −98 C in THF (Scheme 146a). The reason for this lack of 
configurational stability is that −heterosubstituted alkyllithium compounds (where the 
heteroatom is S, Se, P or Si) undergo a three-step racemisation process (Scheme 146b).188 
Dissociation of the lithium ion of 685 forms contact ion pair 686. Hyperconjugation of 
the negative charge into the * orbital of the S−R bond stabilises the configuration where 
the negative charge and sulfur atom bound R group are anti-periplanar to one another; 
however, when the steric repulsion between R groups is great, a rate-determining rotation 
of the C−S bond affords configuration 687. Inversion of the stereocentre restores the 
stabilising hyperconjugation effect, before reassociation of the lithium ion affords the 
enantiomer of the original lithiated species ent-685. This phenomenon is solvent 
dependent and it has been shown within our group that by using TBME as solvent and by 
reducing the lithiation time to five minutes, full deuteration of secondary alkyl STIB 
compounds can be achieved with an er value of 97:3.189 
 
Scheme 146 The configurational instability of lithiated thioesters 
Due to the predicted ease of synthesis we sought to access isothiourea 690 and subject it 
to lithiation reactions (Scheme 147). Treatment of thioureas 645 with iodoethane at reflux 
afforded ethyl isothiouroniums 689 in near quantitative yield. Deprotonation with K2CO3 
then furnished the desired isothiourea 690. Unfortunately, 690 was insoluble in Et2O, 
CPME, TBME, toluene and THF. Attempts were made to lithiate 690 as a suspension; 






Scheme 147 Synthesis of isothiourea 690 
Benzimidazoles as a leaving group in lithiation–borylation reactions 
We next sought to use benzimidazole as a directing group in asymmetric lithiation 
reactions. It was predicted that aromaticity would disfavour direct attack of s-BuLi and 
so prevent decomposition of the substrate through elimination of an alcohol. Due to 
concerns about poor solubility, n-butyl was chosen as the bulky N-alkyl group. The 
synthesis of benzimidazole derivate 693 was achieved in 2 steps (Scheme 148). 
Benzimidazole (691) was first alkylated with n-butyl bromide in high yield to afford 
derivatised benzimidazole 692. A copper-catalysed coupling, modified from the 
procedure reported by Kanai,190 then yielded the desired 2-alkoxy benzimidazole (693). 
 
Scheme 148 Synthesis of benzimidazole derivate 693 
2-alkoxy benzimidazole 693 was then subjected to a lithiation–deuteration study (Table 
20). Treatment of 2-alkoxyl benzimidazole 693 with 1.3 equiv of s-BuLi and 1.3 equiv of 
TMEDA in Et2O at −78 C for 5 h followed by the addition of CD3OD did not lead to 
deuteration (Table 20, entry 1). However, we were encouraged that elimination of alcohol 
660 was not observed. The lack of deuteration was overcome by increasing the 
temperature of the lithiation. Treatment of 2-alkoxyl benzimidazole 693 with s-BuLi at 
–60 °C or –40 °C resulted in complete deuteration after quenching with CD3OD as 
determined by 1H NMR analysis, with no deuterium incorporation at the benzylic position 






Table 20 Lithiation–deuteration studies of 2-alkoxy benzimidazole 693 
With this result in hand we next sought to investigate whether this lithiation could be 
rendered asymmetric by addition of (+)-sparteine. 2-alkoxy benzimidazole 693 was 
treated with s-BuLi and (+)-sparteine at −60 C and the resulting lithiated species trapped 
with trimethyltin chloride to afford stannane 694 (Table 21). Quenching of the lithiated 
species with Me3SnCl afforded the expected stannane 694 in good yield when using either 
TMEDA or (+)-sparteine. Disappointingly, the ee value when lithiation was performed 
in the presence of (+)-sparteine was just 6% (Table 21, entry 2). Poor selectivity in 
asymmetric lithiation reactions can be caused by a number of factors, such as 
configurational instability of the lithiated species, reversible trapping of the electrophile 
or if the electrophile is attacked with a mixture of retention and inversion of the sensitive 
organolithium. Of these, it seems unlikely that reversible trapping is occurring as 
Me3SnCl is not known to trap reversibly with lithiated benzoates.187 Trapping with 
mixtures of retention and inversion are generally observed with benzylic substrates,191 as 
the lithium carbenoid adopts a partially flattened configuration owing to resonance with 
the aryl group, with significant electron density opposite the metal. It is therefore also 
unlikely that this is the cause of the low enantioselectivity. It is known that changing the 
nature of the directing group directly affects configurational stability of the resulting 
lithiated species.186 It is plausible that an aromatic directing group results in the formation 
of a configurationally labile lithiated species. If this is the case, it might be overcome by 
employing bisoxazoline ligands, which have been shown to permit homologation of 
configurationally labile primary benzylic carbamates186,187 and benzoates194 in high ee. 
The success of bisoxazolines in the asymmetric lithiation of primary benzylic carbamates 
and benzoates is because bisoxazolines induce chirality in a thermodynamic manner, ie 
although the initial selectivity of the deprotonation may be low, the enantiomers are in an 
equilibrium that favours one enantiomer. It is also plausible that (+)-sparteine ligated 





substrate 693 in a different way from how it binds to benzoate/carbamate substrates. 
Additionally, it might be that (+)-sparteine is not involved in the lithiation, which could 
arise from a molecule (or molecules) of substrate 693 disaggregating s-BuLi. Due to these 
unfavourable results, 693 was discarded as a target.  
 
Table 21 Synthesis of stannane 694 
Benzotriazole derivatives as a leaving group in lithiation–borylation reactions 
Katritzky has shown that benzotriazole can stabilise -carbanions generated by lithiation 
with organolithiums.195 In light of this interesting reactivity, we next sought to utilize 
benzotriazole as a directing group in lithiation−borylation reactions. Synthesis of 
benzotriazole derivative 697 was achieved in a two-step process from HOBt (695) 
(Scheme 149). Treatment of HOBt (695) with TsCl and imidazole in DCM afforded tosyl 
compound 696 in reasonable yield.196 Simply stirring 696 with 3-phenylpropanol in the 
presence of DBU afforded benzotriazole derivative 697 in 70% yield.197 The lithiation of 
697 was then evaluated in a lithiation–deuteration study (Table 22). 
 
Scheme 149 Synthesis of HOBt derivative 697 
Treatment of benzotriazole derivative 697 with 1.2 equiv of s-BuLi and 1.2 equiv of 
TMEDA at −78 C did not afford deuteration when left for 1, 2 or 3 hours (Table 22, 
entries 1−3). In addition to this, the levels of recovered starting material were poor, and 
3-phenylpropanol (660) was detected by TLC analysis in each case. Due to the observed 
elimination of 660, it was unlikely that successful lithiation conditions would be found 






Table 22 Lithiation–deuteration studies of benzotriazole derivative 697 
Alkoxytetrazole derivatives as a leaving group in lithiation–borylation reactions 
We next turned our attention to the use of tetrazoles. Tetrazole derivative 699 was 
synthesised in 2 steps isopropyl isocyanate (Scheme 150). AlCl3-assisted cycloaddition 
of isopropyl isocyanate and sodium azide afforded tetrazolone 698 in moderate yield. 
Mitsunobu reaction of 698 and 3-phenylpropanol in the presence of DIAD and PPh3 
afforded desired tetrazole derivative 699, which was subjected to a lithiation study. 
 
Scheme 150 Synthesis of tetrazole derivative 699 
Treatment of tetrazole derivative 699 with 1.2 equiv of sBuLi and 1.2 equiv of TMEDA 
in Et2O at −78 C did not afford deuteration incorporation with lithiation times of 1, 2 or 
3 h (Table 23, entries 1−3). However, 3-phenylpropanol was not detected by TLC 
analysis, and the level of starting material recovery was excellent. It is possible that the 
deuterium incorporation could be increased by optimising the lithiation conditions; 






Table 23 Lithiation–deuteration studies of tetrazole 699 
Conclusion 
A new leaving group has been sought to expand the scope of lithiation−borylation 
reactions to include electron-withdrawing groups, with a specific interest in 
perfluorinated alkyl groups. Several candidate groups have been investigated, including 
isoureas, isothioureas, benzimidazoles, benzotriazoles and tetrazoles; however, no 
satisfactory results were obtained. The most common contraindications were poor levels 
of lithiation or instability in the presence of s-BuLi that resulted in decomposition through 
the elimination of an alcohol. A notable exception was benzimidazole 693, which 
underwent lithiation in the presence of s-BuLi and a diamine to afford a chemically stable 
carbenoid that could be quenched with deuterium or tin electrophiles; however, this 
reaction could not be made enantioselective through the utilization of (+)-sparteine. The 
most likely cause of the poor enantioselectivity values obtained when quenching with tin 
electrophiles is that the generated carbenoid is configurationally labile. Utilization of a 
ligand that infers chirality through a thermodynamic deprotonation, such as a 
bisoxazoline, may permit the generation of an enantiopure carbenoid that can be quenched 








This thesis has served to document the contributions made to four projects, three of which 
focussed on the synthesis and reactivity of 1,2-bis(boronic esters) and the fourth 
concentrated on expanding the scope of the lithiation–borylation reaction.  
In the first project, the synthesis of the atorvastatin derivative, 223, was achieved by 
combining Morken’s asymmetric diboration reaction with the Aggarwal group’s 
lithiation–borylation methodology. This method of generating 1,3-bis(boronic esters) 
proved to be superior to reactions of lithiated carbamates/benzoates with diborylmethane 
because benzoate 294 was resistant to deprotonation. 
The total synthesis of bahamaolide A was then undertaken using an iterative 
diboration–homologation sequence to construct the polyol portion of the natural product. 
This synthesis aimed to champion the boronic ester moiety as a functional group handle 
by masking eight of the nine stereodefined hydroxyl groups as boronic esters, which were 
revealed simultaneously through stereospecific oxidation of the carbon–boron bonds. The 
greatest challenge of this project was the purification of poly(boronic ester) intermediates, 
which inhibited the process of carrying material through the synthetic sequence. 
Nevertheless, after optimisation of these bottlenecks we were able to acquire a crude 
sample of the presumed natural product, which is currently awaiting purification by 
reverse phase prepHPLC. 
The third project was concerned with the development of a novel boronic ester protecting 
group to allow the selective homologation of a 1,2-bis(boronic ester) through the more 
hindered internal boron moiety. Aminodiols 590, 591 and 593 were identified as suitable 
candidates, and each displayed 11B NMR chemical shift values, once coordinated to a 
simple boronic acid, that confirmed that all three lowered the Lewis acidity of the boron 
centre relative to a pinacol boronic ester. Disappointingly, boronic esters 594, 595 and 
597 interacted unfavourably with silica gel and so 590, 591 and 593 were discarded as 
targets. Diamine 609 showed an improved stability profile when coordinated to a simple 
boronic acid, and was shown to be a suitable protecting group in the homologation of 
boronic esters with magnesium carbenoids derived from the corresponding α–sulfinyl 
benzoates. The synthesis of mixed diboron species 615 was synthesised in low yield and 






Finally, a new leaving group to be used in lithiation–borylation reactions has been sought. 
A number of functional groups were investigated, such as isoureas, isothioureas, 









Solvents and reagents  
All air- and water-sensitive reactions were carried out in flame-dried glassware under a 
nitrogen or argon atmosphere using standard Schlenk manifold technique. Anhydrous 
solvents were commercially supplied or provided and dried using a purification column 
composed of activated alumina and stored over thoroughly dried 3 Å molecular sieves by 
the communal stills of the School of Chemistry, University of Bristol.198  
n-Butyl lithium [CAS: 109-72-8] was purchased from Acros (181271000) as a 1.60 M 
solution in n-hexane. s-Butyl lithium [CAS: 598-30-1] was purchased from Acros 
(187541000) as a 1.30 M solution in cyclohexane:n-hexane 98:2. t-Butyl lithium [CAS: 
594-19-4] was purchased from Sigma-Aldrich (186198) as a 1.70 M solution in n-pentane. 
(+)-Sparteine and (−)-sparteine were obtained from the commercially available sulphate 
pentahydrate salt (99%, Acros) and isolated according to literature procedure.199 The 
sparteine free base readily absorbs atmospheric carbon dioxide (CO2) and so should be 
stored under argon/nitrogen at −20 °C in a sealed Schlenk-tube. The molarity of 
organolithium solutions was regularly determined by titration using N-benzyl benzamide 
as an indicator.200 
All other reagents were purchased from various commercial sources and used as received 
or synthesised according to the procedures given. 
 
Chromatography, Spectroscopy and Apparatus  
Flash column chromatography (FCC) was carried out using Fluorochem silica gel 
LC60A-40 (63 μm) or Aldrich technical grade silica gel (40-63 μm). All reactions were 
followed by thin-layer chromatography (TLC) when practical, using Merck Kieselgel 60 
F254 fluorescent treated silica which was visualized under UV light or by staining with 
aqueous basic potassium permanganate.  
1H, 13C and 11B NMR spectra were recorded using Jeol ECP(Eclipse) 300 MHz, Jeol ECS 
400 MHz, Bruker 400 MHz, Varian VNMR 400 MHz, Varian VNMR 500 MHz, and 
Bruker Advance III HD 500 MHz cryo spectrometers. Chemical shifts (δ) are given in 
parts per million (ppm), and coupling constants (J) are given in Hertz (Hz), rounded to 
the nearest 0.5 Hz. The 1H NMR spectra are reported as follows: ppm (multiplicity, 





according to spin systems, using two-dimensional (COSY, HSQC, HMBC) NMR 
spectroscopy to assist the assignment. Where an assignment could not be made 
unambiguously, possible assignments are listed.  
High resolution mass spectra (HRMS) were recorded on a VG Analytical Autospec by 
Electron Ionization (EI) or Chemical Ionization (CI), or on a Bruker Daltonics Apex IV 
or Bruker micrOTOF II by Electrospray Ionization (ESI), or on a Bruker Daltonics 
UltrafleXtreme (MALDI). 
IR spectra were recorded on a Perkin Elmer Spectrum One FT-IR as a thin film. Only 
selected absorption maxima (νmax) are reported in wavenumbers (cm–1).  
Melting points were recorded in degrees Celsius (°C), using a Kofler hot-stage 
microscope apparatus and are reported uncorrected.  
Optical rotation ([𝛼]𝐷
𝑇 ) was measured on a Bellingham and Stanley Ltd. ADP220 
polarimeter and is quoted in (° ml)(g dm)–1. 
Chiral HPLC was performed on a HP Agilent 1100 with a Chiralpak IA, IB or IC 
column, or a Chiralcel AD-H column, and monitored by DAD (Diode Array Detector). 
Chiral GC was performed on an Agilent 7890A using Chiraldex -DP 120 (30m x 
0.25mm x 0.25μm). 
Chiral SFC was performed on a Waters TharSFC system using a Diacel Chiralpak IB 
column (4.6 m × 250 mm × 5 μm) and monitored by DAD (Diode Array Detector). 
GC-MS was performed on an Agilent 7820A using a HP-5MS UI column (30 m × 0.25 
mm × 0.25 μm). 
 
Naming of Compounds  
Compound names are those generated by ChemBioDraw 13.0/14.0 software 






Experimental procedures and characterisation data 
Bis(4, 4, 5, 5,-tetramethyl-1, 3, 2-dioxaborolan-2-yl)methane (225) 
 
According to a modified literature procedure,201 Copper(I) iodide (1.87 g, 0.0098 mmol, 
1.0 mol%), triphenylphosphine (3.40 g, 0.013 mmol), lithium methoxide (11.2 g, 0.294 
mmol, 3.0 equiv) and bis(pinacolato)diboron (50.0 g, 0.197 mmol, 2.0 equiv)) were 
charged to a flame-dried three-neck flask under an atmosphere of nitrogen. 
Dibromomethane (6.90 ml, 0.098 mmol, 1.0 equiv) in anhydrous DMF (197 ml,) was 
added at 0 °C resulting in a black solution. The reaction mixture was warmed to ambient 
temperature and stirred for 16 h. The reaction mixture was then diluted with Et2O (50 ml) 
and filtered through a Celite plug. The mother liquor was washed with water (3 x 50 ml), 
brine (50 ml), dried over MgSO4, filtered and concentrated in vacuo to a colourless oil, 
which solidified under high vacuum to afford 225 (13.8 g, 52%) as an amorphous white 
solid. 
Spectral data in accordance with the published values201 
1H NMR (400 MHz, CDCl3) δ 1.22 (m, 24H, 8 x CH3), 0.33 (s, 2H, BCH2B) ppm. 
13C NMR (101 MHz, CDCl3) δ 83.0 (C), 24.7 (CH3) ppm.  
Carbon atom next to boron not observed due to quadrupolar relaxation. 
11B NMR (96 MHz) δ 32.4 (s) ppm. 
3-(Dibenzylamino)propyl 2,4,6-triisopropylbenzoate (266) 
 
According to a modified literature procedure,185 diisopropyldiazodicarboxylate (4.25 ml, 
21.6 mmol, 1.10 equiv) was added dropwise to a stirred solution of 3-
(dibenzylamino)propan-1-ol (265) (5.00 g, 19.6 mmol, 1.00 equiv), triisopropylbenzoic 
acid (5.59 g, 22.5 mmol, 1.15 equiv) and triphenylphosphine (5.64 g, 21.6 mmol, 1.10 





completion of the addition the reaction mixture appeared pale yellow. The reaction 
mixture was warmed to ambient temperature and stirred for 16 h. At this point the reaction 
mixture was concentrated in vacuo to a yellow oil. This oil was triturated in pentane, 
causing the precipitation triphenylphosphine oxide. The triphenylphosphine oxide was 
filtered, and the mother liquor concentrated in vacuo to a yellow oil. The crude residue 
was purified by column chromatography (SiO2, pentane:Et2O 95:5) to yield the title 
compound (266) (8.30 g, 87%) as an amorphous white solid. 
Rf 0.34 (pentane/Et2O, 90:10) 
1H NMR (400 MHz, CDCl3) δ 7.36–7.33 (m, 4H, ArH), 7.29 (m, 4H, ArH), 7.21 (m, 2H, 
ArH), 6.98 (s, 2H, ArH), 4.32 (t, J = 6.8 Hz, 2H, OCH2), 3.57 (s, 4H, N(CH2Ph)2), 2.88 
(sept, J = 6.9 Hz, 1H, para-CH), 2.80 (sept, J=6.8 Hz, 2H, 2 x ortho-CH), 2.57 (t, J = 6.8, 
2H, NCH2), 1.92 (p, J = 6.8, 2H, NCH2CH2), 1.24 (d, J = 6.9 Hz, 6H, para-CH(CH3)2), 
1.20 (d, J = 6.8 Hz, 12H, 2 x ortho-CH(CH3)2) ppm. 
13C NMR (101 MHz, CDCl3) δ 171.0 (C=O), 150.2 (C), 144.9 (C), 139.6 (C), 130.7 (C), 
128.9 (CH), 128.4 (CH), 127.0 (CH), 121.0 (CH), 63.7 (CH2), 58.5 (CH2), 50.8 (CH2), 
34.6 (CH), 31.6 (CH), 26.7 (CH2), 24.3 (CH3), 24.1 (CH3) ppm. 
IR (max/cm–1, neat): 2963.6, 2795.8, 1721.0, 1248.6 and 1081.2. 
HRMS (ESI) calculated for C33H44NO2 [M+H]+ 486.3367, found: 486.3357. 
 
3-(Dibenzylamino)propyl diisopropylcarbamate (267) 
 
According to a modified literature procedure,175 triethylamine (1.81 ml, 13.0 mmol, 1.30 
equiv) was added to a stirred solution of 3-(dibenzylamino)propan-1-ol (265) (2.55 g, 
10.0 mmol, 1.00 equiv) and diisopropylcarbamoyl chloride (1.96 g, 12.0 mmol 1.20 
equiv) in anhydrous toluene (1.00 M, 10.0 ml). The solution was stirred briefly to ensure 
complete dissolution before being heated at 150 °C for 2 h under microwave irradiation. 





concentrated to a yellow oil. This oil was purified by bulb-to-bulb distillation to yield the 
title compound (267) (3.10 g, 81%) as a yellow oil. 
Rf 0.42 (DCM) 
1H NMR (400 MHz, CDCl3) δ 7.36 (m, 4H, ArH), 7.29 (t, J = 7.4, 4H, ArH), 7.23–7.19 
(m, 2H, ArH), 4.10 (t, J = 6.3, 2H, OCH2), 3.56 (s, 4H, N(CH2Ph)2), 2.53 (t, J = 7.1 Hz, 
2H, NCH2), 1.85 (p, J = 6.3 Hz, NCH2CH2), 1.10 (br. s, 12H, N(CH(CH3)2)2) ppm. 
13C NMR (101 MHz, CDCl3) δ 155.7 (C=O), 139.7 (C), 128.7 (CH), 128.2 (CH), 126.8 
(CH), 62.9 (CH2), 58.4 (CH2), 50.3 (CH2), 45.4 (CH), 26.8 (CH2), 20.8 (CH3) ppm. 
IR (max/cm–1, neat): 2965.4, 2796.7, 1687.1, 1451.2 and 1288.8. 
HRMS (ESI) calculated for C24H35N2O2 [M+H]+ 383.2693, found: 383.2681. 
1-(3-Hydroxypropyl)-2,5-dimethylpyrrole (277) 
 
According to a literature procedure,202 p-toluenesulfonic acid (138 mg, 0.80 mmol, 20.0 
mol%) was added to a stirred solution of 3-amino-1-propanol (264) (3.05 ml, 39.9 mmol, 
1.00 equiv) and acetonylacetone (5.60 ml, 47.9 mmol, 1.20 equiv) in toluene (0.11 M, 362 
ml) and the resulting solution was heated at reflux with a Dean−Stark trap for 16 h. After 
this time, the reaction mixture was cooled to ambient temperature and concentrated in 
vacuo to a deep red oil. This oil was purified by column chromatography (SiO2, 
pentane:Et2O 20:80) to yield 277 (6.04 g, 99%) as a red oil.  
All data matched that reported in the literature.203 
1H NMR (400 MHz, CDCl3) δ 5.77 (br. s, 2H, ArH), 3.89 (m, 2H, OCH2), 3.69 (t, J = 
6.0 Hz, 2H, NCH2), 2.24 (s, 6H, 2 x NC(CH3)2), 1.87 (m, 2H, NCH2CH2) ppm. 
13C NMR (101 MHz, CDCl3) δ 127.6 (C), 105.2 (CH), 60.2 (CH2), 40.5 (CH2), 33.7 









According to a modified literature procedure,185 diisopropylazodicarboxylate (2.06 ml, 
10.8 mmol, 1.10 equiv) was added dropwise to a stirred solution of triphenylphosphine 
(2.82 g, 10.77 mmol, 1.10 equiv), 3-(2,5-dimethyl-1H-pyrrol-1-yl)propan-1-ol (277) 
(1.50 g, 9.79 mmol, 1.00 equiv) and 2,4,6-triisopropylbenzoic acid (2.80 g, 11.26 mmol, 
1.15 equiv) in dry THF (0.66 M, 14.8 mmol) at 0 °C over 10 min. The resulting reaction 
mixture was warmed to ambient temperature and stirred at this temperature for 16 h. The 
reaction mixture was then concentrated in vacuo to a yellow oil. This oil was triturated in 
pentane, filtered and concentrated to another yellow oil. This oil was purified by column 
chromatography (SiO2, pentane:Et2O 90:10) to afford the title compound (278) (3.30 g, 
89%) as a colourless oil which later solidified to an amorphous white solid.  
Rf 0.3 (pentane/Et2O, 90:10) 
1H NMR (400 MHz, CDCl3) δ 7.02 (s, 2H, ArH), 5.78 (br. s, 2H, ArH), 4.35 (t, J = 6.2 
Hz, 2H, OCH2), 3.88 (m, 2H, NCH2), 2.90 (hept, J = 6.8 Hz, 1H, para-CH), 2.84 (sep, J 
= 6.8 Hz, 2H, 2 x ortho-CH), 2.22 (s, 6H, N(CCH3)2), 2.09–2.02 (m, 2H, NCH2CH2), 
1.26 (d, J = 7.2 Hz, 18H, 3 x CH(CH3)2) ppm. 
13C NMR (101 MHz, CDCl3) δ 170.9 (C=O), 150.4 (C), 144.9 (C), 130.3 (C), 127.4 (C), 
121.0 (CH), 105.5 (CH), 62.4 (CH2), 40.8 (CH2), 34.5 (CH), 31.7 (CH), 30.3 (CH2), 24.3 
(CH3), 24.0 (CH3), 12.6 (CH3) ppm. 
IR (max/cm–1, neat): 2958.0, 1720.3, 1251.6, 1072.6 and 750.1. 









3-(2,5-Dimethyl-1H-pyrrol-1-yl)propyl diisopropylcarbamate (279) 
 
According to a modified literature procedure,175 triethylamine (1.77 ml, 12.7 mmol, 1.30 
equiv) was added to a stirred solution of 3-(2,5-dimethyl-1H-pyrrol-1-yl)propan-1-ol 
(277) (1.5 g, 9.8 mmol, 1.00 equiv) and diisopropylcarbamoyl chloride (1.91 g, 11.7 
mmol, 1.20 equiv) in anhydrous toluene (1.00 M, 9.80 ml). The resulting reaction mixture 
was heated at 150 °C in a sealed tube for 2 h under microwave irradiation. The reaction 
mixture was cooled to ambient temperature, filtered through a plug of silica gel eluting 
with Et2O and concentrated to a brown oil. This oil was purified by column 
chromatography (SiO2, pentane:Et2O 80:20) to yield 279 (2.18 g, 79%) as a colourless 
oil. 
Rf 0.08 (pentane/Et2O, 90:10) 
1H NMR (400 MHz, CDCl3) δ 5.72 (br. s, 2H, ArH), 4.14 (t, J = 6.0 Hz, 2H, OCH2), 
3.90 (br. s, 2H, N(CH)2), 3.87–3.83 (m, 2H, NCH2), 2.22 (s, 6H, NC(CH3)2), 1.97 (m, 
2H, NCH2CH2), 1.23 (d, J = 6.8 Hz, 12H, 2 x NCH(CH3)2) ppm. 
13C NMR (101 MHz, CDCl3) δ 155.5 (C=O), 127.4 (C), 105.4 (CH), 62.0 (CH2), 46.1 
(CH), 41.0 (CH2), 30.7 (CH2), 21.1 (CH3), 12.5 (CH3) ppm. 
IR (max/cm–1, neat): 2968.4, 1688.1, 1288.0, 1063.8 and 746.4. 




s-BuLi (1.30 M in hexanes, 3.60 ml, 4.70 mmol, 1.20 equiv) was added dropwise to a 
stirred solution of 3-(2,5-dimethyl-1H-pyrrol-1-yl)propyl-2,4,6-triisopropylbenzoate 





in anhydrous Et2O (0.33 M, 11.8 ml) at −78 °C under an atmosphere of nitrogen. The 
resulting mixture was stirred at –78 °C for 3 h. A solution of diborylmethane (225) (1.57 
g, 5.97 mmol, 1.50 equiv) in anhydrous Et2O (0.50 M, 11.9 ml) was added dropwise and 
stirred for 1 h at −78 °C. The reaction mixture was warmed to ambient temperature and 
stirred for 16 h before being diluted with water (50 ml) and Et2O (50 ml). The layers were 
separated, and the aqueous phase extracted with Et2O (3 x 50 ml), washed with brine (50 
ml), dried over MgSO4, filtered and concentrated in vacuo to an orange oil. This residue 
was purified by column chromatography (SiO2, pentane:Et2O 90:10) to afford the title 
compound (227) (0.99 g, 63%, 97:3 er) as a colourless oil.  
Rf 0.17 (pentane/Et2O, 90:10)  
1H NMR (400 MHz, CDCl3) δ 6.07–4.67 (br. s, 2H, ArH), 3.80–3.63 (m, 2H, NCH2), 
2.20 (s, 6H, N(CCH3)2), 1.70 (m, 1H, NCHCHaHb), 1.60 (m, 1H, NCHCHaHb), 1.27–1.18 
(m, 24H, 8 x pinacol-CH3), 1.23 (m, 1H, BCH), 0.96 (dd, J = 15.8, 8.9 Hz, 1H, BCHaHb), 
0.85 (dd, J = 15.8, 6.2 Hz, 1 H, BCHaHb) ppm. 
13C NMR (101 MHz, CDCl3) δ 127.4 (C), 104.8 (CH), 83.2 (pinacol-C), 83.1 (pinacol-
C), 43.4 (CH2), 34.8 (CH2), 25.0 (pinacol-CH3), 25.0 (pinacol-CH3), 25.0 (pinacol-CH3), 
24.9 (pinacol-CH3), 12.4 (CH3) ppm. 
Carbon atoms next to boron not observed due to quadrupolar relaxation 
IR (max/cm–1, neat): 2976.40, 1369.0, 1140.4, 967.6, 845.2 and 743.7. 
HRMS (ESI) calculated for C22H40B2NO4 [M+H]+ 404.3138, found: 404.3140. 
[𝜶]𝑫
𝟐𝟐(CHCl3, c = 1) +1. 
Chiral HPLC: (Diacel Chiralpak IB column (25 cm) with guard, hexane:IPA (1:1), 










According to a modified literature procedure,202 1,3-propanediol (285) (9.50 ml, 126.4 
mmol, 1.00 equiv) was added dropwise to a stirred suspension of NaH (60% dispersion 
in mineral oil, 5.06 g, 126 mmol. 1.00 equiv) in anhydrous THF (0.20 M, 632 ml) at 0 °C 
under an atmosphere of nitrogen. The resulting mixture was warmed to ambient 
temperature and stirred for 1 h. The reaction mixture was then cooled to 0 °C and TBSCl 
(19.1 g, 126 mmol, 1.00 equiv) was added portion wise. The resulting mixture was 
warmed to ambient temperature and stirred for 1 h. The reaction was then quenched with 
a saturated aqueous solution of NH4Cl (250 ml) and was diluted with Et2O (100 ml). The 
phases were separated, and the aqueous phase was extracted with Et2O (3 x 100 ml). The 
combined organics were washed with brine (100 ml), dried over MgSO4, filtered and 





All data matched that reported in the literature.202 
1H NMR (400 MHz, CDCl3) δ 3.84 (m, 2H, OCH2), 3.80 (m, 2H, OCH2), 2.54 (br. s, 1H, 
OH), 1.78 (m, 2H, OCH2CH2), 0.90 (s, 9H, SiC(CH3)3), 0.08 (s, 6H, Si(CH3)2). ppm. 
13C NMR (101 MHz, CDCl3) δ 62.9 (CH2), 62.4 (CH2), 34.2 (CH2), 25.9 (C), 18.2 (CH3), 
–5.5 (CH3) ppm.  
3-((t-Butyldimethylsilyl)oxy)propyl 2,4,6-triisopropylbenzoate (287) 
 
Diisopropyl azodicarboxylate (0.10 ml, 0.52 mmol, 1.10 equiv) was added dropwise to a 
solution of 3-((t-butyldimethylsilyl)oxy)propan-1-ol (286) (89.5 mg, 0.47 mmol, 1.00 
equiv), triphenyl phosphine (136 mg, 0.52 mmol, 1.10 equiv) and 2,4,6-
triisopropylbenzoic acid (134 mg, 0.54 mmol, 1.15 equiv) in anhydrous THF (0.66 M, 
0.71 ml) at 0 °C. The resulting solution was warmed to ambient temperature and was 
stirred at this temperature for 4 h. The reaction mixture was then concentrated in vacuo. 
The crude residue was purified by flash column chromatography (SiO2, pentane:Et2O 
99:1) to yield 287 (135 mg, 68%) as a colourless oil.  
Rf 0.62 (pentane:Et2O 97:3) 
1H NMR (400 MHz, CDCl3)  7.00 (s, 2H, ArH), 4.40 (t, J = 6.4 Hz, 2H, TIBOCH2), 
3.72 (t, J = 6.1, SiOCH2), 2.89 (hept, J = 6.9 Hz, 1H, para-CH(CH3)2), 2.85 (sept, J = 6.9 
Hz, 2H, 2 x ortho-CH(CH3)2), 1.93 (app p, J = 6.4 Hz, 2H, OCH2CH2), 1.24 (d, J = 6.9 
Hz, 18H, 3 x CH(CH3)2), 0.90 (s, 9H, SiC(CH3)3), 0.05 (s, 6H, Si(CH3)2) ppm. 
13C NMR (101 MHz, CDCl3)  171.0 (C=O), 150.1 (C), 144.8 (C), 130.7 (C), 120.9 
(CH), 62.1 (CH2), 59.6 (CH2), 34.5 (CH), 32.0 (CH2), 31.6 (CH), 26.0 (CH3), 24.2 (CH3), 
24.0 (CH3), 18.3 (C), −5.3 (CH3) ppm. 
IR (νmax/cm–1, neat) 2958, 2869, 1726, 1462, 1250, 1073 and 836. 








triisopropylbenzoate (288)  
 
According to a modified literature procedure,52 a flame dried Schlenk tube was attached 
to a vacuum manifold. The reaction flask was evacuated and refilled with nitrogen three 
times. 3-((t-Butyldimethylsilyl)oxy)propyl 2,4,6-triisopropylbenzoate (287) (1.00 g, 2.38 
mmol, 1.00 equiv) and (+)-sparteine (0.71 ml, 3.10 mmol, 1.30 equiv) were added to the 
vessel followed by the addition of anhydrous Et2O (0.24 M, 9.70 ml). The solution was 
cooled to −78 °C and was allowed to equilibrate for 5 min. s-BuLi (1.30 M in hexanes, 
2.38 ml, 3.10 mmol, 1.30 equiv) was added dropwise over 10 min (colour change: 
colourless to brown) and the resulting solution was stirred at −78 °C for 4 h. Me3SnCl 
(1.00 M in hexanes, 3.10 ml, 3.10 mmol, 1.30 equiv) was then added dropwise over 15 
min and the resulting solution was stirred at −78 °C for 20 min (colour change: brown to 
yellow to white). The reaction mixture was warmed to ambient temperature and stirred 
for 1 h. The reaction mixture was diluted with an aqueous solution of HCl (2.00 M, 30.0 
ml) and the layers were separated. The aqueous layer was extracted with Et2O (3 x 50ml) 
and was kept for sparteine recovery. The combined ethereal layers were washed with 
brine (50 ml), dried over MgSO4, filtered and concentrated to a colourless oil. This oil 
was purified by column chromatography (SiO2, pentane:Et2O 96:4) to afford the title 
compound (288) (1.16 g, 84%, 95:5 er) as a colourless oil. 
Rf 0.33 (pentane:Et2O, 98:2) 
1H NMR (400 MHz, CDCl3) δ 6.99 (s, 2H, ArH), 5.09–5.04 (m, 1H, SnCH), 3.72–3.66 
(m, 2H, OCH2), 2.88 (hept, J = 6.8 Hz, 1H, para-CH), 2.81 (hept, J = 6.8 Hz, 2H, 2 x 
ortho-CH), 2.20–1.98 (m, 2H, OCH2CH2), 1.25–1.23 (m, 2 x ortho-CH(CH3)2), 1.22–
1.19 (m, 6H, para-CH(CH3)2), 0.89 (s, 9H, SiC(CH3)3), 0.19 (s and d, J = 54.1 Hz and d, 
J = 51.8 Hz, 9 H, (SnCH3)3), 0.04 (s, 6H, Si(CH3)2) ppm.  
13C NMR (101 MHz, CDCl3) δ 171.3 (C=O), 149.9 (C), 144.8 (C), 130.7 (C), 120.8 (CH), 
68.5 (CH), 61.0 (CH2), 36.9 (CH2), 34.4 (CH), 31.4 (CH), 25.9 (CH3), 24.3 (CH3), 23.9 





IR (max/cm–1, neat): 2958.5, 1707.4, 1461.9, 1250.6, 1069.3 and 773.7. 
HRMS (ESI) calculated for C28H52NaO3SiSn [M+Na]+ 607.2600, found: 607.2603. 
[𝜶]𝑫
𝟐𝟐(CHCl3, c = 1) –34. 
Chiral HPLC: (Diacel Chiralpak IB column (25 cm) with guard, hexane, 0.9 ml/min, 





To a stirred solution of 3-(2,5-dimethyl-1H-pyrrol-1-yl)propyl-2,4,6-
triisopropylbenzoate (278) (0.33 g, 0.85 mmol 1.00 equiv) and (+)-sparteine (0.20 ml, 
0.85 mmol, 1.00 equiv) in anhydrous Et2O (0.33 M, 2.60 ml) under a nitrogen atmosphere 
in the ‘A’ side of the Aggarwal inverse addition vessel at –78  C was added s-BuLi (1.30 
M in hexanes, 0.65 ml, 0.85 mmol, 1.00 equiv) dropwise to give a brown solution. The 
resulting solution was stirred at –78 °C for 3 h. To a stirred solution of (R)-3-((t-





(0.93 g, 1.6 mmol, 1.90 equiv) in anhydrous Et2O (0.33 M, 4.80 ml) in the ‘B’ side of the 
Aggarwal inverse addition vessel at –78 °C was added n-BuLi (1.60 M in hexanes, 0.95 
ml, 1.53 mmol, 1.80 equiv) dropwise at – 78 °C to give a red solution. The resulting 
solution was stirred at this temperature for 1 h. Concurrently, a solution of diborylmethane 
(225) (0.22 g, 0.85 mmol, 1.00 equiv) in anhydrous Et2O (0.50 M, 1.70 ml) was added 
dropwise to the ‘A’ side of the Aggarwal inverse addition vessel and stirred at –78 °C for 
1 h. After this time the carbenoid in side ‘B’ was tipped portionwise into side ‘A’ and the 
resulting solution stirred for a further hour at –78 °C. The reaction was warmed to ambient 
temperature and then heated at 35 °C for 16 h. The reaction mixture was diluted with 
water (50 ml) and Et2O (50 ml). The layers were separated and the aqueous phase 
extracted with Et2O (3 x 50ml), washed with brine (50ml), dried over MgSO4, filtered 
and concentrated in vacuo to an amber oil. This oil was purified by column 
chromatography (SiO2, pentane:Et2O 90:10) to yield the title compound (291) (115 mg, 
24%) as a colourless oil. 
Rf 0.26 (pentane/Et2O, 90:10) 
1H NMR (400 MHz, CDCl3) δ 6.07–5.25 (br. s, 2H, ArH), 3.72–3.63 (m, 2H, NCH2), 
3.63–3.52 (m, 2H, OCH2), 2.22–2.17 (m, 6H, N(CCH3)2), 1.69–1.55 (m, 2H, NCH2CH2), 
1.69–1.55 (m, 2H, OCH2CH2), 1.55–1.47 (m, 2H, NCH2CH2CH and OCH2CH2CH), 
1.26–1.18 (m, 24H, 8 x pinacol-CH3), 1.10–1.00 (m, 2H, BCCH2CB), 0.88 (s, 9H, 
SiC(CH3)3), 0.03 (s, 6H, Si(CH3)2) ppm. 
13C NMR (101 MHz, CDCl3) δ 127.0 (C), 104.5 (CH), 83.3 (pinacol-C), 83.1 (pinacol-
C), 63.1 (CH2), 43.3 (CH2), 35.1 (CH2), 33.1 (CH2), 32.8 (CH2), 25.0 (pinacol-CH3), 25.0 
(pinacol-CH3), 24.7 (CH3), 17.9 (C), 12.1 (CH3), –5.6 (CH3) ppm. 
Carbon atoms next to boron not observed due to quadrupolar relaxation. 
IR (max/cm–1, neat): 2976.2, 2928.3, 2856.8, 1378.3, 1141.7 and 835.0. 











Pivalic acid (0.19 g, 1.81 mmol, 0.20 equiv) was added to a solution of 2-(2-(4-
fluorophenyl)-2-oxo-1-phenylethyl)-4-methyl-3-oxo-N-phenylpentanamide (248) (1.02 
g, 9.05 mmol, 1.00 equiv) and 3-aminopropan-1-ol (1.04 mL, 13.6 mmol, 1.50 equiv) in 
a mixture of toluene (4.5 mL), heptane (18.0 mL) and THF (4.5 mL). The reaction mixture 
was stirred at 120 °C (oil bath) for 16 h. The reaction mixture was cooled to ambient 
temperature and diluted with H2O (50 mL) and Et2O (50 mL). The phases were separated, 
and the aqueous phase was extracted with Et2O (3 × 100 mL) and the combined organic 
phases were washed with brine (50 mL), dried over MgSO4, filtered and concentrated in 
vacuo. The crude residue was purified by flash column chromatography (SiO2, 
Et2O:pentane 60:40) to yield 293 (2.67 g, 65%) as a white solid. 
Rf 0.24 (Et2O:pentane 60:40) 
1H NMR (500 MHz, CDCl3)  7.21−7.15 (m, 9H, ArH), 7.08−7.04 (m, 2H, ArH), 
6.95−7.03 (m, 3H, ArH), 6.86 (br. s, 1H, NH), 4.03−3.99 (m, 2H, OCH2), 3.56 (hept, J = 
7.2 Hz, 1H, CH), 3.51 (dd, J = 10.9, 5.6 Hz, 2H, NCH2), 1.82−1.74 (m, 2H, OCH2CH2), 
1.54 (d, J = 7.2 Hz, 6H, 2 x CH3) ppm. 
13C NMR (126 MHz, CDCl3)  164.7 (C=O), 162.4 (d, JC-F = 248.0, CF), 141.5 (C), 138.4 
(C), 134.6 (C), 133.3 (d, JC-F = 8.2 Hz, CH and C), 130.5 (CH), 128.8 (C), 128.7 (CH), 
128.4 (CH), 128.3 (d, JC-F = 3.4 Hz, C), 126.6 (CH), 123.5 (CH), 121.9 (C), 119.6 (CH), 
115.6 (d, JC-F = 21.9 Hz, CH), 59.9 (CH2), 41.7 (CH2), 34.3 (CH2), 26.2 (CH), 21.7 (CH3) 
ppm. 
IR (max/cm–1, neat) 3404.4, 2960.3, 1658.2, 1651.3, 1594.8, 1525.5 and 1507.3. 







yl)propyl 2,4,6-triisopropylbenzoate (294) 
 
To a stirred solution of triphenylphosphene (0.63 g, 2.41 mmol, 1.10 equiv), 5-(4-
fluorophenyl)-1-(3-hydroxypropyl)-2-isopropyl-N,4-diphenyl-1H-pyrrole-3-
carboxamide (293) (1.00 g, 2.19 mmol, 1.00 equiv) and 2,4,6-triisopropylbenzoic acid 
(0.63 g, 2.52 mmol, 1.15 equiv) in anhydrous THF (0.66 M, 3.32 mL) under a nitrogen 
atmosphere was added DIAD (0.47 mL, 2.41 mmol, 1.10 equiv) dropwise. The resulting 
reaction mixture was stirred at ambient temperature overnight before the volatiles were 
removed in vacuo. The crude residue was purified by column chromatography (Si2O, 
pentane:Et2O 80:20) to yield 294 (1.23 g, 82%) as a white foam. 
Rf 0.67 (pentane:Et2O 60:40) 
1H NMR (500 MHz, CDCl3) 7.20−7.11 (m, 9H, ArH), 7.07–6.96 (m, 5H, ArH), 
6.86−6.79 (m, 2H, ArH), 4.16 (t, J = 6.2 Hz, 2H, OCH2), 3.99−3.96 (m, 2H, NCH2), 3.47 
(hept, J = 7.1 Hz, 1H, CH), 2.91 (hept, J = 6.8 Hz, 1H, CH), 2.74 (hept, J = 6.8 Hz, 2H, 
2 x CH), 2.05−1.98 (m, 2H, OCH2CH2), 1.52 (d, J = 7.1 Hz, 6H, 2 x CH3), 1.26 (d, J = 
6.8 Hz, 6H, 2xCH3), 1.20 (d, J = 6.8 Hz, 12H, 2 x ((CH3)2)) ppm. 
13C NMR (126 MHz, CDCl3)  170.7 (C=O), 164.7 (C=O), 162.3 (d, JC-F = 248.4 Hz, C), 
150.4 (C), 144.7 (C), 141.5 (C), 138.3 (C), 134.5 (C), 133.0 (d, JC-F = 8.3 Hz, CH and C), 
130.5 (CH), 130.0 (CH), 128.7 (C), 128.7 (CH), 128.4 (CH), 127.9 (d, JC-F = 3.4 Hz, C), 
126.7 (CH), 123.6 (CH), 122.0 (C), 120.9 (CH), 119.6 (CH), 115.4 (d, JC-F = 21.5 Hz, 
CH), 62.1 (CH2), 41.9 (CH2), 34.4 (CH), 31.6 (CH), 30.8 (CH2), 26.3 (CH), 24.1 (CH3), 
23.9 (CH3), 21.7 (CH3) ppm. 
HRMS (ESI) calculated for C45H51FN2NaO3 [M+Na]+ 709.3776, found 709.3790. 









Pivalic acid (0.24 g, 2.40 mmol, 0.20 equiv) was added to a solution of 2-(2-(4-
fluorophenyl)-2- oxo-1-phenylethyl)-4-methyl-3-oxo-N-phenylpentanamide (248) (5.00 
g, 12.0 mmol, 1.00 equiv) and but-3-en-1-amine (1.65 mL, 18.0 mmol, 1.50 equiv) in a 
mixture of toluene (5.90 mL), heptane (23.5 mL) and THF (5.90 mL). The reaction 
mixture was stirred at 120 °C (oil bath) for 16 h. The reaction mixture was cooled to 
ambient temperature and diluted with H2O (50 mL) and Et2O (50 mL). The phases were 
separated and the aqueous phase was extracted with Et2O (3 × 100 mL) and the combined 
organic phases were washed with brine (50 mL), dried over MgSO4, filtered and 
concentrated in vacuo. The crude residue was purified by flash column chromatography 
(SiO2, pentane:Et2O 5:1) to yield 304 (5.43 g, 62%) as a white solid. 
Rf 0.52 (pentane:Et2O 80:20) 
1H NMR (400 MHz, CDCl3)  7.21−7.15 (m, 9H, ArH), 7.08−7.04 (m, 2H, ArH), 
6.95−7.03 (m, 3H, ArH), 6.86 (br. s, 1H, NH), 5.57 (ddt, J = 17.1, 10.3, 6.8 Hz, 1H, 
CH=CH2), 5.02−4.92 (m, 2H, CH=CH2), 3.89 (m, 2H, NCH2), 3.57 (sept, J = 7.2 Hz, 
CH(CH3)2), 2.27 (m, 2H, NCH2CH2), 1.54 (d, J = 7.2 Hz, 6H, CH(CH3)2) ppm.  
13C NMR (101 MHz, CDCl3)  164.7 (C=O), 162.4 (d, JC-F = 248.0, CF), 141.4 (C), 138.4 
(C), 134.6 (C), 133.7 (CH=CH2), 133.3 (d, JC-F = 8.2 Hz, CH and C), 130.5 (CH), 128.8 
(C), 128.7 (CH), 128.3 (CH), 128.3 (d, JC-F = 3.4 Hz, C), 126.6 (CH), 123.5 (CH), 121.8 
(C), 119.5 (CH), 117.3 (CH=CH2), 115.5 (d, JC-F = 21.9 Hz, CH), 44.0 (NCH2), 35.7 
(NCH2CH2), 26.2 (CH(CH3)2), 21.7 (CH(CH3)2) ppm. 
IR (max/cm–1, neat) 3392, 2963, 1656, 1529, 1218 and 755. 
HRMS (ESI) calculated for C30H30FN2O [M+H]+ 453.2337, found 453.2333. 








Pt(dba)3 (17.8 mg, 0.02 mmol, 3.00 mol%), (S,S)-297 (36.0 mg, 0.04 mmol, 6.00 mol%) 
and B2pin2 (335 mg, 1.32 mmol, 2.00 equiv) were added to a flame-dried Schlenk-tube 
purged with N2. Anhydrous THF (1.00 M, 0.66 mL) was added before sealing the flask 
and heating at 80 °C (oil bath) for 30 min. After cooling to ambient temperature, 1-(but-
3-en-1-yl)-5-(4-fluorophenyl)-2-isopropyl-N,4-diphenyl-1H-pyrrole-3-carboxamide 
(304) (300 mg, 0.66 mmol, 1.00 eq.) was added before re-sealing and heating for 16 h at 
60 °C (oil bath). The solution was then cooled to ambient temperature and concentrated 
under reduced pressure. The crude residue was directly purified by flash column 
chromatography (SiO2, pentane:Et2O 5:1) to yield ent-296 (287 mg, 62%) as a white 
foam. 
Rf 0.24 (pentane:Et2O 80:20) 
1H NMR (400 MHz, CDCl3)  7.21−7.11 (m, 9H, ArH), 7.08−7.03 (m, 2H, ArH), 
7.00−6.94 (m, 3H, ArH), 6.85 (br. s, 1H, NH), 3.87 (dt, J = 13.0, 4.9 Hz, 1H, NCHaHb ), 
3.73 (dt, J = 13.0, 4.9 Hz, 1H, NCHaHb ), 3.58−3.44 (m, 1H, CH(CH3)2), 1.84−1.71 (m, 
1H, NCH2CHaHb ), 1.69−1.59 (m, 1H, NCH2CHaHb), 1.54 (d, J = 7.1 Hz, 6H, CH(CH3)2), 
1.22 (s, 12H, 2×C(CH3)2), 1.18 (s, 12H, 2 × C(CH3)2), 1.06−0.98 (m, 1H, CHBpin), 0.81 
(dd, J = 15.9, 9.1 Hz, 1H, CHaHbBpin), 0.69 (dd, J = 15.9, 5.8 Hz, 1H, CHaHbBpin) ppm. 
13C NMR (101 MHz, CDCl3)  165.0 (C=O), 161.1 (d, JC-F = 246.7 Hz, CF), 141.5 (C), 
138.6 (C), 135.0 (C), 133.4 (d, JC-F = 8.9 Hz, CH and C), 130.6 (CH), 128.7 (C), 128.5 
(CH), 128.3 (CH), 126.5 (CH), 123.5 (CH), 121.6 (C), 119.6 (CH), 115.3 (d, JC-F = 21.4 
Hz, CH), 83.2 (d, JC-F = 9.3 Hz, C), 44.4 (NCH2), 36.1 (NCH2CH2), 26.2 (CH3), 25.0 
(pinacol-CH3), 24.8 (pinacol-CH3), 21.7 (CH3) ppm. 
Carbon atoms next to boron not observed due to quadrupolar relaxation. 





HRMS (ESI) calculated for C42H53B2FN2NaO5 [M+Na]+ 729.4031, found 729.4040. 
[𝜶]𝑫




3-((t-Butyldimethylsilyl)oxy)propyl 2,4,6-triisopropylbenzoate (287) (117.8 mg, 0.28 
mmol, 2.00 equiv), (+)-sparteine (0.06 mL, 0.28 mmol, 2.00 equiv) and anhydrous Et2O 
(0.23 M, 1.18 mL) were added to a flame-dried Schlenk-tube purged with N2. The solution 
was cooled to −78 °C (dry ice/acetone) before adding s-BuLi (0.22 mL, 0.28 mmol, 2.00 
equiv) dropwise over 5 min and leaving to react for 4 h at this temperature. Ent-296 (100 
mg, 0.14 mmol, 1.00 equiv) dissolved in anhydrous Et2O (0.50 M, 0.28 mL) was added 
dropwise to the reaction mixture over 1 min before leaving to react for a further 1 h at the 
same temperature. MeOH (0.10 mL) was added dropwise before allowing the flask to 
warm to ambient temperature. Water (50 mL) was added and the reaction mixture was 
extracted with Et2O (3 × 50 mL). The combined organic phases were dried over MgSO4, 
filtered and concentrated under reduced pressure. THF (2 mL) and one crystal of BHT 
were added, before cooling to 0 °C (ice/water). A 2:1 v:v mixture of 3.00 M aqueous 
NaOH (2.74 mL) and 30% aqueous H2O2 (1.38 mL) was prepared at 0 °C (ice/water) and 
degassed by gently bubbling N2 through the solution. This aqueous solution was added at 
once to the vigorously stirred reaction mixture, which was subsequently warmed to 
ambient temperature and allowed to react for 16 hr. Water (50 mL) was added and the 
reaction mixture was extracted with Et2O (3 × 50 mL). The combined organic phases 
were dried over MgSO4, filtered and concentrated in vacuo. The crude residue was 
purified by flash column chromatography (SiO2, pentane:Et2O 50:50) to yield 223 (50 
mg, 54%, >95:5 dr) as a white foam.  





1H NMR (500 MHz, CDCl3)  7.21−7.13 (m, 9H, ArH), 7.08−7.05 (m, 2H, ArH), 
7.01−7.69 (m, 3H, ArH), 6.86 (s, 1H, NH), 4.16−4.08 (m, 2H, NCHaHb , OH), 4.05−3.98 
(m, 2H, CH, OH), 3.93 (ddd, J = 14.8, 10.9, 5.3 Hz, 1H, NCHaHb ), 3.88 (app. dt, J = 
9.9, 4.4 Hz, 1H, OCHaHb ), 3.80 (app. td, J = 10.1, 9.9, 3.2 Hz, 1H, OCHaHb ), 3.75 
(tdd, J = 9.9, 5.1, 3.1 Hz, 1H, CH), 3.58 (sept, J = 6.9 Hz, 1H, CH(CH3)2), 1.73−1.59 (m, 
4H, NCH2CH2, OCH2CH2), 1.57−1.52 (d, J = 6.9 Hz, 6H, CH(CH3)2), 1.49−1.45 (m, 1H, 
OHCHCHaHb ), 1.23−1.19 (m, 1H, OHCHCHaHb ), 0.89 (s, 9H, SiC(CH3)3), 0.07 (s, 
6H, Si(CH3)2) ppm. 
13C NMR (126 MHz, CDCl3)  164.8 (C=O), 162.2 (d, JC-F = 247.6 Hz, CF), 141.6 (C), 
138.4 (C), 134.7 (C), 133.2 (d, JC-F = 7.8 Hz, CH and C), 130.5 (CH), 128.7 (C), 128.6 
(CH), 128.4 (d, JC-F = 3.5 Hz, C), 128.3 (CH), 126.5 (CH), 123.4 (CH), 121.7 (C), 119.5 
(CH), 115.3 (d, JC-F = 21.3 Hz, CH), 74.0 (CH), 69.9 (CH), 62.9 (OCH2), 42.8 
(OHCHCH2), 41.4 (NCH2), 39.2 (OCH2CH2), 26.1 (CH(CH3)2), 25.8 (CH3), 21.6 (CH3), 
18.0 (C), –5.6 (CH3) ppm. 
IR (max/cm–1, neat) 3411, 2928, 2856, 1644, 1509, 1312, 1076 and 835. 
HRMS (ESI) calculated for C39H53FN2O4Si [M+H]+ 659.3675, found: 659.3681  
[𝜶]𝑫




According to a literature procedure,65 s-BuLi (30.5 ml, 39.7 mmol, 1.20 equiv) was added 
dropwise to a stirred solution of but-3-en-1-yl 2,4,6-triisopropylbenzoate (10.0 g, 33.1 
mmol, 1.00 equiv) and (+)-sparteine (9.12 ml, 39.7 mmol, 1.20 equiv) in anhydrous Et2O 
(0.12 M, 275 ml) under N2 at –78 °C (acetone/dry ice). The resulting reaction mixture was 
stirred at –78 °C for 1.5 h. Freshly prepared MgBr2·OEt2 (49.6 mmol, 1.50 equiv) was 
added to the reaction dropwise via cannula and the resulting reaction mixture was stirred 





(1.15 M, 43 ml) was added and the resulting reaction mixture was stirred for a further 1 h 
at –78 °C. The reaction mixture was then warmed to ambient temperature and stirred for 
16 h. The reaction was diluted with a 2 M aqueous solution of HCl (100 ml) and Et2O 
(100 ml) and the phases were separated. The aqueous phase was extracted with Et2O 
(3 x 150 ml) and the combined organic phases were dried over MgSO4, filtered and 
concentrated in vacuo. The aqueous phase was saved for (+)-sparteine recovery.  
Sulfoxide 305 co-elutes with menthol and so the menthol was TMS protected to aid 
separation. The crude residue was stirred under high vacuum until it became a paste, at 
which point DCM (0.50 M, 66 ml) was added followed by NEt3 (8.61 ml) and TMSCl 
(6.81 ml). The resulting mixture was stirred at ambient temperature for 2 h before being 
diluted with water (50 ml). The phases were separated, and the aqueous phase extracted 
with DCM (3 x 50 ml). The combined organic phases were dried over MgSO4 filtered 
and concentrated in vacuo. The crude residue was purified using a biotage isolera one 
system (loading method: dry load (~25 g telos), snap ultra 200g, 0% to 10% EtOAc in 
hexane, 15 column volumes) to give the title compound (305) (9479.5 mg, 65%, >95:5 
dr) as a white solid. 
Preparation of MgBr2·OEt2: 
To a flame dried 3 neck flask fitted with a reflux condenser under N2 was charged oven 
dried Mg (3.13 g, 129 mmol) and anhydrous Et2O (70 ml). To this stirred suspension was 
added 1,2-dibromomethane (0.1 ml) and the resulting suspension was gently heated with 
a heat gun (lowest setting) until the reaction initiated (typically ~5 sec). Following 
initiation, 1,2-dibromoethane (4.20 ml, 49.6 mmol (total volume 4.30 ml)) was added 
dropwise at a rate determined by the vigorousness of the reaction. Upon completion of 
the addition of 1,2-dibromoethane, the reaction was biphasic with a colourless upper layer 
and a grey bottom layer. Both layers were transferred by cannula. The unreacted Mg was 
cooled to 0 °C (water/ ice) and quenched through the slow addition of an appropriate 
amount of a 2 M aqueous solution of HCl. 
All data matched that reported in the literature.65 
1H NMR (500 MHz, CDCl3) δ 7.67 (d, J = 8.0 Hz, 2H, ArH), 7.38 (d, J = 8.0 Hz, 2H, 
ArH), 7.04 (s, 2H, ArH), 5.75 (dd, J = 10.0, 3.0 Hz, 1H, OCH), 5.67 (m, 1H, CH2CH), 





OCHCHaHb), 2.44 (s, 3H, ArCH3), 2.42 (m, 1H, OCHCHaHb), 1.28–1.23 (m, 18H, 
Ar(C(CH3)2)3) ppm. 
13C NMR (126 MHz, CDCl3) δ 170.1 (C=O), 150.7 (C), 145.1 (2C, C × 2), 141.6 (C), 
137.2 (C), 131.3 (C), 130.0 (2C, C × 2), 128.7 (CH), 124.3 (2C, C × 2), 120.9 (2C, C × 
2), 119.2 (CH2), 91.3 (CH), 34.3 (CH), 31.4 (CH2), 27.7 (2C, CH x 2), 24.3 (2C, CH3 × 2), 
24.1 (2C, CH3 × 2), 23.8 (2C, CH3 × 2), 21.3 (CH3) ppm.  
Allyl 2,4,6-triisopropylbenzoate (503) 
 
According to a literature procedure,204 K2CO3 (5.60 g, 40.0 mmol, 2.00 equiv) was added 
to a stirred solution of 2,4,6-triisopropylbenzoic acid (5.12 g, 20.0 mmol, 1.00 equiv) in 
acetonitrile (0.33 M, 60 ml). The resulting suspension was stirred vigorously for 10 min 
before allyl bromide (5.76 ml, 40.0 mmol, 2.00 equiv) was added. The resulting reaction 
mixture was heated at 95 ºC (oil bath) for 1 h, at which point the reaction was deemed 
complete by TLC analysis. The reaction mixture was filtered (EtOAc) and the filtrate 
concentrated in vacuo. The residue was diluted with EtOAc (200 ml) and was 
successively washed with water (2 x 50 ml), brine (50 ml), dried over MgSO4, filtered 
and concentrated in vacuo. The crude residue was purified by flash column 
chromatography (SiO2, pentane:Et2O 98:2) to afford the title compound (503) (5.33 g, 
92%) as a colourless oil.  
All spectral data matched that reported in the literature.204 
1H NMR (400 MHz, CDCl3) δ 7.00 (s, 2H, 2 x ArH), 6.02 (ddt, J = 17.2, 10.4, 6.0 Hz, 
1H, OCH2CH), 5.41 (m, 1H, OCH2CHCHaHb), 5.28 (m, 1H, OCH2CHCHaHb), 2.89 
(hept, J = 6.9 Hz, 1H, pArCH,) 2.86 (sep, J = 6.9 Hz, 2H, 2 x oArCH), 1.24 (d, J = 6.9 
Hz, 18H, 3 x ArCH(CH3)2) ppm. 
13C NMR (101 MHz, CDCl3) δ 170.5 (C=O), 150.2 (C), 144.8 (C), 132.0 (CH), 130.2 









According to a literature procedure,204 K2CO3 (11.13 g, 80.5 mmol, 2.00 equiv) was added 
to a stirred solution of 2,4,6-triisopropylbenzoic acid (10.0 g, 40.3 mmol, 1.00 equiv) in 
acetonitrile (0.33 M, 122 ml). The resulting suspension was stirred vigorously for 10 min 
before ethyl bromide (6.01 ml, 80.5 mmol, 2.00 equiv) was added. The resulting reaction 
mixture was heated at 95 ºC (oil bath) for 2 h. The reaction mixture was filtered through 
a pad of celite (EtOAc) and the filtrate concentrated in vacuo. The crude residue was 
purified by flash column chromatography (SiO2, pentane: Et2O 98:2 to 95:5) to afford the 
title compound (10.35 g, 93%) as a colourless oil. 
All spectral data matched that reported in the literature.48 
1H NMR (400 MHz, CDCl3) δ 7.02 (s, 2H, ArH), 4.38 (q, J = 7.2 Hz, 2H, OCH2), 2.88 
(m, 3H, 2 x oArCH and pArCH), 1.38 (t, J = 7.2 Hz, 3H, OCH2CH3), 1.26 (d, J = 6.9 Hz, 
12H, 2 x oArCH(CH3)2), 1.25 (d, J = 6.9 Hz, 6H, pArCH(CH3)2) ppm. 
13C NMR (101 MHz, CDCl3) δ 170.8 (C=O), 150.1 (C), 144.7 (C), 130.6 (C), 120.8 (CH), 
60.8 (CH2), 34.4 (CH), 31.4 (CH), 24.1 (CH3), 24.0 (CH3), 14.3 (CH3) ppm.   
(R)-1-(Trimethylstannyl)ethyl 2,4,6-triisopropylbenzoate (505) 
 
According to a literature procedure,52 ethyl 2,4,6-triisopropylbenzoate (10.05 g, 36.36 
mmol, 1.00 equiv) and (+)-sparteine (10.9 ml, 47.3 mmol, 1.30 equiv) were added to a 
flame dried Schlenk tube. The flask was evacuated and backfilled with N2 three times. 
Anhydrous Et2O (0.25 M, 181 ml) was added and the resulting solution was cooled to 
–78 ºC (acetone/ dry ice). s-BuLi (10.9 ml, 47.3 mmol, 1.30 equiv) was added dropwise 
and the resulting solution was stirred at –78 ºC for 3 h. Me3SnCl (47.3 ml, 47.3 mmol, 
1.30 equiv, 1.00 M in hexanes) was added dropwise and the resulting solution was stirred 





quenched with 2 M aqueous solution of HCl (150 ml) and the phases were separated. The 
organic phase was washed with 2 M HCl (3 x 50 ml) and the combined aqueous phases 
were retained for (+)-sparteine recovery. The organic phase was dried over MgSO4, 
filtered and concentrated in vacuo to an off white solid. The crude material was purified 
by recrystallisation in hot MeOH (3 ml/g) to afford the title compound (505) (8.304 g, 
52%, 99.9:0.1 er) as white needles. 
All data matched that reported in the literature.52 
1H NMR (500 MHz, CDCl3) δ 6.99 (s, 2H, 2xArH), 5.04 (q, J = 6.9 Hz, 1H, OCH), 2.80–
2.95 (m, 3H, 2 x oArCH and pArCH), 1.58 (m, 3H, OCHCH3), 1.24 (d, J = 6.9 Hz, 18H, 
3 x ArCH(CH3)2), 0.18 (s and d, J = 54.1 Hz and d, J = 51.8 Hz, 9H, Sn(Me)3) ppm. 
13C NMR (126 MHz, CDCl3) δ 171.3 (C=O), 149.9 (C), 144.8 (C), 130.8 (C), 120.8 (CH), 
67.0 (CH), 34.4 (CH), 31.3 (CH), 24.3 (CH3), 24.1 (CH3), 24.0 (CH3), 19.2 (CH3), –9.9 
(CH3) ppm. 
 [𝜶]𝑫
𝟐𝟐 (CHCl3, c = 1) +40. Literature52[𝜶]𝑫
𝟐𝟎 (CHCl3, c = 1.1) +38.3. 
Chiral HPLC (Diacel Chiralpak-IB with guard, hexane, 0.9 mL/min, rt, 210 nm) tR = 5.1 
min (minor), 8.1 min (major), er 99.9:0.1. 


































Isobutyl 2,4,6-triisopropylbenzoate (507) 
 
According to a modified literature procedure,204 K2CO3 (5.60 g, 40.0 mmol, 2.00 equiv) 
was added to a stirred solution of 2,4,6-triisopropylbenzoic acid (5.12 g, 20.0 mmol, 1.00 
equiv) in acetonitrile (0.33 M, 60 ml). The resulting suspension was stirred vigorously for 
10 min before isobutyl bromide (4.40 ml, 40.0 mmol, 2.00 equiv) was added. The 
resulting reaction mixture was heated at 95 ºC (oil bath) for 4 h. The reaction mixture was 
filtered through a pad of celite (EtOAc) and the filtrate concentrated in vacuo. The crude 
residue was purified by flash column chromatography (SiO2, pentane:DCM 90:10 to 
70:30) to afford the title compound (507) (5.35 g, 88%) as a colourless oil.  
All data matched that reported in the literature.205 
1H NMR (400 MHz, CDCl3) δ 7.01 (s, 2H, 2 x ArH), 4.09 (d, J = 6.6 Hz, 2H, OCH2), 
2.95–2.80 (m, 3H, 3 x ArCH), 2.03 (app non, J = 6.6 Hz, 1H, OCH2CH), 1.25 (d, J = 
6.9 Hz, 18H, 3 x ArCH(CH3)2), 0.99 (d, J = 6.6 Hz, 6H, 2 x CH3) ppm. 
13C NMR (101 MHz, CDCl3) δ 171.1 (C=O), 150.0 (C), 144.7 (C), 130.8 (C), 120.8 (CH), 
71.3(CH2), 34.4 (CH), 31.5 (CH), 27.7 (CH), 24.2 (CH3), 24.0 (CH3), 19.3 (CH3) ppm.  
 


































3-(4,4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-yl)propyl 2,4,6-triisopropylbenzoate (504) 
 
According to a modified literature procedure,204 allyl 2,4,6-triisopropylbenzoate (503) 
(1.00 g, 3.47 mmol, 1.00 equiv) and Wilkinson’s catalyst (32.1 mg, 3.47 µmol, 1.00 
mol%) were added to a flame dried Schlenk tube. The flask was evacuated and backfilled 
with N2 three times. DCM (1.00 M, 3.47 ml) was added and the resulting solution cooled 
to 0 ºC (water/ice). Pinacol borane (0.65 ml, 4.5 mmol, 1.3 equiv) was added dropwise 
over 5 min and the resulting solution was stirred at 0 ºC for 15 min before being warmed 
to ambient temperature and stirred for 16 h. The reaction mixture was then diluted with 
water (5 ml) and the phases separated. The aqueous phase was extracted with DCM 
(3 x 10ml). The combined organic phases were dried over MgSO4, filtered and 
concentrated in vacuo. The crude residue was purified by flash column chromatography 
(SiO2, pentane:Et2O 96:4 to 94:6) to yield the title compound (504) (861 mg, 60%) as a 
white solid. 
All data matched that reported in the literature.204 
1H NMR (500 MHz, CDCl3) δ 6.99 (s, 2H, 2 x ArH), 4.27 (t, J = 6.7 Hz, 2H, OCH2), 
2.92-2.81 (m, 3H, 3 x ArCH), 1.84 (tt, J = 7.9, 6.7 Hz, 2H, OCH2CH2), 1.24 (d, J = 7.0 
Hz, 18H, 3 x ArCH(CH3)2), 1.23 (s, 12H, 4 x BOCCH3), 0.87 (t, J = 7.9 Hz, 2H, BCH2) 
ppm. 
13C NMR (126 MHz, CDCl3) δ 171.2 (C=O), 150.1 (C), 144.8 (C), 130.9 (C), 120.9 (CH), 
83.3 (C), 66.9 (CH2), 34.6 (CH), 31.6 (CH), 24.9 (CH3), 24.3 (CH3), 24.1 (CH3), 23.3 
(CH2) ppm.  










(4S,5S)-5-Hydroxy-4,6-dimethylheptyl 2,4,6-triisopropylbenzoate (509) 
 
(R)-1-(Trimethylstannyl)ethyl 2,4,6-triisopropylbenzoate (505) (5.43 g, 12.4 mmol, 1.30 
equiv) was charged to a flame dried Schlenk tube under N2. Anhydrous Et2O (0.26 M, 
48 ml) was added and the resulting solution was cooled to –78 °C (acetone/dry ice). 
n-BuLi (1.60 M in hexane, 7.73 ml, 12.4 mmol, 1.30 equiv) was added dropwise and the 
resulting reaction mixture was stirred at –78 °C for 1 h. A solution of 3-(4,4,5,5-
tetramethyl-1,3,2-dioxaborolan-2-yl)propyl 2,4,6-triisopropylbenzoate (504) (3.963 g, 
9.52 mmol, 1.00 equiv) in anhydrous Et2O (1.00 M, 9.52 ml) was added dropwise and the 
resulting solution was stirred at –78 °C for 1 h, at which point 11B NMR showed full 
boronate complex formation. The reaction mixture was warmed to ambient temperature 
and then heated at 40 °C (oil bath) for 2 h, at which point 11B NMR showed full 
consumption of the boronate complex. The reaction mixture was cooled to ambient 
temperature, filtered through a small pad of SiO2 (Et2O) and concentrated to yield boronic 
ester 506, which was used immediately with no further purification. 
Isobutyl 2,4,6-triisopropylbenzoate (507) (5.797 g, 19.0 mmol, 2.00 equiv) and 
(+)-sparteine (4.37 ml, 19.0 mmol, 2.00 equiv) were charged to a flame dried Schlenk 
tube, under N2. Anhydrous Et2O (0.26 M, 95 ml) was added and the resulting solution was 
cooled to –78 °C (acetone/dry ice). s-BuLi (1.30 M in hexane, 14.6 ml, 19.0 mmol, 2.00 
equiv) was added dropwise and the resulting reaction mixture was stirred at –78 °C for 
8 h. A solution of 507 (4.232 g, 9.52 mmol, 1.00 equiv) in anhydrous Et2O (1.00 M, 9.52 
ml) was added dropwise and the resulting solution was stirred at –78 °C for 1 h, at which 
point 11B NMR showed full boronate complex formation. The reaction mixture was 





11B NMR showed full consumption of the boronate complex. The reaction mixture was 
cooled to ambient temperature, quenched with a 2 M aqueous solution of HCl (150 ml) 
and the phases separated. The organic phase was washed with 2 M HCl (3x50 ml) and the 
combined aqueous phases were retained for (+)-sparteine recovery. The organic phase 
was dried over MgSO4 filtered, and concentrated in vacuo to yield boronic ester 508, 
which was used immediately with no further purification. 
To a stirred solution of boronic ester 508 (4.766 g, 9.52 mmol, 1.00 equiv) in THF 
(0.15 M, 64 ml) at 0 °C (water/ice) was added a degassed mixture of NaOH(aq) (3.00 M, 
61.8 ml) and H2O2 (30.9 ml) in one go. The reaction mixture was warmed to ambient 
temperature and stirred vigorously for 16 h. The reaction mixture was then diluted with 
water (10 ml) and Et2O (10 ml) and the phases separated. The aqueous phase was 
extracted with Et2O (3 x 20 ml). The combined organic phases were dried over MgSO4, 
filtered and concentrated in vacuo. The crude residue was purified by flash column 
chromatography (SiO2, pentane:Et2O 80:20) to yield the title compound (509) (2789 g, 
75%, >95:5 dr) as a colourless oil. 
1H NMR (500 MHz, CDCl3) δ 7.01 (s, 2H, ArH), 4.31 (m, 2H, TIBOCH2), 3.10 (m, 1H, 
CHOH), 2.93–2.81 (m, 3H, 3 x ArCH), 1.85–1.70 (m, 3H, OCH2CH2 and CHCHOH), 
1.67 (m, 1H, OCH2CH2CH2CH), 1.55–1.47 (m, 1H, CHCHaHb), 1.41–1.32 (m, 1H, 
CHCHaHb), 1.25 (d, J = 6.9 Hz, 12H, 2 x oArC(CH3)2), 1.25 (d, J = 7.0 Hz, 6H, 
pArC(CH3)2), 0.97 (d, J = 6.6 Hz, HOCHCHCH3), 0.88 (app t, 6H, 2 x CH3) ppm. 
13C NMR (126 MHz, CDCl3) δ 171.1 (C=O), 150.2 (C), 144.9 (C), 130.8 (C), 121.0 (CH), 
80.2 (CH), 65.4 (CH2), 34.9 (CH), 34.6 (CH), 31.7 (CH), 31.2 (CH), 30.8 (CH2), 26.6 
(CH2), 24.3 (CH3), 24.1 (CH3), 19.5 (CH3), 18.8 (CH3), 12.9 (CH3) ppm. 
HRMS (ESI) calculated for C25H42NaO3 [M+Na]+ 413.3026, found 413.3017. 
IR (νmax/cm–1, neat) 3547.3, 2959.0, 2869.9, 1724.0, 1606.3, 1461.7 and 1251.6. 
Rf 0.23 (4:1 pentane:Et2O). 
[𝜶]𝑫










Triethylsilyltrifluoromethanesulfonate (0.26 ml, 1.13 mmol, 1.20 equiv) and 2,6-lutidine 
(0.22 ml, 1.88 mmol, 2.00 equiv.) were added to a stirred solution of (4S,5S)-5-hydroxy-
4,6-dimethylheptyl 2,4,6-triisopropylbenzoate (509) (365.4 mg, 0.94 mmol, 1.00 equiv.) 
in anhydrous DCM (0.34 M, 2.80 ml) at –78 °C (acetone/dry ice). The resulting solution 
was stirred at –78 °C for 1 h, at which point TLC analysis suggested full consumption of 
the starting material. The reaction was diluted with water (10 ml) and the phases 
separated. The aqueous phase was extracted with DCM (3x20ml). The combined organic 
phases were dried over MgSO4, filtered and concentrated in vacuo. The crude residue was 
purified by flash column chromatography (SiO2, pentane:Et2O 98:2) to yield the title 
compound (510) (414 mg, 87%, >95:5 dr) as a colourless oil. 
1H NMR (500 MHz, CDCl3) δ 7.00 (s, 2H, ArH), 4.28 (m, 2H, TIBOCH2), 3.24 (dd, J = 
6.1, 3.6 Hz, 1H, CHOH), 2.93–2.81 (m, 3H, 3 x ArCH), 1.86–1.65 (m, 3H, OCH2CH2 
and OCH2CH2CH2CH), 1.61 (m, 1H, TESOCHCH(CH3)2), 1.48 (m, 1H, 
OCH2CH2CHaHb), 1.32–1.24 (m, 19H, 3 x (ArCH(CH3)2) and OCH2CH2CHaHb), 0.97 (t, 
J = 7.9 Hz, 9H, Si(CH2CH3)3), 0.91–0.86 (m, 9H, OCHCH(CH3)2) and CHCH3), 0.62 (q, 
J = 7.9 Hz, 6H, Si(CH2CH3)3) ppm. 
13C NMR (126 MHz, CDCl3) δ 171.2 (C=O), 150.2 (C), 144.8 (C), 130.8 (C), 121 (CH), 
81.6 (CH), 65.5 (CH2), 36.2 (CH), 34.6 (CH), 31.8 (CH), 31.6 (CH), 31.1 (CH2), 27.0 
(CH2), 24.3 (CH3), 24.1 (CH3), 20.2 (CH3), 19.0 (CH3), 14.3 (CH3), 7.3 (CH3), 5.8 (CH2) 
ppm. 
HRMS (ESI) calculated for C31H57O3Si [M+H]+ 505.4071, found 505.4050. 
IR (νmax/cm–1, neat) 3579.0, 2956.3, 2873.7, 1726.1, 1606.5, 1462.5 and 1249.9. 
[𝜶]𝑫
𝟐𝟏 (CHCl3, c = 1) –4. 







((triethylsilyl)oxy)heptyl 2,4,6-triisopropylbenzoate (497) 
 
According to a modified literature procedure,65 s-BuLi (1.3 M in hexane, 6.3 ml, 8.1 
mmol, 1.3 equiv) was added dropwise to a stirred solution of benzoate 510 (3.147 g, 6.23 
mmol, 1.00 equiv) and (+)-sparteine (1.86 ml, 8.10 mmol, 1.30 equiv) in anhydrous Et2O 
(0.25 M, 25 ml) under N2 at –78 °C (acetone/dry ice). The resulting reaction mixture was 
stirred at –78 °C for 3 h. Freshly prepared MgBr2·OEt2 (9.35 mmol, 1.50 equiv) was 
added to the reaction dropwise via cannula and the resulting reaction mixture was stirred 
for 2 h at –78 °C. A solution of ((((1R,2S,5R)-2-Isopropyl-5-methylcyclohexyl)oxy)(p-
tolyl)-λ3-sulfaneyl)-λ1-oxidane (2.754 g, 9.35 mmol, 1.50 equiv) in anhydrous THF 
(1.15 M, 8.13 ml) was added and the resulting reaction mixture was stirred for a further 
1 h at –78 °C. The reaction mixture was then warmed to ambient temperature and stirred 
for 16 h. The reaction was diluted with a 2 M aqueous solution of HCl (30 ml) and Et2O 
(30 ml) and the phases separated. The aqueous phase was extracted with Et2O (3 x 50ml). 
The combined organic phases were dried over MgSO4, filtered and concentrated in vacuo 
and the aqueous phase was saved for (+)-sparteine recovery. The crude residue was 
purified using a biotage isolera one system (loading method: dry load (~ 10g Telos), snap 
ultra 50 g, 0% to 20% Et2O in pentane, 13 column volumes) to give the title compound 
(497) (224 g, 56%, >95:5 dr) as a colourless oil. 
Preparation of MgBr2·OEt2: 
To a flame dried 3 neck flask fitted with a reflux condenser under N2 was charged oven 
dried Magnesium turnings (682 mg, 28.1 mmol) and anhydrous Et2O (14.4 ml). To this 
stirred suspension was added 1,2-dibromomethane (0.1 ml) and the resulting suspension 
was gently heated with a heat gun (lowest setting) until the reaction initiated (typically 
~5 sec). Following initiation, 1,2-dibromoethane (0.71 ml, 9.35 mmol (total volume 
0.81 ml)) was added dropwise at a rate determined by the vigorousness of the reaction. 





colourless upper layer and a grey bottom layer. Both layers were transferred by cannula. 
The unreacted Magnesium turnings were cooled to 0 °C (water/ice) and quenched through 
the slow addition of 2 M HCl(aq). 
1H NMR (500 MHz, CDCl3) δ 7.65 (d, J = 8.2 Hz, 2H, ArH), 7.37 (d, J = 8.2 Hz, 2H, 
ArH), 7.05 (s, 2H, ArH), 5.63 (dd, J = 10.2, 2.6 Hz, 1H, OCHS), 3.11 (dd, J = 5.9, 3.5 Hz, 
1H, TESOCH), 2.99–2.88 (m, 3H, 3 x ArCH), 2.43 (s, 3H, ArCH3), 1.95 (dtd, J = 15.0, 
10.3, 4.9 Hz, 1H, TIBOCHCHaHb), 1.66–1.57 (m, 2H, TESOCHCH(CH3)2 and 
TIBOCHCHaHb), 1.44 (m, 1H, TIBOCHCH2CH2CH), 1.31–1.24 (m, 20H, ArCH(CH3)3 
and TIBOCHCH2CH2), 1.27 (d, J = 6.9 Hz, 12H, 2 x oArCH(CH3)2), 0.86 (t, J = 7.9 Hz, 
9H, Si(CH2CH3)3), 0.80 (dd, J = 6.8, 5.6 Hz, 6H, TESOCHCH(CH3)2), 0.68 (d, J = 
6.8 Hz, 3H, TESOCHCHCH3), 0.45 (qd, J = 7.9, 3.6 Hz, 6H, Si(CH2CH3)3) ppm. 
13C NMR (126 MHz, CDCl3) δ 170.7 (C=O), 151.0 (C), 145.3 (C), 141.6 (C), 137.7 (C), 
130.1 (CH), 129.0 (C), 124.4 (CH), 121.2 (CH), 93.3 (CH), 80.6 (CH), 36.4 (CH), 
34.6 (CH), 31.8 (CH), 31.6 (CH), 29.2 (CH2), 24.6 (CH3), 24.4 (CH3), 24.1 (CH3), 
21.6 (CH3), 21.3 (CH2), 20.4 (CH3), 19.0 (CH3), 14.4 (CH3), 7.2 (CH3), 5.6 (CH2) ppm. 
HRMS (ESI) calculated for C38H62NaO4SSi [M+H]+ 665.4030, found 665.4021. 
IR (νmax/cm–1, neat) 2958.9, 2873.8, 1732.7, 1606.1 1460.1, 1233.6 and 1045.2. 
[𝜶]𝑫
𝟐𝟐 (CHCl3, c = 0.5) –94. 














(R)-3-((tert-butyldimethylsilyl)oxy)hex-5-en-1-yl 2,4,6-triisopropylbenzoate (515) 
 
Oxidation of alcohol 511 
According to a modified literature procedure.206 To a stirred solution of alcohol 511 
(1.51. g, 4.94 mmol, 1.00 equiv) in DCM (0.80 M, 6.2 ml) at 0 °C was added sequentially 
TEMPO (7.66 mg, 49.0 µmol, 1.00 mol%) as a solution in DCM (0.008 M, 6.18 ml), KBr 
(58.3 mg, 0.49 mmol, 10.0 mol%) as a solution in H2O (0.50 M, 0.98 ml) and NaOCl·5H2O 
(1.02 g, 6.17 mmol, 1.25 equiv) as a solution in H2O (0.35 M, 17.6 ml). The resulting 
biphasic mixture was stirred vigorously at ambient temperature for 30 min. After this time 
the organic phase was separated, dried over MgSO4 and filtered through a small silica 
plug washing with Et2O (15 ml). The filtrate was diluted with anhydrous THF (0.50 M, 
9.88 ml) and concentrated at ambient temperature until only the volume of THF remained 
to yield aldehyde 512 as a rough 0.5 M solution in THF. 
Allylboration 
According to a modified literature procedure,206 allylMgBr (1.00 M in Et2O, 14.8 ml, 14.8 
mmol. 3.00 equiv) was added to a stirred solution of (+)-Ipc2BOMe (4.68 g, 14.8 mmol, 
3.00 equiv) in anhydrous Et2O (0.33 M, 14.8 ml) under an N2 atmosphere at 0 °C 
(water/ice). The resulting mixture was warmed to ambient temperature and stirred for 1 
h before the volatile components were removed under high vacuum. Pentane (20 ml) was 
added and the mixture was stirred vigorously for 30 sec before the stirring was stopped 





through a sintered cannulation needle and the above process was repeated a further two 
times. The combined pentane extracts were then concentrated under high vacuum. The 
resulting residue was diluted with anhydrous Et2O (0.33 M, 14.8 ml) and was cooled to 
–100 °C (MeOH/N2(l)), at which point aldehyde 512 was added dropwise as a rough 0.5 M 
solution in THF. The reaction was stirred at –100 °C for 1 h, warmed to –78 °C and stirred 
for a further 1 h at –78 °C (acetone/dry ice). MeOH (HPLC grade, 10 ml) was added and 
the reaction was warmed to ambient temperature. NaOH (3.0 M aqueous solution, 12 ml) 
and H2O2 (6.0 ml) were added and the resulting mixture heated to reflux for 1 h. The 
reaction mixture was cooled to ambient temperature and Et2O (50 ml) was added. The 
phases were separated, and the aqueous phase was extracted with Et2O (3 x 50 ml). The 
combined organics were dried with MgSO4, filtered and concentrated in vacuo. The crude 
residue was purified by column chromatography (SiO2, pentane:Et2O 80:20) to give 
secondary alcohol 513 as an inseparable mixture with (+)-isopinocampheol (514). 
Silyl ether protection 
To a stirred solution of secondary alcohol 513 and (+)-isopinocampheol (514) (4.69 g. 
13.5 mmol. 1.00 equiv) in anhydrous DCM (0.10 M, 135 ml) under an N2 atmosphere at 
0 °C was added DIPEA (3.50 ml, 20.3 mmol, 1.50 equiv) dropwise followed by the 
dropwise addition of TBSOTf (3.72 ml, 16.2 mmol, 1.20 equiv). The resulting mixture 
was warmed to ambient temperature and stirred for 3 h. The reaction was diluted with 
H2O (75 ml) and the phases were separated. The aqueous phase was extracted with DCM 
(3 x 100 ml) and the combined organics were dried over MgSO4, filtered and concentrated 
in vacuo. The crude residue was purified by column chromatography (SiO2, pentane: 
removal of TBS-protected isopinochampheol, then pentane:Et2O 98:2) to yield 515 
(1.62 g, 71%, 92:8 er) as a colourless oil. 
1H NMR (400 MHz, CDCl3) δ 7.00 (s, 2H, ArH), 5.79 (m, 1H, alkene-CH), 5.09–5.03 
(m, 2H, alkene-CH2), 4.45 (ddd, J = 10.9, 6.9, 5.6 Hz, 1H, TIBOCHaHb), 4.33 (ddd, J = 
10.9, 7.6, 6.5 Hz, 1H, TIBOCHaHb), 3.88 (m. 4.1 Hz, 1H, TBSOCH), 2.93–2.79 (m, 3H, 
3xArCH), 2.26 (ddt, J = 7.1, 5.8, 1.2 Hz, 2H, alkene-CHCH2), 1.91 (dddd, J = 14.4, 7.6, 
6.9, 4.1 Hz, 1H, TIBOCH2CHaHb), 1.82 (dddd, J = 14.4, 7.7, 6.5, 5.6 Hz, 1H, 
TIBOCH2CHaHb), 1.24 (m, 18H, 3 x ArCH(CH3)2), 0.90 (s, 9H, SiC(CH3)3), 0.07 (s, 3H, 





13C NMR (101 MHz, CDCl3) δ 171.0 (C=O), 150.2 (C), 144.9 (C), 134.6 (CH), 
130.7 (C), 121.0 (CH), 117.5 (CH2), 69.0 (CH), 62.1 (CH2), 42.4 (CH2), 35.8 (CH2), 34.6 
(CH), 31.7 (CH), 26.0 (CH3), 24.4 (CH3), 24.3 (CH3), 24.1 (CH3), 18.2 (C), –4.2 (CH3), 
–4.6 (CH3) ppm. 
HRMS (ESI) calculated for C28H48NaO3Si [M+Na]+ 483.3265, found 483.3267. 
IR (νmax/cm–1, neat) 2958.7, 2928.9, 2858.2, 1725.7, 1250.5 and 1074.3. 
[𝜶]𝑫
𝟐𝟑 CHCl3, c = 1) –8 
Rf 0.66 (2:98 Et2O:pentane) 
Chiral HPLC Chiral separation was achieved by deprotecting a small aliquot of 515 to 
give secondary alcohol 513 (Diacel Chiralpak-IA (25cm) with guard, hexane:IPA 99:1, 
1.0 mL/min, rt, 210 nm) tR = 17.7 min (minor), 18.6 min (major), er = 92:8. 







































en-1-yl 2,4,6-triisopropylbenzoate (499) 
 
According to a modified literature procedure,65 s-BuLi (2.52 ml, 3.28 mmol, 1.30 equiv) 
was added dropwise to a stirred solution of benzoate 515 (1.16 g, 2.52 mmol, 1.00 equiv) 
and (+)-sparteine (0.75 ml, 3.28 mmol, 1.30 equiv) in anhydrous Et2O (0.25 M, 10.1 ml) 
under N2 at –78 °C (acetone/dry ice). The resulting reaction mixture was stirred at –78 °C 
for 3 h. Freshly prepared MgBr2·OEt2 (3.78 mmol, 1.50 equiv) was added to the reaction 
dropwise via cannula and the resulting reaction mixture was stirred for 2 h at –78 °C. A 
solution of 700 (1.11 g, 3.78 mmol, 1.50 equiv) in anhydrous THF (1.15 M, 3.29 ml) was 
added and the resulting reaction mixture was stirred for a further 1 h at –78 °C. The 
reaction mixture was then warmed to ambient temperature and stirred for 16 h. The 
reaction was diluted with a 2 M aqueous solution of HCl (30 ml) and Et2O (30 ml) and the 
phases were separated. The aqueous phase was extracted with Et2O (3 x 50 ml). The 
combined organic phases were dried over MgSO4, filtered and concentrated in vacuo and 
the aqueous phase was saved for (+)-sparteine recovery.  



































Sulfoxide 499 co-elutes with menthol and so the menthol was TMS protected to aid 
separation. The crude residue was stirred under high vacuum until it became a paste, at 
which point DCM (0.50 M, 5.0 ml) was added followed by NEt3 (0.52 ml) and TMSCl 
(0.43 ml). The resulting mixture was stirred at ambient temperature for 2 h before being 
diluted with water (5.0 ml). The phases were separated and the aqueous phase extracted 
with DCM (3 x 10 ml). The combined organic phases were dried over MgSO4 filtered 
and concentrated in vacuo. The crude residue was purified using a biotage isolera one 
system (loading method: dry load (~2.5 g telos), snap ultra 50g, 0% to 20% Et2O in 
pentane, 25 column volumes) to give the title compound (499) (935.8 mg, 62%, >95:5 dr) 
as a white solid. 
Preparation of MgBr2·OEt2: 
To a flame dried 3 neck flask fitted with a reflux condenser under N2 was charged oven 
dried Mg (238.9 mg, 9.83 mmol) and anhydrous Et2O (6.30 ml). To this stirred 
suspension was added 1,2-dibromomethane (0.05 ml) and the resulting suspension was 
gently heated with a heat gun (lowest setting) until the reaction initiated (typically ~5 
sec). Following initiation, 1,2-dibromoethane (0.28 ml, 3.78 mmol (total volume 0.33 
ml)) was added dropwise at a rate determined by the vigorousness of the reaction. Upon 
completion of the addition of 1,2-dibromoethane, the reaction was biphasic with a 
colourless upper layer and a grey bottom layer. Both layers were transferred by cannula. 
The unreacted Mg was cooled to 0 °C (water/ice) and quenched through the slow addition 
of an appropriate amount of a 2 M aqueous solution of HCl. 
1H NMR (500 MHz, CDCl3) δ 7.64 (d, J = 8.2, 2H, ArH), 7.35 (d, J = 7.8 Hz, 2H, ArH), 
7.06 (s, 2H, ArH), 5.79 (dd, J = 10.3, 1.4 Hz, 1H, TIBOCH), 5.63 (m, 1H, alkene-CH), 
5.04–4.99 ( m, 2H, alkene-CH2), 3.71 (m, 1H, TBSOCH), 3.01 (hept, J = 6.9 Hz, 2H, 
2 x oArCH), 2.92 (hept, J = 6.9 Hz, 1H, pArCH), 2.41 (s, 3H, ArCH3), 2.23 (m, 1H, 
alkene-CHCHaHb), 2.15 (m, 1H, alkene-CHCHaHb), 2.00 (ddd, J = 15.0, 10.3, 1.8 Hz, 
1H, TIBOCHCHaHb), 1.69 (ddd, J = 15.0, 10.1, 1.4 Hz, 1H, TIBOCHCHaHb), 1.32–1.25 
(m, 18H, 3xArCH(CH3)2), 0.67 (s, 9H, SiC(CH3)3), –0.05 (s, 6H, Si(CH3)2) ppm. 
13C NMR (126 MHz, CDCl3) δ 170.6 (C=O), 151.0 (C), 145.5 (C), 141.5 (C), 137.7 (C), 
133.5 (CH), 130.1 (CH), 129.0 (C), 124.3 (CH), 121.2 (CH), 118.3 (CH2), 91.9 (CH), 
68.0 (CH), 42.9 (CH2), 34.6 (CH), 31.8 (CH), 30.9 (CH2), 25.7 (CH3), 24.6 (CH3), 24.4 





HRMS (ESI) calculated for C35H54NaO4SSi [M+Na]+ 621.3404, found 621.3411. 
IR (νmax/cm–1, neat) 2959.6, 2929.3, 1733.2, 1462.0, 1363.7, 1235.7 and 1043.3. 
[𝜶]𝑫
𝟐𝟑 (CHCl3, c = 0.5) –43. 




The characterisation of tetra(boronic ester) 447 was performed by Dr Alexander Fawcett 
and is included for completeness. 
 
Pt(dba)3 (174 mg, 0.19 mmol, 1.00 mol%), (R,R)-297 (211 mg, 0.23 mmol, 1.20 mol%) 
and B2pin2 (10.32 g, 40.63 mmol, 2.10 equiv) were dissolved in THF (20.0 ml) before 
sealing the flask and heating to 80 °C (oil bath) for 30 min. After cooling to ambient 
temperature 1,4-pentadiene (448) (2.00 ml, 19.4 mmol, 1.00 equiv) was quickly added 
before resealing the vessel and heating for 16 h at 60 °C (oil bath). The solution was then 
cooled to ambient temperature and concentrated in vacuo. The crude residue was directly 
purified by flash column chromatography (SiO2, pentane:Et2O 80:20) to yield 
tetra(boronic ester) 447 (9.94 g, 89%, 95:5 dr) as a colourless solid. The solid was 
recrystallized (pentane; 0.80 ml/g; freezer overnight) to yield tetra(boronic ester) (447) 
(6.68 g, 60%, >95:5 dr) as a colourless crystalline solid. 
Rf  0.19 (85:15 pentane:Et2O) 
1H NMR (400 MHz, CDCl3) δ 1.41 (t, J = 7.7 Hz, 2H, CH(CH2)CH), 1.18 (s, 48H, CH3), 
1.31-1.03 (m, CHBpin, 2H), 0.80 (dd, J = 15.8, 5.4 Hz, 2H, HaHbCBpin), 0.71 (dd, J = 
15.8, 9.8 Hz, 2H, HaHbCBpin) ppm. 
13C NMR (101 MHz, CDCl3) δ 83.0 (C(CH3)2), 82.8 (C(CH3)2), 37.0 (CH(CH2)CH), 25.2 
(CH3), 25.2 (CH3), 25.1 (CH3), 25.0 (CH3), 17.2 (CHBpin), 12.5 (CH2Bpin) ppm. 





HRMS (ESI) calculated for C29H56B4O8Na [M+Na]+ 599.4259, found: 599.4251. 
m.p. 100‒104 °C (pentane). 
[𝜶]𝑫











i-PrMgCl·LiCl (1.17 M in THF, 5.00 ml, 5.90 mmol, 3.40 equiv) was added to a solution 
of tetra(boronic ester) 447 (1.00 g, 1.74 mmol, 1.00 equiv) and sulfoxide 305 (2448 mg, 
5.56 mmol, 3.20 equiv) in anhydrous DCM (0.20 M, 8.70ml) at –78 °C (acetone/dry ice) 
under an N2 atmosphere. The resulting mixture was stirred at –78 °C for 1 h. The reaction 
was warmed to ambient temperature, then heated to 45 °C (oil bath) for 4 h. The reaction 
was cooled to ambient temperature, filtered through celite washing with DCM and 
concentrated in vacuo. The crude residue was purified by flash column chromatography 
(SiO2, hexane:acetone 96:4) to yield tetra(boronic ester) 446 (952.4 mg, 80%, >95:5 dr) 
as a colourless oil. 
1H NMR (500 MHz, CDCl3) δ 6.05–5.47 (m, 2H, 2 x CH=CH2), 4.97 (dd, J = 17.1, 2.2 





CH2CH=CH2), 1.51–1.40 (m, 2H, CH2), 1.39–1.27 (m, 4H, CH2), 1.20 (s, 48H, 4 x 
pinacol-CH3), 1.16–1.01 (m, 4H, CH-Bpin) ppm. 
13C NMR (126 MHz, CDCl3) δ 138.8 (CH), 114.5 (CH2) 82.6 (pinacol-C), 82.4 
(pinacol-C),35.7 (CH2), 33.4 (CH2), 32.8 (CH2), 24.8 (pinacol-CH3), 24.7 (pinacol-CH3), 
24.6 (pinacol-CH3) ppm. 
Carbon atom next to boron not observed due to quadrupolar relaxation. 
HRMS (ESI) calculated for C37H68O8Na [M+Na]+ 707.5202, found 707.5214. 
IR (νmax/cm–1, neat) 2977, 2915, 1378, 1370, 1306, 1141, 967, 862 and 670. 
[𝜶]𝑫
𝟐𝟑  (CHCl3, c = 1.3) +7.2. 




Pt(dba)3 (19.8 mg, 0.011 mmol, 1.00 mol%), (S,S)-297 (12.2 mg, 13.0 µmol, 1.20 mol%) 
and B2pin2 (599 mg, 2.36 mmol, 2.10 equiv) were dissolved in anhydrous THF (0.74 ml) 
before sealing the flask and heating to 80 °C (oil bath) for 30 min. After cooling to 
ambient temperature, tetra(boronic ester) 446 (767 mg, 1.12 mmol, 1.00 equiv) was added 
as a solution in anhydrous THF (0.37 ml) and the vessel was resealed and heated for 16 h 
at 60 °C (oil bath). The solution was then cooled to ambient temperature and concentrated 
in vacuo. The crude residue was directly purified by flash column chromatography (SiO2, 
hexane:acetone 96:4) to yield octa(boronic ester) 444 (867.8 mg, 65%) as a white foam 
that was crushed into a fluffy white solid and diboration–hydroboration product 449 (83.6 






1H NMR (500 MHz, CDCl3) δ 1.60–0.98 (m, 112H), 0.91 (dd, J = 15.9, 4.3 Hz, 2H, 
2xBCHaHb), 0.72 (dd, J = 15.9, 11.0 Hz, 2H, 2 x BCHaHb) ppm. 
13C NMR (126 MHz, CDCl3) δ 82.7 (pinacol-C), 82.6 (pinacol-C), 82.5 (pinacol-C), 82.5 
(pinacol-C), 36.1 (CH2), 35.2 (CH2), 35.1 (CH2), 25.2 (pinacol-CH3), 25.1 (pinacol-CH3), 
25.1 (pinacol-CH3),.25.0 (pinacol-CH3), 25.0 (pinacol-CH3), 25.0 (pinacol-CH3), 24.9 
(pinacol-CH3), 24.9 (pinacol-CH3) ppm. 
Carbon atom attached to boron not observed due to quadrupolar relaxation. 
HRMS (MALDI) calculated for C61H116B8NaO16 [M+Na]+ 1214.3971, found 1214.3968. 
IR (νmax/cm–1, neat) 2978 2927, 1370, 1306, 1140, 968, 863, 848 and 672. 
[𝜶]𝑫
𝟐𝟒  (CHCl3, c = 1) +0.98. 
Rf 0.17 (92:8 hexane:acetone). 
449 
1H NMR (500 MHz, CDCl3) δ 1.60–0.70 (m, 105H) ppm. 
13C NMR (126 MHz, CDCl3) δ 82.9 (pinacol-C), 82.8 (pinacol-C), 82.7 (pinacol-C), 82.7 
(pinacol-C), 82.7 (pinacol-C), 82.5 (pinacol-C), 82.5 (pinacol-C), 35.8 (CH2), 35.4 (CH2), 
35.3 (CH2), 35.2 (CH2), 25.2 (pinacol-CH3), 25.1 (pinacol-CH3), 25.1 (pinacol-CH3), 25.1 
(pinacol-CH3), 25.1 (pinacol-CH3), 25.1 (pinacol-CH3), 25.0 (pinacol-CH3), 25.0 
(pinacol-CH3), 25.0 (pinacol-CH3), 24.9 (pinacol-CH3), 24.8 (pinacol-CH3) ppm. 
HRMS (MALDI) calculated for C55H105B7NaO14[M+Na]+ 1088.8112, found 1088.8125. 
IR (νmax/cm–1, neat) 2976.4, 2928.5, 1369.9, 1307.6, and 1141.1. 
[𝜶]𝑫
𝟐𝟓  (CHCl3, c = 1) –14. 













Octaboronic ester 444 (20.0 mg, 17.0 µmol, 1.00 equiv) and homoallylic sulfoxide 305 
(19.6 mg, 42.5 µmol, 2.50 equiv) were charged to a flame dried Schlenk tube under N2, 
which was put under high vacuum and stirred for 15 min. The Schlenk tube was backfilled 
with N2 and anhydrous DCM (0.2 M, 0.09 ml) was added. The resulting mixture was 
cooled to –78 °C (acetone/dry ice) and i-PrMgCl∙LiCl (0.04 ml, 44.2 µmol, 2.60 equiv) 
was added dropwise. The resulting reaction mixture was stirred at –78 °C for 1 h and was 
then warmed to 40 °C and stirred at this temperature for 3 h. The reaction was cooled to 
ambient temperature and the solvent removed under high vacuum. The crude residue was 
directly purified by column chromatography (SiO2, hexane:acetone 96:4) to yield 
desymmetrised octaboronic ester 450 (9.9 mg, 47%) as a white foam and over 
homologated octaboronic ester 451 (6.0 mg, 27%) as a white foam.   
450 
1H NMR (500 MHz, CDCl3) δ 5.85 (ddt, J = 17.1, 10.2, 6.9 Hz, 1H, alkene-CH), 5.00 
(m, 1H, alkene-CHaHb), 4.87 (m, 1H, alkene-CHaHb), 2.26–2.18 (m, 1H, 
alkene-CH2CHCHaHb), 2.11–2.02 (m, 1H, alkene-CH2CHCHaHb), 1.55–0.79 (m, 117H) 
ppm. 
13C NMR (126 MHz, CDCl3) δ 139.1 (CH), 114.6 (CH2), 82.8 (pinacol-C), 82.6 (pinacol-
C), 82.6 (pinacol-C), 82.5 (pinacol-C), 35.5 (CH2), 34.9 (CH2), 34.4 (CH2), 34.0  (CH2), 
31.1 (CH2), 29.9 (CH2), 27.3 (CH2), 25.2 (pinacol-CH3), 25.2 (pinacol-CH3), 25.1 
(pinacol-CH3), 25.1 (pinacol-CH3), 25.0 (pinacol-CH3), 25.0 (pinacol-CH3), 25.0 
(pinacol-CH3), 24.9 (pinacol-CH3) ppm. 





HRMS (MALDI) calculated for C65H122NaO16B8 [M+Na]+ 1268.9442, found 1268.9454. 
IR (νmax/cm-1, neat) 2992.6, 2912.1, 1377.7, 1144.12 and 1067.2. 
[𝜶]𝑫
𝟐𝟑 (CHCl3, c = 0.1) –2. 
Rf 0.4 (92:8 hexane:acetone). 
451 
1H NMR (500 MHz, CDCl3) δ 5.82 (ddt, J = 17.1, 10.1, 6.9 Hz, 2H, 2 x alkene-CH), 5.00 
(d, J = 17.1 Hz, 2H, 2 x alkene-CHaHb), 4.88 (d, J = 10.1 Hz, 2H, 2 x alkene-CHaHb), 
2.26–2.18 (m, 2H, 2 x alkene-CH2CHCHaHb), 2.11–2.02 (m, 2H, 2 x 
alkene-CH2CHCHaHb), 1.55 – 0.79 (m, 118H) ppm. 
13C NMR (126 MHz, CDl3) δ 139.1 (CH), 114.6 (CH2), 82.8 (pinacol-C), 82.6 
(pinacol-C), 82.6 (pinacol-C), 82.5 (pinacol-C), 35.5 (CH2), 34.9 (CH2), 34.6 (CH2), 34.4 
(CH2), 34.0 (CH2), 31.0 (CH2), 25.2 (pinacol-CH3), 25.2 (pinacol-CH3), 25.1 
(pinacol-CH3) , 25.0 (pinacol-CH3), 25.0 (pinacol-CH3), 24.9 (pinacol-CH3) ppm. 
Carbon atom next to boron not observed due to quadrupolar relaxation. 
HRMS (MALDI) calculated for C69H128B8NaO16 [M+Na]+ 1322.9913, found 1322.9926. 
IR (νmax/cm–1, neat) 2977.3, 1375.3, 1307.7 and 1142.6. 
[𝜶]𝑫
𝟐𝟓 (CHCl3, c = 0.1) –2. 
















Octaboronic ester 444 (101 mg, 8.40 µmol, 1.00 equiv) and sulfoxide 497 (109 mg, 
0.169 mmol, 2.00 equiv) were charged to a flame dried Schlenk tube under N2, which 
was put under high vacuum and stirred for 15 min. The Schlenk tube was backfilled with 
N2 and anhydrous DCM (0.20 M, 0.42 ml) was added. The resulting mixture was cooled 
to –78 °C (acetone/dry ice) and i-PrMgCl∙LiCl (0.16 ml, 0.18 mmol, 2.10 equiv) was 
added dropwise. The resulting reaction mixture was stirred at –78 °C for 1 h and was then 
warmed to 40 °C and stirred at this temperature for 3 h. The reaction was cooled to 
ambient temperature and the solvent removed in vacuo. The crude residue was directly 
purified by flash column chromatography (SiO2, hexane:acetone 96:4) to yield 
desymmetrised octaboronic ester 498 (44 mg, 48%) as a colourless oil and over 
homologated octaboronic ester 516 (40.7 mg, 28%) as a colourless oil.   
498 
1H NMR (600 MHz, CDCl3) δ 3.17 (app t, J = 5.0 Hz, 1H, OCH), 1.72 (m, 1H, OCHCH), 
1.58–0.99 (m, 140H), 0.94 (t, J = 7.9 Hz, 9H, Si(CH2CH3)3), 0.85–0.80 (m, 9H, 
OCHCH(CH3)2) and CHCH3), 0.70 (dd, J = 15.9, 11.0 Hz, 1H, BCHaHb), 0.59 (q, J = 
7.9 Hz, 6H, Si(CH2CH3)3) ppm. 
13C NMR (151 MHz, CDCl3) δ 82.7 (pinacol-C), 82.6 (pinacol-C), 82.6 (pinacol-C), 82.6 
(pinacol-C), 82.6 (pinacol-C), 82.5 (pinacol-C), 82.5 (pinacol-C), 82.4 (CH), 36.9 (CH), 
35.5 (CH2), 35.3 (CH2), 35.1 (CH2), 34.9 (CH2), 34.7 (CH2), 34.0 (CH2), 32.1 (CH2), 31.5 
(CH), 30.5 (CH), 28.4 (CH2), 25.2 (pinacol-CH3), 25.2 (pinacol-CH3), 25.1 (pinacol-





24.9 (pinacol-CH3), 24.9 (pinacol-CH3), 20.5 (CH3), 18.3 (CH3), 14.6 (CH3), 7.4 (CH3), 
5.8 (CH2) ppm. 
Carbon atom next to boron not observed due to quadrupolar relaxation. 
HRMS (MALDI) calculated for C76H148NaO17B8Si [M+Na]+ 1471.1201, found 
1471.1218. 
IR (νmax/cm–1, neat) 2976.5, 1370.3, 1306.6, and 1141.1. 
[𝜶]𝑫
𝟐𝟒 (CHCl3, c = 1) –11. 
Rf 0.36 (90:10 hexane:acetone). 
516 
1H NMR (500 MHz, CDCl3) δ 3.18 (t, J = 5.0 Hz, 2H, 2 x OCH), 1.73 (m, 6H), 1.55–1.00 
(m, 124H), 0.95 (t, J = 7.9 Hz, 18H, 2 x Si(CH2CH3)3), 0.86–0.80 (m, 18H, 
OCHCH(CH3)2) and CHCH3), 0.60 (q, J = 7.9 Hz, 12H, 2 x Si(CH2CH3)3) ppm. 
13C NMR (126 MHz, CDl3) δ 82.6 (pinacol-C), 82.5 (pinacol-C), 82.5 (pinacol-C), 82.5 
(pinacol-C), 82.4 (pinacol-C), 82.4 (CH), 36.9 (CH), 35.0 (CH2), 34.7 (CH2), 34.1 (CH2), 
32.2 (CH2), 31.6 (CH), 29.9 (CH2), 28.5 (CH2), 25.2 (pinacol-CH3), 25.1 (pinacol-CH3), 
25.1 (pinacol-CH3), 25.1 (pinacol-CH3), 25.0 (pinacol-CH3), 25.0 (pinacol-CH3), 24.9 
(pinacol-CH3), 24.9 (pinacol-CH3), 20.5 (CH3), 18.3 (CH3), 14.7 (CH3), 7.4 (CH3), 5.8 
(CH2) ppm. 
Carbon atom next to boron not observed due to quadrupolar relaxation. 
HRMS (MALDI) calculated for C91H180NaO18B8Si2 [M+Na]+ 1728.3421, found 
1728.3436. 
IR (νmax/cm–1, neat) 2974.9, 1459.0, 1377.9, 1307.1 and 1141.9. 
[𝜶]𝑫
𝟐𝟒 (CHCl3, c = 0.1) –7. 











Octaboronic ester 444 (47.7 mg, 4.00 µmol, 1.00 equiv) and sulfoxide 499 (59.9 mg, 
0.10 mmol, 2.50 equiv) were charged to a flame dried Schlenk tube under N2, which was 
put under high vacuum and stirred for 15 min. The Schlenk tube was backfilled with N2 
and anhydrous DCM (0.2 M, 0.2 ml) was added. The resulting mixture was cooled to 
–78 °C (acetone/dry ice) and i-PrMgCl∙LiCl (0.09 ml, 0.104 mmol, 2.60 equiv) was added 
dropwise. The resulting reaction mixture was stirred at –78 °C for 1 h and was then 
warmed to 40 °C and stirred at this temperature for 3 h. The reaction was cooled to 
ambient temperature and the solvent removed under high vacuum. The crude residue was 
purified using a Biotage Isolera one system (loading method: dry load (~500 mg Telos), 
Snap Ultra 25g, 0% to 15% acetone in hexane, 15 column volumes) to give the title 
compound (519) (23 mg, 41%) as a white foam and over homologated octaboronic ester 
520 (13.1 mg, 20%) as a white foam. 
519 
1H NMR (500 MHz, CDCl3) δ 5.83 (ddt, J = 17.2, 10.3, 7.0 Hz, 1H, alkene-CH), 
5.06–4.97 (m, 2H, alkene CH2), 3.68 (m, 1H, TBSOCH), 2.19 (m, 2H, alkene-CHCH2), 
1.61–0.90 (m, 117H), 0.94 (dd, J = 16.0, 4.3 Hz, 1H, BCHaHb)  0.89 (s, 9H, SiC(CH3)3), 
0.73 (dd, J = 16.0, 11.1 Hz, 1H, BCHaHb), 0.08 (s, 3H, SiCH3), 0.05 (s, 3H, SiCH3) ppm. 
13C NMR (126 MHz, CDCl3) δ 136.1 (CH), 116.3 (CH2), 82.7 (pinacol-C), 82.6 (pinacol-





(CH2), 35.6 (CH2), 35.3 (CH2), 35.2 (CH2), 34.9 (CH2), 33.7 (CH2), 32.5 (CH2), 26.2 
(CH3), 25.2 (pinacol-CH3), 25.2 (pinacol-CH3), 25.2 (pinacol-CH3), 25.1 (pinacol-CH3), 
25.1 (pinacol-CH3), 25.0 (pinacol-CH3), 25.0 (pinacol-CH3), 25.0 (pinacol-CH3), 25.0 
(pinacol-CH3), 24.9 (pinacol-CH3), 24.9 (pinacol-CH3), 18.3 (C), –4.0 (CH3), –4.3 (CH3) 
ppm. 
Carbon atom next to boron not observed due to quadrupolar relaxation. 
HRMS (MALDI) calculated for C73H140NaO17B8Si [M+Na]+ 1427.0573, found 
1427.0585. 
IR (νmax/cm–1, neat) 2976.7, 1370.1, 1306.1, and 1141.3. 
[𝜶]𝑫
𝟐𝟑 (CHCl3, c = 0.1) +1. 
Rf 0.31 (90:10 hexane:acetone). 
520 
1H NMR (500 MHz, CDCl3) δ 5.81 (m, 2H, 2 x alkene-CH), 5.03–4.95 (m, 4H, 2 x alkene 
CH2), 3.75–3.63 (m, 2H, 2 x TBSOCH), 2.30–2.12 (m, 4H, 2 x alkene-CHCH2), 1.56–
0.95 (m, 122H), 0.86 (s, 18H, 2 x SiC(CH3)2), 0.06 (s, 6H, 2 x SiCH3), 0.03 (s, 6H, 2 x 
SiCH3) ppm. 
13C NMR (126 MHz, CDCl3) δ 136.1 (CH), 116.3 (CH2),  82.7 (pinacol-C), 82.6 (pinacol-
C), 82.5 (pinacol-C), 82.5 (pinacol-C), 72.6 (CH), 42.9 (CH2), 38.5 (CH2), 35.0 (CH2), 
33.8 (CH2), 32.5 (CH2), 26.2 (CH3), 25.2 (pinacol-CH3), 25.2 (pinacol-CH3), 
25.1(pinacol-CH3), 25.1 (pinacol-CH3), 25.1 (pinacol-CH3), 25.0 (pinacol-CH3), 25.0 
(pinacol-CH3), 25.0 (pinacol-CH3), 18.3 (C), –4.0 (CH3), –4.3 (CH3) ppm. 
Carbon atom next to boron not observed due to quadrupolar relaxation. 
HRMS (MALDI) calculated for C85H164 B8NaO18Si2 [M+Na]+ 1640.2166, found 
1640.2185. 
IR (νmax/cm–1, neat) 2976.5, 2927.9, 1378.2 1306.6 and 1142.1. 
[𝜶]𝑫
𝟐𝟑 (CHCl3, c = 1) +24. 










Octaboronic ester 519 (50.0 mg, 36.5 µmol, 1.00 equiv) and sulfoxide 497 (115 mg, 
0.178 mmol, 5.00 equiv) were charged to a flame dried Schlenk tube under N2, which 
was put under high vacuum and stirred for 15 min. The Schlenk tube was backfilled with 
N2 and anhydrous DCM (0.20 M, 0.18 ml) was added. The resulting mixture was cooled 
to –78 °C (acetone/dry ice) and i-PrMgCl∙LiCl (0.16 ml, 0.18 mmol, 5.1 equiv) was added 
dropwise. The resulting reaction mixture was stirred at –78 °C for 1 h and was then 
warmed to 40 °C and stirred at this temperature for 3 h. The reaction was cooled to 
ambient temperature and the solvent removed under high vacuum. The crude residue was 
purified using a Biotage Isolera one system (loading method: dry load (~500 mg Telos), 
Sfär Silica HC D 25g, 0% to 15% acetone in hexane, 15 column volumes) to give the title 
compound (500) (43.3 mg, 72%) as a white foam. 
1H NMR (500 MHz, CDCl3) δ 5.81 (m, 1H, alkene-CH), 5.03–4.95 (m, 2H, alkene-CH2), 
3.66 (m, 1H, TBSOCH), 3.18 (app t, J = 5.0 Hz, 1H, TESOCH), 2.17 (m, 2H, 
CH2=CHCH2), 1.73 (m, 2H), 1.54–1.00 (m, 124H), 0.95 (t, J = 7.9 Hz, 9H, Si(CH2CH3)3), 
0.88–0.81 (m, 18H, TESOCHCH(CH3)2) and CHCH3 and SiC(CH3)3), 0.60 (q, J = 7.9 
Hz, 6H, Si(CH2CH3)3), 0.06 (s, 3H, SiCH3), 0.03 (s, 3H, SiCH3) ppm. 
13C NMR (126 MHz, CDCl3) δ 130.1 (CH), 116.3 (CH2), 82.6 (pinacol-C), 82.6 
(pinacol-C), 82.6 (pinacol-C), 82.5 (pinacol-C), 82.5 (pinacol-C), 82.4 (CH), 72.6 (CH), 
42.9 (CH2), 38.5 (CH2), 36.9 (CH), 35.8 (CH2), 34.7 (CH2), 34.1 (CH2), 33.8 (CH2), 32.5 
(CH2), 32.1 (CH2), 31.6 (CH), 26.2 (CH3), 25.2 (pinacol-CH3), 25.2 (pinacol-CH3), 25.1 
(pinacol-CH3), 25.1 (pinacol-CH3), 25.1 (pinacol-CH3), 25.1 (pinacol-CH3), 25.0 
(pinacol-CH3), 25.0 (pinacol-CH3), 24.9 (pinacol-CH3), 20.5 (CH3), 18.3 (CH3), 18.3 (C), 





HRMS (MALDI) calculated for C88H172B8NaO18Si2 [M+Na]+ 1684.2793, found 
1684.2780. 
IR (νmax/cm–1, neat) 2975.4, 1378.2 1306.5 and 1141.8.  
[𝜶]𝑫
𝟐𝟑 (CHCl3, c = 0.1) +12. 






Urea·H2O2 complex (900 mg, 15.0 mmol, 60.0 equiv) was added to a stirred solution of 
500 (421.4 mg, 0.25 mmol, 1.00 equiv) in anhydrous MeOH (0.10 M, 2.50 ml). The 
resulting reaction mixture was stirred at 50 °C for 16 h. The reaction mixture was then 
cooled to 0 °C and DMS (2.20 ml, 30.0 mmol, 120 equiv) was added, after which the 
reaction mixture was warmed to ambient temperature and stirred for 10 min before the 
volatiles were removed in vacuo. The crude nonol 523 was diluted with 
dimethoxypropane (3.00 ml, 24.4 mmol, 97.6 equiv), and CSA (11.6 mg, 0.005 mmol, 
20 mol%) was added. The resulting reaction mixture was stirred at ambient temperature 
for 16 h. TLC analysis showed many spots, which were presumably differing levels of 
acetonide protection. The reaction mixture was then filtered through a small pad of sand 
washing with EtOAc and concentrated in vacuo. The residue was diluted with 





mol%) was added. The resulting reaction mixture was stirred at ambient temperature for 
a further 3 h, after which TLC analysis showed a single product spot. The reaction mixture 
was concentrated in vacuo and the crude residue purified by column chromatography 
(SiO2, pentane:Et2O 70:30) to yield 494 (120 mg 58%, >95:5 dr). 
1H NMR (500 MHz, CDCl3) δ 5.80 (ddt, J = 18.5, 8.7, 7.1 Hz, 1H, alkene-CH), 5.06–
4.99 (m, 2H, alkene-CH2), 4.02–3.91 (m, 8H, 8 x acetonideOCH), 3.81–3.75 (m, 1H, 
TBSOCH), 1.30 (dd, J = 7.7, 3.9 Hz, 1H, HOCH), 2.29–2.16 (m, 2H, CH2=CHCH2), 
1.86–1.77 (m, 2H, CH2), 1.75–1.66 (m, 2H, CH2), 1.65–1.39 (m, 16H), 1.36 (s, 3H, syn-
acetonide CH3), 1.34 (s, 3H, syn-acetonide CH3), 1.32 (s, 12H, 4 x anti-acetonide CH3), 
1.25 (s, 3H, syn-acetonide CH3), 1.23 (s, 3H, syn-acetonide CH3), 1.16 (m, 2H, CH2), 
0.96 (d, J = 6.6 Hz, 3H, HOCHCHCH3), 0.90–0.84 (m, 15H, OCHCH(CH3)2) and 
SiC(CH3)3), 0.07 (s, 3H, SiCH3), 0.05 (s, 3H, SiCH3) ppm.  
13C NMR (126 MHz, CDCl3) δ 134.8 (CH), 117.2 (CH2), 100.5 (anti-acetonide C), 100.4 
(anti-acetonide C), 98.5 (syn-acetonide C), 98.5 (syn-acetonide C), 80.0 (CH), 69.2 (CH), 
67.8 (CH), 65.8 (CH), 65.6 (CH), 65.6 (CH), 63.1 (CH), 62.8 (CH), 44.4 (CH2), 42.8 
(CH2), 42.6 (CH2), 42.5 (CH2), 42.2 (CH2), 38.9 (CH2), 37.6 (CH2), 36.8 (CH2), 35.0 
(CH), 34.1 (CH2), 31.7 (CH2), 31.1 (CH), 30.5 (syn-acetonide CH3), 30.4 (syn-acetonide 
CH3), 29.3 (CH2), 26.1 (CH3), 25.0 (anti-acetonide CH3), 24.9 (anti-acetonide CH3), 22.8 
(CH2), 20.4 (syn-acetonide CH3), 20.0 (syn-acetonide CH3), 19.5 (CH3), 18.7 (CH3), 18.3 
(C), 14.3 (CH3), 13.2 (CH3), 1.17 (CH3), –3.8 (CH3), –4.3 (CH3) ppm. 
HRMS (MALDI) calculated for C46H86NaO10Si [M+Na]+ 849.5882, found 849.5889. 
IR (νmax/cm–1, neat) 3500.0 (br), 2958.7, 2928.2, 2870.4, 1461.7 and 1251.3. 
[𝜶]𝑫
𝟐𝟐(CHCl3, c = 0.37) –3. 














According to a modified literature procedure,125 Grubbs first generation metathesis 
catalyst (528) (3.00 mg, 0.0037 mmol, 10.0 mol%) was added to a stirred solution of 
poly(acetonide) 494 (30.8 mg, 0.037 mmol, 1.00 equiv) and trienal 470 (45.5 mg, 0.37 
mmol, 10.0 equiv) in anhydrous DCM (0.025 M, 1.48 ml) under an atmosphere of N2. The 
resulting mixture was stirred at 45 °C (sand bath) for 6 h, at which point TLC analysis 
showed incomplete consumption of 494. A further portion of Grubbs first generation 
catalyst (528) (3.00 mg, 0.0037 mmol, 10 mol%) was added and the reaction was stirred 
for a further 16 h at 45 °C. The reaction was cooled to ambient temperature and the 
volatile components were removed in vacuo. The crude residue was purified by column 
chromatography (SiO2, pentane:Et2O 1:1) to yield 529 (24.5 mg, 73%, 89% brsm) as a 
pale yellow oil. 
1H NMR (500 MHz, CDCl3) δ 9.76 (d, J = 7.8 Hz, 1H, CHO), 7.13–7.09 (m, 1H), 6.65 
(dd, J = 14.9, 10.8 Hz, 1H), 6.33–6.30 (m, 1H), 6.23–6.20 (m, 1H), 6.18–6.11 (m, 2H), 
4.02–3.92 (m, 8H, 8 x acetonideOCH), 3.83–3.75 (m, 1H, TBSOCH), 3.11 (m, 1H, 
HOCH), 2.34–2.28 (m, 2H, CH2=CHCH2), 1.86–1.77 (m, 2H, CH2), 1.75–1.66 (m, 2H, 
CH2), 1.65–1.39 (m, 16H), 1.36 (s, 3H, syn-acetonide CH3), 1.34 (s, 3H, syn-acetonide 
CH3), 1.32 (s, 12H, 4 x anti-acetonide CH3), 1.25 (s, 3H, syn-acetonide CH3), 1.23 (s, 3H, 
syn-acetonide CH3), 1.16 (m, 2H, CH2), ), 0.96 (d, J = 6.6 Hz, 3H, HOCHCHCH3), 0.90–
0.84 (m, 15H, OCHCH(CH3)2) and SiC(CH3)3), 0.07 (s, 6H, Si(CH3)2) ppm. 
13C NMR (126 MHz, CDCl3) δ 193.2 (CH), 148.8 (CH), 143.0 (CH), 135.1 (CH), 132.2 
(CH), 131.1 (CH), 130.5 (CH), 100.5 (anti-acetonide C), 98.5 (syn-acetonide C), 80.0 
(CH), 69.2 (CH), 66.1 (CH), 65.8 (CH), 65.6 (CH), 63.1 (CH), 62.8 (CH), 44.8 (CH2), 





(CH), 30.5 (syn-acetonide CH3), 30.4 (syn-acetonide CH3), 29.9 (CH2), 26.0 (CH3), 25.0 
(anti-acetonide CH3), 25.0 (anti-acetonide CH3), 20.3 (syn-acetonide CH3), 20.0 (syn-
acetonide CH3), 19.5 (CH3), 18.8 (CH3), 18.3 (C), 14.3 (CH3), 13.2 (CH3), 1.18 (CH3), –
3.8 (CH3), –4.3 (CH3) ppm. 
HRMS (MALDI) calculated for C51H90NaO11Si [M+Na]+ 929.6145, found 929.6154. 
IR (νmax/cm–1, neat) 3498.7, 2927.0, 1610.0, 1461.7 and 1224.9. 
[𝜶]𝑫
𝟐𝟏 (CHCl3, c = 1) –3. 






According to a modified literature procedure,125 n-BuLi (1.6 M in hexane, 30 µl, 0.049 
mmol, 3.5 equiv) was added to a stirred solution of i-Pr2NH (7.0 µl, 0.051 mmol, 
3.7 equiv) in anhydrous THF (0.23 M, 0.22 ml) at –78 °C (acetone/dry ice) under an 
atmosphere of N2. The resulting mixture was warmed to ambient temperature and stirred 
for 10 min, then cooled to –78 °C. A solution of phosphonate 469 (13.5 mg, 0.049 mmol, 
3.50 equiv) in anhydrous THF (0.22 M, 0.22 ml) was added dropwise and the resulting 
mixture was stirred at –78 °C for 30 min. A solution of aldehyde 529 (12.6 mg, 
0.014 mmol, 1.00 equiv) in anhydrous THF (0.38 M, 36 µl) was added dropwise and the 
resulting mixture stirred –78 °C for 30 min, and then at ambient temperature for 16 h. The 
reaction was quenched with a saturated aqueous solution of NaHCO3 (1.00 ml) and was 
diluted with Et2O (1.0 ml). The phases were separated, and the aqueous phase was 
extracted with Et2O (3 x 1.0 ml). The combined organic phases were dried over MgSO4, 
filtered and concentrated in vacuo. The crude residue was purified by column 
chromatography (SiO2, pentane:Et2O 60:40) to yield the title compound (493) (10.4 mg, 





1H NMR (500 MHz, CDCl3) δ 7.32 (dd, J = 15.2, 11.6 Hz, 1H, O=CCHCH), 6.60 (dd, J 
= 14.8, 11.2 Hz, 1H), 6.47–6.41 (m, 1H), 6.39–6.24 (m, 6H), 6.22–6.07 (m, 2H), 5.86 (d, 
J = 15.2 Hz, 1H, O=CCH), 4.01–3.92 (m, 8H, 8 x acetonideOCH), 3.79 (m, 1H, 
TBSOCH), 3.11 (m, 1H, HOCH), 2.43–2.29 (m, 2H, CH2=CHCH2), 1.82 (m, 2H, CH2), 
1.72 (m, 2H, CH2), 1.65–1.39 (m, 16H), 1.37 (s, 3H, syn-acetonide CH3), 1.35 (s, 3H, 
syn-acetonide CH3), 1.33 (s, 12H, 4 x anti-acetonide CH3), 1.25 (s, 3H, syn-acetonide 
CH3), 1.23 (s, 3H, syn-acetonide CH3), 1.16 (m, 2H, CH2), 0.96 (d, J = 6.6 Hz, 3H, 
HOCHCHCH3), 0.90–0.84 (m, 15H, OCHCH(CH3)2) and SiC(CH3)3), 0.07 (s, 6H, 
Si(CH3)2) ppm. 
13C NMR (126 MHz, CDCl3) δ 167.3 (C=O), 144.6 (CH), 141.0 (CH), 137.5 (CH), 136.0 
(CH), 135.0 (CH), 133.0 (CH), 132.7 (CH), 132.2 (CH), 131.7 (CH), 131.1 (CH), 129.9 
(CH), 120.6 (CH), 100.4 (anti-acetonide C), 98.5 (syn-acetonide C) 80.0 (CH), 69.2 (CH), 
68.1 (CH), 65.8 (CH), 65.6 (CH), 63.1 (CH), 63.1 (CH), 62.8 (CH) 44.7 (CH2), 42.6 
(CH2), 42.4 (CH2), 42.2 (CH2), 38.9 (CH2), 37.5 (CH2), 36.8 (CH2), 35.0 (CH), 34.2 
(CH2), 31.7 (CH2), 31.1 (CH), 30.4 (syn-acetonide CH3), 30.4 (syn-acetonide CH3), 29.3 
(CH2), 26.1 (CH3), 25.0 (anti-acetonide CH3), 25.0 (anti-acetonide CH3), 22.9 (CH2), 
20.4 (syn-acetonide CH3), 20.0 (syn-acetonide CH3), 19.5 (CH3), 18.7 (CH3), 18.3 (C), 
14.5 (CH3), 13.2 (CH3), 1.18 (CH3), –3.8 (CH3), –4.3 (CH3) ppm. 
HRMS (MALDI) calculated for C59H100NaO12Si [M+Na]+ 1051.6876, found 1051.6889. 
IR (νmax/cm–1, neat) 3506.8, 2928.3, 1708.3, 1620.3 and 1562.8. 
[𝜶]𝑫
𝟐𝟐(CHCl3, c = 2) –8. 












Protected bahamaolide A (502) 
 
Ester saponification 
LiOH·H2O (13.0 mg, 0.31 mmol, 64.5 equiv) was added to a stirred solution of compound 
493 (5.00 mg, 4.86 µmol, 1.00 equiv) in a mixture of THF:H2O:MeOH (0.65 ml:0.16 
ml:0.16 ml). The resulting mixture was stirred at ambient temperature for 5 h. The 
reaction was diluted with H2O (0.50 ml) and EtOAc (0.50 ml) and the phases were 
separated. The aqueous phase was extracted with EtOAc (3 x 0.50 ml) and the combined 
organics were dried over MgSO4, filtered and concentrated. The crude residue was taken 
forward to the next step with no additional purification. 
Formation of mixed anhydride 531 
NEt3 (6.00 µl, 0.05 mmol, 10.3 equiv) and 2,4,6-trichlorobenzoyl chloride (5.00 µl, 
0.03 mmol, 7.00 equiv) were added to a stirred solution of carboxylic acid 530 in 
anhydrous THF (0.0075 M, 0.65 ml) under an atmosphere of N2. The resulting mixture 
was stirred at ambient temperature for 16 h before being filtered through a celite pad, 
which had been pre-washed with 5.0 ml of anhydrous THF. The mother liquor was 
concentrated and used directly in the next step with no additional purification. 
Macrolactonisation 
A solution of mixed anhydride 531 in anhydrous PhMe (0.002 M, 2.43 ml) was added to 





(0.009 M, 10.8 ml) via syringe pump over 6 h at ambient temperature under an atmosphere 
of N2. After the addition was complete, the syringe was washed with 0.41 ml of anhydrous 
PhMe, which was also added to the reaction. The resulting mixture was stirred at ambient 
temperature for 16 h, after which the solvent was removed in vacuo. The crude residue 
was filtered through a pad of silica gel (hexane:EtOAc 8:1) and the mother liquor 
concentrated to afford protected bahamaolide A (502) (2.6 mg, 53%) as a yellow oil. 
Sammakia has shown that the corresponding intermediate in the synthesis of dermostatin 
A is not stable to purification and so 502 was characterised by HRMS only and then 
carried forward to the deprotection step.  
HRMS (MALDI) calculated for C57H94NaO11Si [M+Na]+ 1005.6458 found 1005.6468. 
3-Hydroxypropyl 2,4,6-triisopropylbenzoate (511) 
 
According to a modified literature procedure,43 DIAD (4.87 ml, 24.7 mmol, 1.00 equiv.) 
was added dropwise to a stirred solution of propane-1,3-diol (5.35 ml, 74.1 mmol, 3.00 
equiv.), triisopropylbenzoic acid (6.00 g, 27.2 mmol, 1.10 equiv.) and triphenylphosphine 
(7.13 mg, 27.2 mmol, 1.10 equiv.) in THF (0.70 M, 35 ml) at 0 °C (water/ice). The 
resulting reaction mixture was stirred at ambient temperature for 16 h before being 
concentrated in vacuo. The crude residue was purified directly by column 
chromatography (SiO2, petroleum ether:EtOAc 8:2), to afford the title compound (511) 
(6.51 g, 86%) as a colourless oil. 
All data matched that reported in the literature.207 
1H NMR (500 MHz, CDCl3) δ 7.00 (s, 2H, ArH), 4.44 (t, J = 6.3 Hz, 2H, TIBOCH2), 
3.76 (t, J = 6.1 Hz, 2H, CH2OH), 2.94–2.77 (m, 3H, 3xArCH), 2.02–1.93 (m, 2H, 
CH2CH2OH), 1.23 (d, J = 6.9 Hz, 18H, 6 x CH3) ppm. 
13C NMR (126 MHz, CDCl3) δ 171.3 (C), 150.3 (C), 144.8 (C), 130.4 (C), 121.0 (CH), 







2-(Dimethylamino)ethyl 2,4,6-triisopropylbenzoate (490) 
 
According to a modified literature procedure,43 DIAD (1.21 ml, 6.17 mmol, 1.10 equiv.) 
was added dropwise to a stirred solution of 2-(dimethylamino)ethan-1-ol (0.56 ml, 5.61 
mmol, 1.00 equiv.), 2,4,6-triisopropylbenzoic acid (1602 mg, 6.45 mmol, 1.15 equiv.) 
and triphenylphosphine (1618 mg, 6.17 mmol, 1.10 equiv.) in THF (0.66 M, 8.5 ml) at 
0 °C (water/ice). The resulting reaction mixture was stirred at ambient temperature for 
1 h before being concentrated in vacuo. The crude residue was purified directly by column 
chromatography (SiO2, pentane:Et2O 2:8), to afford the title compound (490) (1049 mg, 
59%) as a colourless oil.  
1H NMR (400 MHz, CDCl3) δ 6.99 (s, 2H, ArH), 4.42 (t, J = 6.1 Hz, 2H, OCH2), 
2.94–2.83 (m, 3H, 3 x ArCH), 2.67 (t, J = 6.1 Hz, 2H, NCH2), 2.31 (s, 6H, N(CH3)2), 1.24 
(d, J = 6.8 Hz, 12H, 2 x oArC(CH3)2), 1.24 (d, J = 6.9 Hz, 6H, pArC(CH3)2) ppm. 
13C NMR (101 MHz, CDCl3) δ 170.8 (C=O), 150.1 (C), 144.8 (C), 130.4 (C), 120.8 (CH), 
62.4 (CH2), 57.6 (CH2), 45.5 (CH3), 34.4 (CH), 31.5 (CH), 24.2 (CH3), 24.0 (CH3) ppm. 
HRMS (ESI) calculated for C20H33NO2 [M+H]+ 320.2584, found 320.2583. 
IR (νmax/cm–1, neat) 2957.72, 2768.63, 1724.61, 1605.1, 1451.29 and 1248.85. 
Rf 0.28 (7:3 Et2O:pentane). 
2-Hydroxyethyl 2,4,6-triisopropylbenzoate (488) 
 
According to a modified literature procedure,204 a suspension of 2,4,6-triisopropylbenzoic 
acid (500 mg, 2.01 mmol, 1.00 equiv) and K2CO3 (556 mg, 4.02 mmol, 2.00 equiv.) in 
MeCN (0.33 M, 6.1 ml) was stirred vigorously for 15 min. 2-Bromoethanol (0.28 ml, 
4.0  mmol, 2.0 equiv) was added and the resulting suspension heated at 100 °C (oil bath) 
for 2 h. The reaction mixture was cooled to ambient temperature, filtered through celite 





column chromatography (SiO2, pentane:Et2O 70:30) to afford 488 (546.2 mg, 93%) as a 
colourless oil.  
1H NMR (400 MHz, CDCl3) δ 7.02 (s, 2H, ArH), 4.44 (m, 2H, TIBOCH2), 3.92 (m, 2H, 
HOCH2), 2.95–2.81 (m, 3H, 3 x ArCH), 1.87 (t, J = 6.2 Hz, 1H, OH), 1.26 (d, J = 6.8 Hz, 
12H, 2 x oArC(CH3)2), 1.25 (d, J = 6.9 Hz, 6H, pArC(CH3)2) ppm. 
13C NMR (101 MHz, CDCl3) δ 171.0 (C=O), 150.4 (C), 144.8 (C), 130.0 (C), 120.9 (CH), 
66.5 (CH2), 61.3 (CH2), 34.5 (CH), 31.6 (CH), 24.2 (CH3), 24.0 (CH3) ppm. 
HRMS (ESI) calculated for C18H29O3 [M+H]+ 293.2111, found 293.2116. 
IR (νmax/cm–1, neat). 3438.74 (br), 2960.1, 2870.2, 1725.8, 1650.9 and 1460.5. 
Rf 0.23 (70:30 pentane:Et2O). 
2-((t-Butyldimethylsilyl)oxy)ethyl 2,4,6-triisopropylbenzoate (486) 
 
According to a modified literature procedure,43 DIAD (0.64 ml, 3.24 mmol, 1.10 equiv) 
was added dropwise to a stirred solution of 2-((t-butyldimethylsilyl)oxy)ethan-1-ol 
(520 mg, 2.95 mmol, 1.00 equiv), 2,4,6-triisopropylbenzoic acid (842 mg, 3.39 mmol, 
1.15 equiv) and triphenylphosphine (850 mg, 3.24 mmol, 1.10 equiv) in THF (0.66 M, 
4.5 ml) at 0 °C (water/ice). The resulting reaction mixture was stirred at ambient 
temperature for 3 hr before being concentrated in vacuo. The crude residue was purified 
directly by column chromatography (SiO2, pentane:Et2O 90:10), to afford 486 (560 mg, 
47%) as a colourless oil.  
1H NMR (400 MHz, CDCl3) δ 7.00 (s, 2H, ArH), 4.36 (m, 2H, OCH2), 3.90 (m, 2H, 
OCH2), 2.94–2.83 (m, 3H, 3 x ArCH), 1.24 (d, J = 7.0 Hz, 6H, pArC(CH3)2), 1.24 (d, 
J = 6.9 Hz, 12H, 2 x oArC(CH3)2), 0.89 (s, 9H, SiC(CH3)3), 0.06 (s, 6H, Si(CH3)2) ppm. 
13C NMR (101 MHz, CDCl3) δ 171.0 (C=O), 150.2 (C), 145.0 (C), 130.6 (C), 121.0 (CH), 
66.4 (CH2), 61.3 (CH2), 34.6 (CH), 31.6 (CH), 26.0 (CH3), 24.3 (CH3), 24.1 (CH3), 
18.4 (CH3), –5.2 (C) ppm. 
HRMS (ESI) calculated for C24H42NaO3Si [M+Na]+ 429.2795, found 429.2804. 





Rf 0.8 (90:10 pentane:Et2O). 
(E)-6-Methyl-2-(2-(tributylstannyl)vinyl)-1,3,6,2-dioxazaborocane-4,8-dione (461) 
 
According to a literature procedure,208 tributyltin hydride (0.45 ml, 1.66 mmol, 1.50 
equiv) was added to a stirred solution of 2-ethynl-6-methyl-1,3,6,2-dioxazaborocane-4,8-
dione (460) (200 mg, 1.11 mmol, 1.00 equiv) and AIBN (18 mg, 0.11 mmol. 0.10 equiv) 
in THF (0.20 M, 5.6 ml). The resulting reaction mixture was heated at 70 °C for 18 h 
before being cooled to ambient temperature and successively washed with a 1 M aqueous 
solution of HCl (10 ml), a saturated aqueous solution of NaHCO3 (10 ml) and brine 
(10 ml). The organic phase was dried over MgSO4 and concentrated in vacuo. The crude 
residue was purified by column chromatography (SiO2, Et2O to Et2O:MeCN 5:1) to afford 
the title compound (461) (336 mg, 64%, E/Z >95:5) as a white solid. 
All spectral data matched that reported in the literature.208 
1H NMR (400 MHz, DMSO-d6) δ 6.80 (d, J = 21.7 Hz and dd, 122.7, 2.2 Hz and dd, 
79.6, 2.2 Hz, 1H, CH), 6.29 (d, J = 21.7 Hz and dd, J = 113.3, 2.1 Hz dd, J = 69.9, 2.1 
Hz, 1H, CH), 4.20 (d, J = 17.0 Hz, 2H, NCH2), 3.98 (d, J = 17.0 Hz, 2H, NCH2), 2.74 (s, 
3H, NCH3), 1.54–1.43 (m, 6H, 3 x SnCH2CH2), 1.33–1.23 (m, 6H, 3 x SnCH2CH2CH2), 
0.91–0.82 (m, 15H, 3 x SnCH2 and 3 x SnCH2CH2CH2CH3) ppm. 
13C NMR (101 MHz, DMSO-d6) δ 169.2 (C=O), 145.6 (CH), 61.5 (CH2), 46.8 (CH3), 
28.6 (CH2), 26.6 CH2), 13.6 (CH2), 9.0 (CH3) ppm. 
Carbon atom next to boron not observed due to quadrupolar relaxation. 
(E)-2-(2-Chlorovinyl)-6-methyl-1,3,6,2-dioxazaborocane-4,8-dione (462) 
 
Cu(II)Cl (1.15 g, 8.59 mmol, 2.50 equiv) was added to a stirred solution of 461 (1.62 g, 
3.43 mmol, 1.00 equiv) in anhydrous THF (0.90 M, 9.5 ml). The resulting suspension was 
stirred at ambient temperature for 36 h. The reaction mixture was filtered through celite 





directly by column chromatography (SiO2, Et2O:MeCN 80:20) to afford 462 (609 mg, 
82%) as a white solid. 
1H NMR (500 MHz, DMSO-d6) δ 6.41 (d, J = 14.6 Hz, 1H, CH), 5.98 (d, J = 14.6 Hz, 
1H, CH), 4.24 (d, J = 17.2 Hz, 2H, NCH2), 4.03 (d, J = 17.2 Hz, 2H, NCH2), 2.80 (s, 3H, 
NCH3) ppm.  
13C NMR (126 MHz, DMSO-d6) δ 169.3 (C=O), 128.2 (CH), 62.0 (CH2), 47.4 (CH3) 
ppm. 
Carbon atom next to boron not observed due to quadrupolar relaxation. 
HRMS (ESI) calculated for C7H10BClNO4 [M+H]+ 218.0391, found 218.0387. 
IR (νmax/cm–1, neat). 1749.8, 1608.7, 1567.6, 1452.3, 1298.3 and 1023.4. 
Ethyl (2E,4E,6E)-octa-2,4,6-trienoate (527) 
 
According to a modified literature procedure,124 ethyl 2-(diethoxyphosphoryl)acetate 
(526) (3.10 ml, 15.6 mmol, 1.50 equiv) was added dropwise to a stirred suspension of 
NaH (60% dispersion in mineral oil, 582 mg, 14.6 mmol, 1.40 equiv) in anhydrous THF 
(0.28 M, 52 ml) at 0 °C. The resulting mixture was warmed to ambient temperature and 
stirred for 30 min. Freshly distilled sorbaldehyde (524) (1.12 ml, 10.4 mmol, 1.00 equiv) 
was then added in anhydrous THF (2.68 M, 3.90 ml) and the resulting mixture heated at 
70 °C for 16 h. The reaction mixture was diluted with water (50 ml) and Et2O (50 ml) and 
the phases were separated. The aqueous phase was extracted with Et2O (3 x 50 ml) and 
the combined organics were washed with brine (25 ml), dried over MgSO4, filtered and 
concentrated in vacuo. The crude residue was purified by flash column chromatography 
(SiO2, hexane:EtOAc 95:5) to yield the title compound (527) (899 mg, 52%, E/Z 8:1) as 
a pale yellow oil. 
All data matched that reported in the literature.209  
1H NMR (400 MHz, CDCl3) δ 7.29 (dd, J = 15.3, 11.3 Hz, 1H, CCHCH), 6.52 (dd, 
J = 14.9, 10.7 Hz, 1H, CCHCHCHCH), 6.24–6.10 (m, 2H, CCHCHCH and CH3CHCH), 
5.93 (m, 1H, CH3CH), 5.83 (d, J = 15.3 Hz, 1H, CCH), 4.20 (q, J = 7.1 Hz, 2H, OCH2), 
1.83 (d, J = 6.9 Hz, 3H, CHCH3) 1.29 (t, J = 7.1 Hz, 3H, OCH2CH3) ppm. 
13C NMR (101 MHz, CDCl3) δ 167.4 (C), 144.9 (CH), 141.1 (CH), 135.2 (CH), 







According to a modified literature procedure,124 DiBAlH (1.00 M in hexane, 11.4 ml, 
11.4 mmol, 2.10 equiv) was added dropwise to a stirred solution of polyene 527 (899 mg, 
2.40 mmol. 1.00 equiv) in anhydrous DCM (0.40 M, 13.5 ml) at –78 °C. The resulting 
mixture was warmed to ambient temperature and stirred for 4 h. The reaction was then 
diluted with Et2O (20 ml) and quenched through the slow addition of a saturated aqueous 
solution of Rochelle’s salt (100 ml). The reaction was stirred at ambient temperature for 
16 h, after which two phases were visible. The phases were separated, and the organic 
phase was dried over MgSO4, filtered and concentrated in vacuo. The crude residue was 
dissolved in anhydrous DCM (0.20 M, 27 ml) and cooled to 0 °C. Dess–Martin 
periodinane (2.41 g, 5.67 mmol. 1.05 equiv) was added in one portion and the reaction 
was warmed to ambient temperature and stirred for 18 h. The reaction was filtered through 
a celite plug (DCM), diluted with a saturated aqueous solution of NaHCO3 (20 ml) and 
the phases were separated. The organic phase was dried over MgSO4, filtered and 
concentrated in vacuo. The crude residue was purified by flash column chromatography 
(SiO2, hexane:EtOAc 95:5) to afford the title compound (470) (261 mg, 89%, E/Z 8:1) as 
a pale yellow oil. 
All data matched that reported in the literature.209 
1H NMR (400 MHz, CDCl3) δ 9.55 (d, J = 8.0 Hz, 1H, CHO), 7.11 (dd, J = 14.6, 11.1 Hz, 
1H, OCHCHCH), 6.64 (dd, J = 14.8, 10.6 Hz, 1H, OCHCHCHCHCH), 6.38–6.29 (m, 
1H, OCHCHCHCH), 6.16 (m, 1H, CH3CHCH), 6.13 (m, 1H, OCHCH), 6.04 (m, 1H, 
CH3CH), 1.86 (m, 3H, CH3) ppm. 
13C NMR (101 MHz, CDCl3) δ 193.7 (CH), 152.6 (CH), 143.2 (CH), 137.3 (CH), 131.3 










Ethyl (2E,4E)-6-(diethoxyphosphoryl)hexa-2,4-dienoate (469) 
 
According to a modified literature procedure,206 AlCl3 (581 mg, 4.36 mmol, 0.40 equiv) 
was added portionwise to a stirred suspension of LiAlH4 (451 mg, 12.0 mmol, 1.10 equiv) 
in anhydrous Et2O (0.62 M, 19 ml) under an atmosphere of N2 at –50 °C (acetone/dry ice). 
The resulting suspension was warmed to ambient temperature and stirred for 30 min, then 
cooled to –78 °C (acetone/dry ice). A solution of ester 701 (1.31 ml, 10.9 mmol, 
1.00 equiv) in anhydrous Et2O (1.40 M, 7.79 ml) was added dropwise and the resulting 
mixture was stirred at –78 °C for 3 h. The reaction was warmed to 0 °C (water/ice) and 
the excess LiAlH4 was quenched according to the Fieser method; specifically, the reaction 
was sequentially diluted with H2O (0.5 ml), NaOH (15% aqueous solution, 0.5 ml), H2O 
(1.5 ml), and was then warmed to ambient temperature and stirred for 30 min. The mixture 
was filtered through a pad of celite (Et2O) and concentrated in vacuo to an orange oil. 
This orange oil was dissolved in DCM (0.31 M, 35 ml) and oven activated MnO2 (18.95 
g, 218 mmol, 20.0 equiv) was added portionwise. The resulting suspension was stirred at 
ambient temperature for 1 h and was filtered through a celite pad (DCM) and concentrated 
in vacuo to a yellow oil (702, 1.43 g), which was used directly in the next step 
Triethylphosphonoacetate (2.23 ml, 11.5 mmol, 1.20 equiv) was added dropwise to a 
stirred suspension of NaH (60% dispersion in mineral oil, 460 mg, 11.5 mmol, 1.20 equiv) 
in anhydrous THF (0.20 M, 48 ml) under a N2 atmosphere at 0 °C (water/ice). The mixture 
was stirred until the suspension became clear and then for a further 10 min, at which point 
it was cooled to –78 °C (acetone/dry ice). 702 (1.43 g, 9.57 mmol, 1.00 equiv) was added 
and the resulting mixture stirred for 1 h at –78 °C before being warmed to ambient 
temperature. The reaction was quenched with a saturated aqueous solution of NH4Cl 
(50 ml) and was diluted with Et2O (75 ml). The phases were separated, and the aqueous 
phase was extracted with Et2O (3 x 50 ml). The combined organics were dried over 





chromatography (SiO2, pentane:Et2O 90:10) to yield vinylogous ester 703 (886 mg, 37% 
over 3 steps). 
P(OEt)3 (1.04 ml, 6.07 mmol, 1.50 equiv) was added to ester 703 (886 mg, 4.04 mmol, 
1.00 equiv) at ambient temperature and heated at 140 °C for 3 h. The reaction was cooled 
to ambient temperature and the excess P(OEt)3 was removed through azeotropic 
co-evaporation with toluene (3 x 50 ml) and the crude residue was purified by flash 
column chromatography (SiO2, DCM:MeOH 98:2) to yield 469 (276 mg, 83%, E/Z 95:5) 
as a pale yellow oil. 
All spectral data matched that reported in the literature.210,211 
1H NMR (400 MHz, CDCl3) δ 7.25 (dd, J = 15.4, 11.1 Hz, 1H, PCH2CHCHCH), 6.30 
(ddd, J = 15.4, 11.1, 4.8 Hz, 1H, PCH2CHCH), 6.05 (app sext, 1H, PCH2CH), 5.85 (dd, 
J = 15.3, 2.3 Hz, 1H, C(O)CH), 4.20 (q, J = 7.1 Hz, 2H, C(O)OCH2), 4.15–4.05 (m, 4H, 
2 x P(O)OCH2), 2.72 (dd, J = 23.1, 7.6 Hz, 2H, PCH2), 1.31 (t, J = 7.1 Hz, 6H, 2 x 
P(O)OCH2CH3), 1.29 (t, J = 7.1 Hz, 3H, C(O)OCH2CH3) ppm. 
13C NMR (101 MHz, CDCl3) δ 167.0 (C=O), 143.6 (d, J = 4.6 Hz, CH), 132.9 (d, 
J = 14.5 Hz, CH), 131.7 (d, J = 12.7 Hz, CH), 121.5 (d, J = 4.3 Hz, CH), 62.4 (d, 




t-BuLi (1.6 M in pentane, 52 µl, 83 µmol, 1.5 equiv) was added to a stirred solution of 
1,2-bis(boronic ester) 463 (24 mg, 55 µmol, 1.0 equiv) and sulfoxide 499 (50 mg, 
83 µmol, 1.5 equiv) in anhydrous THF (0.20 M, 0.28 ml) under an atmosphere of N2 at 
–78 °C (acetone/dry ice). The resulting mixture was stirred at –78 °C for 1 h. The excess 
carbenoid was quenched through the dropwise addition of MeOH (HPLC grade, 0.10 ml) 
and the reaction was warmed to ambient temperature and then heated at 45 °C for 3 h. 





under high vacuum. The crude residue was purified directly by column chromatography 
(SiO2, pentane:Et2O 96:4) to give 1,3-bis(boronic ester) 517 (10.6 mg, 30%, >95:5 dr) as 
a colourless oil and over homologated product 518 (7.9 mg, 17%, >95:5 dr) as a 
colourless oil. 
Compounds 517 and 518 were part of an unsuccessful model study and were 
characterised by 1H NMR only. 
517 
1H NMR (400 MHz, CDCl3) δ 7.80–7.71 (m, 3H, 3 x ArH), 7.60 (s, 1H, ArH), 7.45–7.31 
(m, 3H, 3 x ArH), 5.82 (ddt, J = 17.2, 10.4, 7.0 Hz, 1H, CH=CH2), 5.06–4.96 (m, 2H, 
CH=CH2), 3.72 (app p, 1H, OCH), 2.81–2.73 (m, 2H, ArCH2), 2.30–2.21 (m, 1H, 
CH2=CHCHaHb), 2.21–2.12 (m, 1H, CH2=CHCHaHb), 1.80–1.72 (m, 2H), 1.55–1.36 (m, 
6H) 1.27 (s, 24H, 2 x pinacol-CH3), 1.15 (app d, 9H, SiC(CH3)3), 0.06 (s, 3H, SiCH3), 
0.05 (s, 3H, SiCH3) ppm. 
518 
1H NMR (400 MHz, CDCl3) δ 7.80–7.70 (m, 3H, 3xArH), 7.61 (s, 1H, ArH), 7.45–7.32 
(m, 3H, 3xArH), 5.85 (m, 2H, 2 x CH=CH2), 5.09–4.98 (m, 4H, 2x CH=CH2), 3.70 (m, 
2H, 2xOCH), 2.77 (m, 2H, ArCH2), 2.29–2.16 (m, 4H, 2 x CH2=CHCH2), 1.80–1.23 (m, 
11H), 1.21 (s, 12H, pinacol-CH3), 1.16 (s, 12H, pinacol-CH3), 0.88 (m, 18H, 




According to a modified literature procedure,127 vinyl magnesium chloride (1.6 M in THF, 
0.21 ml, 0.33 mmol, 3.0 equiv) was added dropwise to a stirred solution of 
1,2-bis(boronic ester) 479 in anhydrous THF (0.22 M, 0.50 ml), at 0 °C (water/ice). The 
resulting mixture was warmed to ambient temperature and stirred for 30 min. The reaction 
was then cooled to –78 °C (acetone/dry ice) and a solution of I2 (84 mg, 0.33 mmol, 
3.00 equiv) in anhydrous THF (0.50 M, 0.66 ml) was added dropwise. The reaction was 





in anhydrous MeOH (3.0 M, 0.11 ml) was added dropwise and stirred at –78 °C for 
30 min. The reaction was warmed to ambient temperature and stirred for 16 h. The excess 
I2 was quenched through the addition of a saturated aqueous solution of Na2S2O3 (2.0 ml) 
before the reaction was diluted with Et2O (5 ml). The phases were separated, and the 
aqueous phase was extracted with Et2O (3 x 5 ml), dried over MgSO4, filtered and 
concentrated in vacuo. The crude residue was purified by column chromatography (SiO2, 
pentane:Et2O 96:4) to yield boronic ester 480 (5.2 mg, 13%) as a colourless oil and diene 
481 (18.7 mg, 65%) as a colourless oil. 
Compounds 480 and 481 were part of an unsuccessful model study and were 
characterised by 1H NMR only. 
480 
1H NMR (400 MHz, CDCl3) δ 7.58 (d, J = 8.0 Hz, 2H, ArH), 7.50 (d, J = 8.0 Hz, 2H, 
ArH), 7.43 (m, 2H, ArH), 7.33 (t, J = 7.3 Hz, 1H, ArH), 7.27–7.23 (m, 2H, ArH), 5.75 
(ddt, J = 17.2, 10.2, 8.3 Hz, 1H, CH=CH2), 5.09–4.96 (m, 2H, CH=CH2), 2.73–2.53 (m, 
2H, PhCH2), 2.37 (m, 1H, BCH), 1.80–1.60 (m, 2H, CH2=CHCH2), 1.24 (s, 12H, 
pinacol-CH3), 1.00–0.87 (m, 2H, ArCH2CH2) ppm. 
481 
1H NMR (400 MHz, CDCl3) δ 7.59 (d, J = 8.1 Hz, 2H, ArH), 7.51 (d, J = 8.1 Hz, 2H, 
ArH), 7.43 (m, 2H, ArH), 7.33 (m, 1H, ArH), 7.27–7.23 (m, 2H, ArH), 5.78 (ddt, J = 17.1, 
10.2, 6.7 Hz, 1H, CH=CH2), 5.67 (ddd, J = 17.1, 10.2, 8.0 Hz, 1H, CH=CH2), 5.11–4.98 
(m, 4H, 2xCH=CH2), 2.71 (ddd, J = 13.7, 10.3, 5.3 Hz, 1H, ArCHaHb), 2.58 (ddd, 
J = 13.8, 10.2, 6.2 Hz, 1H, ArCHaHb), 1.79 (m, 1H, CH2=CHCHaHb), 1.66–1.56 (m, 1H, 
CH2=CHCHaHb) 1.35–1.23 (m, ArCH2CH2 and CH) ppm 
Methylenediboronic acid(620) 
 
According to a modified literature procedure,212 HCl (40.4 ml, aqueous, 6.0 M) was added 
to a stirred suspension of diborylmethane (225) (5.00 g, 18.7 mmol, 1.0 equiv) in water 
(67.5 ml) and the resulting mixture stirred at 100 °C for 16 h. The reaction mixture was 





solid. This was triturated in Et2O and the solid collected by filtration to afford the title 
compound (620) (1.77 g, 92%) as a white solid. 
Spectral data in accordance with the published values.212  
1H NMR (400 MHz, DMSO-d6) δ 5.00-7.00 (s (br), 4H, (OH)4), 0.03 (s, 2H, BCH2) ppm.  
13C NMR (101 MHz, DMSO-d6) δ 5.2 (CH2) ppm. 
2-(Dimethylamino)propane-1,3-diol (590) 
 
According to a literature procedure,213 formaldehyde (37% in H2O, 9.90 ml, 132 mmol, 
2.40 equiv) was added to a stirred solution of 2-aminopropane-1,3-diol (598) (5.00 g, 54.9 
mmol, 1.00 equiv) in formic acid (12.1 ml, 275 mmol, 5.00 equiv) at 0 °C. The reaction 
mixture was stirred at ambient temperature for 2 h and then at 80 °C for 16 h. The reaction 
mixture was cooled to ambient temperature and HCl (12.1 M, 0.7 ml) was added and the 
resulting solution was stirred at ambient temperature for 1 h. The pH value was adjusted 
to pH 12 by addition of NaOH pellets and the resulting solution was concentrated to 
dryness in vacuo. Excess methanol (100 ml) was added and NaOH removed via filtration. 
The filtrate was concentrated to dryness in vacuo and the resulting solid was taken up in 
chloroform (50 ml), dried over MgSO4, filtered and concentrated to a yellow oil. This oil 
was purified by Kugelrohr distillation to afford 590 (5.44 g, 83%) as a thick brown oil 
which solidified under high vacuum to an amorphous brown solid. 
Spectral data in accordance with published values.213  
1H NMR (400 MHz, CDCl3) δ 3.66 (d, J = 6.05 Hz, 4H, OCH2), 2.62 (p, J = 6.05 Hz, 
1H, NCH), 2.47 (s (br), 2H, OH), 2.39 (s, 6H, NCH3) ppm. 











According to a literature procedure,214 nitroethane (599) (4.70 ml, 67.0 mmol, 1.00 equiv) 
was added dropwise to a stirred solution of formaldehyde (37% in H2O, 21.0 ml, 280 
mmol, 4.20 equiv) and trimethylamine (0.045 ml, 0.32 mmol, 0.05 mol%) in methanol 
(7.70 ml) at ambient temperature under a nitrogen atmosphere. The reaction mixture was 
stirred at ambient temperature for 16 h. The reaction mixture was then diluted with EtOAc 
(100 ml) and water (50 ml), and the phases were separated. The aqueous phase was 
extracted in EtOAc (3 x 100 ml) and the combined organic layers were washed with brine 
(50 ml), dried over MgSO4, filtered and concentrated in vacuo to a afford a white solid, 
which was recrystallised in hot methanol to afford 600 (5.13 g, 57%) as white needles. 
Spectral data in accordance with published values.214 
1H NMR (400 MHz, DMSO-d6) δ 5.2 (m, 2H, (OH)2), 3.77 (dd, J = 11.5, 5.9 Hz, 2H 
OCH2), 3.54 (dd, J = 11.43, 5.57 Hz, 2H, OCH2), 1.42 (s, 3H, CH3) ppm.  
13C NMR (101 MHz, CD3OD) δ 92.28 (C), 64.12 (CH2), 16.42 (CH3) ppm. 
2-(Dimethylamino)-2-methylpropane-1,3-diol (591) 
 
According to a literature procedure,214 RaNi (0.34 g, 0.68 ml, excess) in MeOH (2.1 ml) 
was added to an autoclave under a nitrogen atmosphere. A solution of 2-methyl-2-
nitropropane-1,3-diol (600) (0.50 g, 3.7 mmol, 1.00 equiv) and formaldehyde (0.24 mg, 
8.1 mmol, 2.20 equiv) in MeOH (0.77 ml) premixed in a separate Schlenk tube under 
nitrogen was added to the autoclave reactor. H2 gas was added to a pressure of 700 psi 
and the resulting reaction mixture was stirred at 45 °C for 16 h. The pressure was released 
from the autoclave and the reaction mixture was filtered through a Celite pad (MeOH) 
under a flow of nitrogen. The filtrate was concentrated in vacuo to yield 591 (0.35 g, 70 





Spectral data in accordance with published values.214  
1H NMR (400 MHz, CDCl3) δ3.63 (d, J = 10.9 Hz, 2H, OCH2), 3.57 (d, J = 11 Hz, 2H, 
OCH2), 3.07 (s (br), 2H, OH), 2.32 (s, 6H, (NCH3)2), 0.78 (s, 3H, CH3) ppm. 
13C NMR (101 MHz, CDCl3) 75.2 (C), 71.7 (CH2), 49.1 (CH3), 23.7 (CH3) ppm. 
2-((Dimethylamino)methyl)-2-methylpropane-1,3-diol (593) 
 
According to a modified literature procedure,215 dimethylamine (40% in water, 1.50 ml, 
12.0 mmol, 2.40 equiv) was added (3-methyloxetan-3-yl)methanol (601) (0.49 ml, 4.9 
mmol, 1.00 equiv) in a thick walled pressure tube. Without sealing the vessel, the mixture 
was cooled to −78 °C and left for 5 min. The tube was sealed at −78 °C and was warmed 
to ambient temperature. The reaction mixture was heated at 150 °C for 24 h. The reaction 
mixture was cooled to ambient temperature before being concentrated in vacuo to afford 
a colourless oil. The crude residue was purified by bulb to bulb distillation to yield 593 
(0.58 g, 80%) as a colourless oil. 
Spectral data in accordance with published values.215 
1H NMR (400 MHz, CDCl3) δ 3.72–3.60 (m, 4H, O(CH2)2), 2.49 (s, 2H, NCH2), 2.33 (s, 
6H, N(CH3)2), 0.78 (s, 3H, CH3) ppm. 




2-(Dimethylamino)propane-1,3-diol (590) (0.98 mg, 0.82 mmol, 1.00 equiv) was added 
to a stirred suspension of phenylboronic acid (0.10 mg, 0.82 mmol, 1.00 equiv) and 
flame-dried MgSO4 (0.99 mg, 0.82 mmol, 1.00 equiv) in Et2O (2.7 ml) under a nitrogen 





The reaction mixture was filtered through Celite and concentrated in vacuo to yield the 
crude product (594) (139 mg, 82%) as a dark orange solid that decomposed on silica gel.  
Full characterisation not obtained due to compound instability. 
1H NMR (400 MHz, CDCl3) δ 7.76 (m, 2H, ArH), 7.40 (m, 1H, ArH), 7.33 (m, 2H, ArH), 
4.24 (dd, J = 11.0, 3.9 Hz, 2H, NCHCH2), 4.08 (dd, J = 11.0, 7.3 Hz, 2H, NCHCH2), 
2.65 (tt, J = 7.5, 3.9 Hz, 1H, NCH), 2.37 (s, 6H, N(CH3)2) ppm. 
11B NMR (96 MHz) δ 26.0 ppm. 
N,N-Trimethyl-2-phenyl-1,3,2-dioxaborinan-5-amine (595) 
 
2-(Dimethylamino)-2-methylpropane-1,3-diol (591) (100 mg, 0.75 mmol, 1.00 equiv) 
was added to a stirred suspension of phenylboronic acid (91.5 mg, 0.75 mmol, 1.00 equiv) 
and flame-dried MgSO4 (90.3 mg, 0.75 mmol, 1.00 equiv) in Et2O (2.50 ml) under a 
nitrogen atmosphere. The resulting reaction mixture was stirred at ambient temperature 
for 16 h. The reaction mixture was filtered through Celite and concentrated in vacuo to 
yield 595 as a white solid that decomposed on silica gel.  
Full characterisation not obtained due to compound instability. 
1H NMR (400 MHz, CDCl3) δ 7.72 (m, 2H, ArH), 7.39–7.27 (m, 3H, ArH), 3.97–3.90 
(m, 4H, (OCH2)2), 2.33 (s, 6H, (NCH3)2), 1.05 (s, 3H, CH3) ppm. 
11B NMR (96 MHz) δ 14.9 ppm. 
N,N-Dimethyl-1-(5-methyl-2-phenyl-1,3,2-dioxaborinan-5-yl)methanamine (597) 
 
2-((Dimethylamino)methyl)-2-methylpropane-1,3-diol (593) (0.10 mg, 0.69 mmol, 1.00 
equiv) was added to a stired suspension of phenylboronic acid (0.83 g, 0.69 mmol, 1.00 
equiv) and flame-dried MgSO4 (0.82 mg, 0.69 mmol, 1.00 equiv) in Et2O (2.30 ml) under 





for 16 h. The reaction mixture filtered through Celite and concentrated in vacuo to yield 
the crude product (597) as a white solid that was immobile on silica gel.  
Full characterisation not obtained due as compound was not purified. 
1H NMR (300 MHz, CDCl3) δ 7.61 (m, 2H, ArH), 7.25–7.20 (m, 3H, ArH), 3.97 (m, 2H, 
OCH2), 3.83 (m, 2H, OCH2), 2.89 (m, 2H, NCH2), 2.43 (s, 6H, N(CH3)2), 0.73 (s, 3H, 
CH3) ppm.  
11B NMR (96 MHz) δ 3.9 ppm. 
N,N-Dimethyl-1-(5-methyl-2-phenethyl-1,3,2-dioxaborinan-5-yl)methanamine (605) 
 
2-((dimethylamino)methyl)-2-methylpropane-1,3-diol (593) (0.49 mg, 3.30 mmol, 1.00 
equiv) was added to a stirred suspension of phenethylboronic acid (0.50 mg, 3.30 mmol, 
1.00 equiv) and flame-dried MgSO4 (0.40 mg, 3.30 mmol, 1.00 equiv) in Et2O (11 ml) 
under a nitrogen atmosphere. The resulting reaction mixture was stirred at ambient 
temperature for 16 h. Reaction mixture filtered through Celite and concentrated in vacuo 
to yield the crude product (605) as a white solid that was immobile on silica gel.  
Full characterisation not obtained as compound was not purified. 
1H NMR (300 MHz, CDCl3) δ 7.26–7.19 (m, 5H, ArH), 7.10 (m, 1H, ArH), 3.87 (m, 2H, 
OCH2), 3.67 (m, 2H, OCH2), 2.79 (s, 2H, NCH2), 2.64–2.57 (m, 2H, PhCH2), 2.53 (s, 6H, 
N(CH3)2), 0.68 (s, 3H, CH3), 0.63–0.57 (m, 2H, BCH2) ppm.  
11B NMR (96 MHz) δ 5.9 ppm. 
1,2,3,4,7,8,9,10-Octahydro-1,10-phenanthroline (609) 
 
According to a modified literature procedure,168 KOH (2.0 g, 35.0 mmol, 6.36 equiv) in 
water (6.0 ml) was added to a stirred solution of 1,10-phenanthroline (1.0 g, 5.5 mmol 





in small portions. Addition of Ni−Al alloy resulted in an exothermic reaction and 
spontaneous refluxing. The mixture was allowed to reflux without cooling; another 
portion of Ni−Al was added as it calmed. Following complete addition of Ni−Al, the 
reaction mixture appeared as a green-tinted black solution and was stirred at ambient 
temperature for 16 h. The reaction mixture was then diluted with Et2O (50 ml) and filtered 
through a Celite plug. The filtrate was concentrated to ~50 ml and water (50 ml) was 
added. The phases were separated, and the aqueous phase extracted with Et2O (3 x 50 
ml). The combined organics were washed with brine (20 ml), dried over Na2SO4, filtered 
and concentrated to a yellow oil which solidified under high vacuum to afford 609 
(897 mg, 86%) as a yellow powder. 
Spectral data in accordance with published values.168 
Rf: 0.25 (pentane/Et2O, 50:50). 
1H NMR (400 MHz, DMSO-d6) δ 6.12 (s, 2H, ArH), 4.26 (s, 2H, (NH)2), 3.15 (m, 4 H, 
(NHCH2)2), 2.56 (t, J = 6.5 Hz, 4H, (NHCH2CH2CH2)2), 1.71 (m, 4H, (NHCH2CH2)2) 
ppm.  
13C NMR (101 MHz, DMSO-d6) δ 132.4 (C), 118.4 (C), 117.8 (CH), 42.1 (CH2), 27.4 




To a stirred solution of 1,2,3,4,7,8,9,10-octahydro-1,10-phenanthroline (609) (0.10 mg, 
0.53 mmol, 1.00 equiv) and phenylboronic acid (0.71 mg, 0.58 mmol, 1.10 equiv) in 
toluene (7.92 ml) was added DBU (0.016 ml, 0.11 mmol, 20 mol%). The resulting 
solution was heated at reflux for 16 h with azeotropic removal of water using a 
Dean–Stark trap. After this time, the reaction mixture was cooled to ambient temperature 
and concentrated in vacuo to a thick orange oil. This oil was purified by column 
chromatography (SiO2, petrol:EtOAc 95:5) to yield 611 (113 mg, 78%) as a purple solid. 





1H NMR (400 MHz, CDCl3) δ 7.69 (m, 2H, ArH), 7.48–7.39 (m, 3H, ArH), 6.67 (s, 2H, 
ArH), 3.93–3.89 (m, 4H, (NCH2)2), 2.90–2.83 (m, 4H, (NCH2CH2CH2)2), 2.11–2.03 (m, 
4H, (NCH2CH2)2) ppm.  
13C NMR (101 MHz, CDCl3) δ 134.0 (CH), 133.0 (C), 128.7 (CH), 128.1 (CH), 118.6 
(C), 116.8 (CH), 42.0 (CH2), 24.8 (CH2), 23.79 (CH2) ppm. 
11B NMR (128 MHz) δ 26.4 (s). 
IR (max/cm-1, neat): 2927.25, 1605.06, 1347.37, 987.51 and 698.97. 




According to a modified literature procedure,158 in a flame-dried Schlenk tube under a 
nitrogen atmosphere was added freshly distilled tetrakis(dimethylamido)diboron (0.12ml, 
0.58 mmol, 1.10 equiv) to anhydrous THF (2.0 M, 0.27 ml), followed by 1,2,3,4,7,8,9,10-
octahydro-1,10-phenanthroline (609) (0.10 g, 0.53 mmol, 1.0 equiv), To this solution was 
added anhydrous HCl (2.0 M in Et2O, 0.015 ml, 0.03 mmol, 5 mol%) and the resulting 
solution was stirred at 50 °C for 4 d. At this point, the reaction mixture was basified with 
K2CO3 (0.586 mg, 4.24 mmol, 8.0 equiv). Pinacol (0.076 mg, 0.64 mmol, 1.20 equiv) 
was then added and the resulting suspension was stirred at 50 °C for 16 h. After this time, 
the reaction mixture was cooled to ambient temperature and was diluted with water (25 
ml) and Et2O (25 ml). The phases were separated, and the aqueous phase was extracted 
with Et2O (3 x 25 ml). The combined ethereal extracts were washed with brine (25 ml), 
dried over MgSO4, filtered and concentrated in vacuo to an orange film. This film was 
purified by column chromatography (SiO2, pentane:Et2O 97:3) to afford 615 (18 mg, 
10.5%) as a white solid. 





1H NMR (400 MHz, CDCl3) δ 6.64 (s, 2H, ArH), 4.04–4.01 (m, 4H, NCH2), 2.84 (t, J = 
6.0 Hz, 4H, (NHCH2CH2CH2)2), 2.10–2.03 (m, 4H, (NCH2CH2)2, 1.32 (s, 6H, 
BOC(CH3)2),), 1.31 (s, 6H, BOC(CH3)2) ppm.  
13C NMR (96 MHz, CDCl3) δ 133.6 (C), 118.8 (C), 116.5 (CH), 82.6 (C), 42.6 (CH2), 
25.3 (CH3), 24.8 (CH2), 23.9 (CH2) ppm. 
11B NMR (128 MHz) δ 31.9 (s), 23.8 (s) ppm. 
IR (max/cm–1, neat): 2914.25, 1476.04, 1346.56, 1265.58 and 1041.63. 
HRMS: (ESI) calculated for C18H26B2N2O2 [M+H]+ 325.2253, found: 325.2260. 
1-Isopropylimidazolidine-2-thione (654) 
 
According to a modified literature procedure,177 thiocarbonyldiimidazole (1.704 g, 9.56 
mmol, 1.20 equiv) in anhydrous THF (0.80 M, 12.0 mL) was added to a stirred solution 
of N-isopropylethylenediamine (652) (0.819 g, 7.97 mmol, 1.00 equiv) in anhydrous THF 
(0.1 M, 79.7 mL) under a nitrogen atmosphere. The resulting reaction mixture was stirred 
at ambient temperature for 18 h. The reaction mixture was concentrated in vacuo to a 
bronze solid which was purified by column chromatography (SiO2; Et2O) to a white solid. 
Recrystallisation from methanol yielded 654 (783.9 mg, 68%) as colourless needles. 
1H NMR (500 MHz, CDCl3)  5.99 (s(br), 1H, NH), 4.79 (hept, J = 6.8 Hz, 1H, NCH), 
3.62−3.52 (m, 4H, HNCH2 and HNCH2CH2), 1.17 (d, J = 6.8 Hz, 6H, NH(CH3)2) ppm. 
13C NMR (126 MHz, CDCl3)  182.5 (C), 46.9 (CH), 42.9 (CH2), 41.5 (CH2), 19.3 (CH3) 
ppm. 
HRMS (ESI) calculated for C6H13N2S [M+H]+ 145.0794, found 145.0794. 
IR (max/cm–1, neat) 3199.1, 1506.7, 1448.1 and 1264.7. 
MP 163–164 C (MeOH). 





4-Isopropyl-5-(methylthio)-3,4-dihydro-2H-pyrrol-1-ium iodide (655) 
 
According to a modified literature procedure,177 methyl iodide (3.89 mL, 62.4 mmol, 5.00 
equiv) was added dropwise to isopropylimidazolidine-2-thione 22 (1.80 g, 12.5 mmol, 
1.00 equiv) at ambient temperature under a nitrogen atmosphere. The resulting mixture 
was heated at 50 C (oil bath) for 18 h. The excess methyl iodide was removed in vacuo 
and the residue was taken up in anhydrous MeOH and concentrated (2 x 20 mL) to afford 
29 (3.436 g, 96%) as an amorphous yellow solid that was used as such. 
1H NMR (500 MHz, CDCl3)  9.48 (s (br), 1H, NH), 4.10−4.05 (m, 2H, CH2), 3.97−3.90 
(m, 3H, CH2 and NCH), 2.98 (s, 3H, SCH3), 1.29 (d, J = 6.7 Hz, 6H, NC(CH3)2) ppm. 
13C NMR (126 MHz, CDCl3)  169.7 (C), 49.1 (CH), 44.8 (CH2), 43.5 (CH2), 19.8 (CH3), 
16.7 (CH3) ppm. 
HRMS (ESI) calculated for C7H15N2S [M+H]+ 159.0950, found 159.0956. 
IR (max/cm–1, neat) 3180.7, 2976.2, 2874.4, 1566.5, 1516.2 and1292.6. 
1-Isopropylimidazolidin-2-one (657) 
 
According to a modified literature procedure,177 carbonyldiimidazole (1.904 g, 11.7 
mmol, 1.20 equiv) was added portion wise to a stirred solution of 
N-isopropylethylenediamine (652) (1.20 mL, 9.78 mmol, 1.00 equiv) in anhydrous THF 
(0.17 M, 59.0 mL) under a nitrogen atmosphere. The resulting reaction mixture was stirred 
at ambient temperature for 18 h. The reaction mixture was then concentrated under 
reduced pressure to an orange oil. This oil was diluted with 2 M HCl (200 mL) and 
dichloromethane (200 mL). The layers were separated, and the aqueous layer extracted 





and concentrated in vacuo to afford 657 (0.828 g, 66%) as an amorphous white solid that 
was used as such. 
1H NMR (500 MHz, CDCl3)  4.13 (hept, J = 6.6 Hz, 1H, NCH), 3.39 (s, 4H, (CH2)2), 
1.12 (d, J = 6.6 Hz, 6H, (CH3)2) ppm. 
13C NMR (126 MHz, CDCl3)  43. 1 (CH), 39.6 (CH2), 38.5 (CH2), 19.7 (CH3) ppm. 
HRMS (ESI) calculated for C6H12N2NaO [M+Na]+ 151.0842, found 151.0840.  
IR (max/cm–1, neat) 3198.8, 3086.6, 2974.9, 2866.5 and 1683.1.  
Rf 0.17 (96:4 DCM:MeOH). 
1-Isopropyltetrahydropyrimidin-2-one (664) 
 
According to a modified literature procedure,177 carbonyldiimidazole (1.671 g, 
10.3 mmol, 1.20 equiv) was added portion wise to a stirred solution of 
N-isopropylpropane-1,3-diamine (669) (1.20 mL, 8.61 mmol, 1.00 equiv) in anhydrous 
THF (0.17 M, 52.2 mL) under a nitrogen atmosphere. The resulting reaction mixture was 
stirred at ambient temperature for 18 h. The reaction mixture was then concentrated in 
vacuo to a colourless oil. This oil was diluted with 2 M HCl (200 mL) and 
dichloromethane (200 mL). The layers were separated, and the aqueous layer extracted 
with dichloromethane (3 x 100 mL). The combined organics were dried (MgSO4), filtered 
and concentrated in vacuo to afford 664 (0.660 g, 54%) as an amorphous white solid that 
was used as such. 
All data matched that reported in the literature.216 
1H NMR (500 MHz, CDCl3)  4.56 (hept, J = 6.6 Hz, 1H, NCH), 3.31 (t, J = 5.6 Hz, 2H, 
NCH2), 3.19 (t, J = 5.6 Hz, 2H, NCH2), 1.91 (app p, 2H, NCH2CH2), 1.11 (d, J = 6.6 Hz, 
6H, CH3)2) ppm. 
13C NMR (126 MHz, CDCl3)  156.5 (C), 45.7 (CH), 39.5 (CH2), 38.2 (CH2), 21.2 (CH2), 





1-Isopropyl-4,5-dihydro-1H-imidazol-2-yl trifluoromethanesulfonate (659) 
 
To a stirred solution of 1-isopropylimidazolidin-2-one (657) (400 mg, 3.12 mmol, 
1.00 equiv) in anhydrous DCM (0.08 M, 39 mL) under a nitrogen atmosphere was added 
trimethylamine (0.52 mL, 3.74 mmol, 1.20 equiv) followed by the dropwise addition of 
triflic anhydride (0.63 mL, 3.74 mmol, 1.20 equiv). The resulting mixture was stirred at 
ambient temperature for 4 d. The reaction mixture was diluted with water (20 mL) and 
the phases separated. The aqueous phase was extracted with DCM (3 x 50 mL), and the 
combined organics were, dried over MgSO4 and concentrated in vacuo to a crude brown 
solid. The crude material was purified by column chromatography (SiO2, DCM) to afford 
659 (764.1 mg, 94%) as an amorphous white solid that was used as such. 
1H NMR (400 MHz, CDCl3)  4.21 (hept, J = 6.8 Hz, 1H, NCH), 4.00−3.96 (m, 2H, 
NCH2), 3.49−3.46 (m, 2H, NCH2), 1.20 (d, J = 6.8 Hz, 6H, (CH3)2) ppm. 
13C NMR (101 MHz, CDCl3)  150.1 (C), 119.7 (q, JC–F = 323.4 Hz, CF3), 45.0 (CH), 
42.8 (CH2), 36.8 (CH2), 19.4 (CH3) ppm. 
HRMS (ESI) calculated for C7H11F3N2NaO3S [M+Na]+ 283.2204, found 283.0337. 
IR (max/cm–1, neat) 2989.4, 1742.4, 1396.8 and 1191.1. 
Rf 0.54 (Et2O). 
1-Isopropyl-1,4,5,6-tetrahydropyrimidin-2-yl trifluoromethanesulfonate (670) 
 
To a stirred solution of 1-isopropyltetrahydropyrimidin-2-one (664) (3.204 g, 22.5 mmol, 
1.00 equiv) in anhydrous DCM (0.08 M, 281.3 mL) under a nitrogen atmosphere was 
added trimethylamine (3.80 mL, 27.0 mmol, 1.20 equiv) followed by the dropwise 
addition of triflic anhydride (4.50 mL, 27.0 mmol, 1.20 equiv). The resulting mixture was 





mL) and the phases separated. The aqueous phase was extracted with DCM (3 x 250 mL), 
and the combined organics were dried over MgSO4, filtered and concentrated in vacuo to 
an orange oil. This oil was purified by column chromatography (SiO2, DCM) to afford 
670 (4.984 g, 81%) as an amorphous white solid that was used as such. 
1H NMR (400 MHz, CDCl3)  4.67 (hept, J = 6.8 Hz, 1H, NCH), 3.86 (app t, J = 5.8 Hz, 
2H, NCH2), 3.25 (app t, J = 5.8 Hz, 2H, NCH2), 2.08 (app p, 2H, NCH2CH2), 1.17 (d, J 
= 6.8 Hz, 6H, (CH3)2). 
13C NMR (101 MHz, CDCl3)  149.2 (C), 119.7 (q, JC–F = 323.5 Hz, CF3), 46.6 (CH), 
46.6 (CH2), 38.8 (CH2), 22.8 (CH2), 19.3 (CH3). 
HRMS (ESI) calculated for C8H13F3N2NaO3S [M+Na]+ 297.0491, found 297.0503.   
IR (max/cm–1, neat) 1682.9, 1384.6, 1186.4. 
Rf 0.54 (Et2O). 
2-(Ethylthio)-1-isopropyl-4,5-dihydro-1H-imidazol-3-ium iodide (689) 
 
According to a modified literature procedure.177 Iodoethane (1.39 mL, 17.3 mmol, 5.00 
equiv) was added to isopropylimidazolidine-2-thione (654) (500 mg, 3.47 mmol, 
1.00 equiv) drop wise under a nitrogen atmosphere. The resulting mixture was heated at 
80 C (oil bath) for 18 h. The reaction was cooled to ambient temperature and the excess 
iodoethane was removed in vacuo. The resulting solid was dissolved in anhydrous MeOH 
and concentrated in vacuo (3 x 50 mL) to yield 689 (984 mg, 94%) as an amorphous 
orange solid which was used as such.  
1H NMR (500 MHz, CDCl3)  9.56 (s (br) 1H, NH), 4.09−4.04 (m, 2H, NCH2), 3.95 
(hept, J = 6.6 Hz, 1H, NCH), 3.94−3.87 (m, 2H, NCH2), 3.59 (q, J = 7.4 Hz, 2H, SCH2), 
1.44 (t, J = 7.4 Hz, 3H, SCH2CH3), 1.29 (d, J = 6.6 Hz, 6H, NCH(CH3)2) ppm. 
13C NMR (126 MHz, CDCl3)  168.8 (C), 48.9 (CH), 44.4 (CH2), 43.5 (CH2), 28.5 (CH2), 
19.8 (CH3), 14.0 (CH3) ppm. 





IR (max/cm–1, neat) 3141.6, 3021.4, 2967.1, 2947.2, 1557.0 and 1515.7. 
2-(Ethylthio)-1-isopropyl-4,5-dihydro-1H-imidazole (690) 
 
According to a modified literature procedure.177 To a stirred solution of 2-(ethylthio)-1-
isopropyl-4,5-dihydro-1H-imidazol-3-ium iodide (689) (500 mg, 1.67 mmol, 1.00 equiv) 
in DCM (0.11 M, 14.9 mL) was added K2CO3 (2.308 g, 16.7 mmol, 10.0 equiv). The 
resulting suspension was stirred at ambient temperature for 2 h. The reaction mixture was 
filtered through a celite pad eluting with DCM and water (20mL) was added to the mother 
liquor. The phases were separated, and the aqueous phase was extracted with DCM (3 x 
50 mL). The combined organic phases were dried with MgSO4, filtered and concentrated 
in vacuo to yield 690 (241.4 mg, 91%) as a viscous white oil. 
1H NMR (500 MHz, CDCl3)  3.86−3.80 (m, 3H, NCH and NCH2), 3.50 (app t, J = 9.6 
Hz, 2H, NCH2), 3.24 (q, J = 7.4 Hz, 2H, SCH2), 1.36 (t, J = 7.4 Hz, 3H, SCH2CH3), 1.17 
(d, J = 6.6 Hz, 6H, NCH(CH3)2) ppm. 
13C NMR (126 MHz, CDCl3)  165.9 (C), 49.4 (CH2), 47.1 (CH), 44.1 (CH2), 26.5 (CH2), 
19.7 (CH3), 14.4 (CH3) ppm. 
HRMS (ESI) calculated for C8H17N2S [M+H]+ 173.1107, found 173.1108. 
IR (max/cm–1, neat) 2968.7, 2930.0, 2870.5, 1554.3 and 1244.5. 













According to a modified literature procedure.217 To a stirred solution of 1-isopropyl-4,5-
dihydro-1H-imidazol-2-yl trifluoromethanesulfonate (659) (2.585 g, 9.90 mmol, 
1.00 equiv) in anhydrous xylene (1.0 M, 9.9 mL) in a flame dried microwave vial under a 
nitrogen atmosphere was added 3-phenyl propan-1-ol (1.35 mL, 9.90 mmol, 1.00 equiv), 
CuI (95.3 mg, 0.50 mmol, 5.00 mol%), 3,4,7,8-tetramethyl-1,10-phenanthroline (704) 
(236.3 mg, 1.00 mmol, 10.0 mol%) and CsCO3 (4854.4 mg, 14.9 mmol, 1.50 equiv). The 
vial was sealed and heated under microwave irradiation at 200 C for 8 h. Once the 
reaction had cooled to ambient temperature it was concentrated in vacuo to a brown oil. 
This oil was purified by column chromatography (SiO2, Et2O:pentane:DCM 2.5:6.5:1) to 
yield 671 (886 mg, 36%) as a colourless oil.  
1H NMR (400 MHz, CDCl3)  7.32−7.25 (m, 2H, ArH), 7.23−7.17 (m, 3H, ArH), 4.20 
(s(br), 1H, NCH), 4.15 (t, J = 6.5 Hz, 2H, OCH2), 3.39 (s(br), 4H, (NCH2)2), 2.71 (t, J = 
7.5 Hz, 2H, PhCH2), 2.01 (app p, J = 7.5, 6.5 Hz, 2H, OCH2CH2), 1.15 (d, J = 6.8 Hz, 
6H, (CH3)2) ppm. 
13C NMR (101 MHz, CDCl3)  141.1 (C), 128.5 (CH), 128.3 (CH), 126.0 (CH), 65.7 
(CH2), 47.9 (CH), 45.4 (CH2), 41.9 (CH2), 32.3 (CH2), 30.4 (CH2), 20.7 (CH3) quaternary 
carbon at isourea position not observed. 
HRMS (ESI) calculated for C15H22N2NaO [M+Na]+ 269.1624, found 269.1633. 
IR (max/cm–1, neat) 3141.0, 2965.3, 1664.2, 1375.2 and 1188.2. 










According to a modified literature procedure.217 To a stirred solution of 1-isopropyl-
1,4,5,6-tetrahydropyrimidin-2-yl trifluoromethanesulfonate (670) (200 mg, 0.73 mmol, 
1.00 equiv) in anhydrous xylene (1.0 M, 0.73 mL) in a flame dried microwave vial under 
an atmosphere of air was added 3-phenyl propan-1-ol (0.10 mL, 0.73 mmol, 1.00 equiv), 
CuI (7.6 mg, 0.04 mmol, 5.00 mol%), 3,4,7,8-tetramethyl-1,10-phenanthroline (704) 
(16.5 mg, 0.07 mmol, 10.0 mol%) and CsCO3 (355.1 mg, 1.09 mmol, 1.50 equiv). The 
vial was sealed and heated under microwave irradiation at 200 C for 6 h. Once the 
reaction had cooled to ambient temperature it was concentrated in vacuo to a brown oil. 
This oil was purified by column chromatography (SiO2, Et2O:pentane:DCM 2.0:7.5:0.5) 
to yield the title compound (673) (93 mg, 49%) as a colourless oil.  
1H NMR (400 MHz, CDCl3)  7.32−7.27 (m, 2H, ArH), 7.23−7.17 (m, 3H, ArH), 4.14 
(t, J = 6.5 Hz, 2H, OCH2), 4.07 (m, 1H, NCH), 3.36 (s(br), 2H, NCH2), 3.27 (t(br), J = 
5.8 Hz, 2H, NCH2), 2.70 (t, J = 7.6 Hz, 2H, PhCH2), 1.99 (app p(br), J = 6.2, 5.6 Hz 2H, 
OCH2CH2), 1.75 (p(br), J = 5.8 Hz, 2H, NCH2CH2), 1.18 (d, J = 6.8 Hz, 6H, (CH3)2) 
ppm. 
13C NMR (101 MHz, CDCl3)  140.8 (C), 128.6 (CH), 128.4 (CH), 126.2 (CH), 64.9 
(CH2), 48.2 (CH), 47.9 (CH2), 46.6 (CH2) 32.5 (CH2), 30.9 (CH2), 30.0 (CH2), 20.8 (CH3) 
ppm. 
quaternary carbon at isourea position not observed. 
HRMS (ESI) calculated for C16H24N2NaO [M+Na]+ 283.1781, found 283.1790 
IR (max/cm–1, neat) 3138.3, 2964.8, 1663.1, 1373.5, 1229.2 and 1186.1. 






4,5-Dihydroimidazol-2-yl trifluoromethanesulfonate (683) 
 
To a stirred solution of imidazolidin-2-one (682) (1.00 g, 11.6 mmol, 1.00 equiv) in 
anhydrous DCM (0.3 M, 38.7 mL) under a nitrogen atmosphere at 0 C was added 
trimethylamine (1.94 mL, 13.9 mmol, 1.20 equiv) followed by the dropwise addition of 
triflic anhydride (2.34 mL, 13.9 mmol, 1.20 equiv). The resulting mixture was stirred at 
ambient temperature for 4 d. The reaction mixture was then diluted with water (100 mL) 
and the phases separated. The aqueous phase was extracted with DCM (3 x 50 mL) and 
the combined organics were dried (MgSO4), filtered and concentrated in vacuo to an 
orange oil. This oil was purified by column chromatography (SiO2; DCM:MeOH 98:2) 
to afford 683 (883.6 mg, 35%) as an amorphous white solid that was used as such. 
1H NMR (400 MHz, CDCl3)  6.23 (s(br), 1H, NH), 4.10 (app t, J = 7.8 Hz, 2H, NCH2), 
3.62 (app t, 2H, NCH2) ppm. 
13C NMR (100 MHz, CDCl3)  153.2 (C), 100.0 (C), 45.4 (CH2), 37.4 (CH2) ppm. 
HRMS (ESI) calculated for C4H5F3N2NaO3S [M+Na]+ 240.9865, found 240.9876. 
IR (max/cm–1, neat) 3256.8, 3171.2, 1754.1, 1399.2, 1192.3. 
Rf 0.20 (Et2O). 
2-Ethoxy-4,5-dihydro-1H-imidazole (684) 
 
4,5-dihydroimidazol-2-yl trifluoromethanesulfonate (683) (250 mg, 1.15 mmol, 1.00 
equiv) was heated at 90 C (oil bath) in anhydrous EtOH (5 mL) for 16 h. The reaction 
was cooled to ambient temperature and concentrated in vacuo to a light brown oil. This 
oil was purified by column chromatography (SiO2, pentane:Et2O 1:1) to yield the title 
compound (684) (118.7 mg, 90%) as a colourless oil. 
1H NMR (500 MHz, CDCl3)  5.07 (s(br), 1H, NH), 4.13 (q, J = 7.0 Hz, 2H, OCH2), 





13C NMR (125 MHz, CDCl3)  159.1 (C), 61.8 (CH2), 45.3 (CH2), 40.8 (CH2), 14.5 (CH3) 
ppm. 
HRMS (ESI) calculated for C8H16N2NaO [M+Na]+ 179.1155, found 179.1148. 
IR (max/cm–1, neat) 3433.7, 3136.5, 1689.0, 1528.3, 1367.7 and 1268.3. 
Rf 0.19 (1:1 pentane:Et2O). 
1-Butyl-1H-benzimidazole (692) 
 
According to a modified literature procedure.218 To a suspension of NaH (60% dispersion 
in mineral oil, 2.032 g, 50.8 mmol, 1.20 equiv) in anhydrous THF (0.68 M, 74.7 mL) was 
added benzimidazole (691) (5.00 g, 42.3 mmol, 1.00 equiv) portion wise. The resulting 
suspension was heated for 1 h at 60 C (oil bath). A solution of n-butylbromide (4.99 mL, 
46.6 mmol, 1.10 equiv) in anhydrous THF (0.93 M, 50.0 mL) was added over 10 min. The 
resulting reaction mixture was heated at 60 C (oil bath) for 24 h. After this time the 
reaction mixture was concentrated in vacuo. The resulting residue was diluted with DCM 
(200 mL) and water (200 mL). The phases were separated, and the aqueous phase was 
extracted with DCM (3 x 100 mL). The combined organics were, dried (MgSO4), filtered 
and concentrated in vacuo to an orange oil. This oil was purified by column 
chromatography (SiO2; 5% MeOH in DCM) to afford an orange oil which was identified 
as a mixture of the title compound and mineral oil. This oil was diluted with petroleum 
ether (50 mL) and acetonitrile (50 mL). The phases were separated, and the petroleum 
ether layer was extracted with acetonitrile (3 x 10 mL). The combined acetonitrile layers 
were concentrated in vacuo to afford 692 (6.524 g, 89%) as a yellow oil. 
All data matched that reported in the literature.218 
1H NMR (400 MHz, CDCl3)  7.88 (s, 1H, NCH), 7.81 (m, 1H, ArH), 7.39 (m, 1H, ArH), 
7.32 − 7.25 (m, 2H, ArH), 4.16 (t, J = 7.2 Hz, 2H, NCH2), 1.85 (app p, J = 7.5, 7.2 Hz, 
2H, NCH2CH2), 1.35 (app sext, J = 7.5, 7.4 Hz, 2H, NCH2CH2CH2), 0.95 (t, J = 7.4 Hz, 





13C NMR (101 MHz, CDCl3)  143.9 (C), 142.9 (CH), 133.8 (C), 122.7 (CH), 121.9 
(CH), 120.4 (CH), 109.6 (CH), 44.8 (CH2), 31.8 (CH2), 20.0 (CH2), 13.5 (CH3) ppm. 
1-Butyl-2-(3-phenylpropoxy)-1H-benzimidazole (693) 
 
According to a modified literature procedure.217 To a solution of 1-butyl-1H-
benzimidazole (692) (1.00 g, 5.74 mmol, 1.00 equiv) in anhydrous xylene (0.5 M, 11.5 
mL) in a flame dried microwave vial under a nitrogen atmosphere was added 3-phenyl 
propan-1-ol (0.78 mL, 5.74 mmol, 1.00 equiv), CuCl (28.4 mg, 0.29 mmol, 5.00 mol%), 
di t-butylperoxide (2.12 mL, 11.5 mmol, 2.00 equiv) and 3,4,7,8-tetramethyl-1,10-
phenanthroline (704) (67.8 mg, 0.29 mmol, 5.00 mol%). The vial was sealed and heated 
under microwave irradiation at 200 C for 6 h. Once the reaction had cooled to ambient 
temperature it was concentrated in vacuo to a brown oil. This oil was purified by column 
chromatography (SiO2, pentane:Et2O 70:30) to yield 693 (363.8 mg, 21%) as an amber 
oil.  
1H NMR (400 MHz, CDCl3)  7.54 (m, 1H, ArH), 7.33−7.27 (m, 2H, ArH), 7.24−7.20 
(m, 3H, ArH), 7.19−7.13 (m, 3H, ArH), 4.58 (t, J = 6.4 Hz, 2H, OCH2), 3.96 (t, J = 7.0 
Hz, 2H, NCH2), 2.82 (app t, 2H, OCH2CH2CH2), 2.24−2.16 (m, 2H, OCH2CH2), 1.76 
(app p, J = 7.0, 7.6 Hz, 2H, NCH2CH2), 1.36 (app sext, J = 7.4, 7.6 Hz, 2H, 
NCH2CH2CH2), 0.96 (t, J = 7.4 Hz, 3H, CH3) ppm. 
13C NMR (101 MHz, CDCl3)  141.1 (C), 140.1 (C), 133.7 (C), 128.5 (CH), 128.4 (CH), 
126.0 (CH), 121.2 (CH), 120.7 (CH), 117.6 (CH), 108.1 (CH), 69.4 (CH2), 41.7 (CH2), 
32.1 (CH2), 31.1 (CH2), 30.6 (CH2), 20.0 (CH2), 13.7 (CH3) ppm. quaternary carbon at 
isourea position not observed. 
HRMS (ESI) calculated for C20H24N2NaO [M+Na]+ 331.1781, found 331.1771. 
IR (max/cm–1, neat) 2954.3, 1708.2, 1621.0, 1535.5 and 1455.2. 







According to a modified literature procedure.52 To a stirred solution of 1-butyl-2-(3-
phenylpropoxy)-1H-benzimidazole (693) (50.0 mg, 0.16 mmol, 1.00 equiv) in THF 
(0.33 M, 0.48 mL) was added TMEDA (0.03 mL, 0.21 mmol, 1.30 equiv). The resulting 
solution was cooled to −60 C (acetone/dry ice) and s-BuLi (0.16 mL, 0.21 mmol, 1.30 
equiv) was added dropwise over 2 min. The reaction was stirred at −60 C (acetone/dry 
ice) for 5 h, after which Me3SnCl (1.00 M in hexanes, 0.21 mL, 0.21 mmol, 1.30 equiv) 
was added dropwise over 2 min. The reaction was warmed to ambient temperature and 
stirred at this temperature for 16 h. The volatiles were removed under high vacuum and 
the residue purified by column chromatography (SiO2, pentane:Et2O 90:10) to afford 694 
(46 mg, 61%) as an orange oil.  
1H NMR (400 MHz, CDCl3)  7.53 (m, 1H, ArH), 7.25−7.22 (m, 2H, ArH), 7.19−7.11 
(m, 6H, ArH), 5.31 (dd, J = 10.2, 3.8 Hz, 1H, OCH), 3.95 (t, J = 7.0 Hz, 2H, NCH2), 2.79 
(ddd, J = 13.6, 10.8, 5.6 Hz, 1H, OCHCH2CHaHb), 2.72 (m, 1H, OCHCH2CHaHb), 2.15 
(m, 1H, OCHCHaHb), 2.06 (dddd, J = 14.3, 10.8, 6.2, 3.8 Hz, 1H, OCHCHaHb), 1.83−1.71 
(m, 2H, NCH2CH2), 1.40 (p, J = 7.5 Hz, 2H, CH3CH2), 0.96 (t, J = 7.5 Hz, 3H, CH3), 
0.10 (s, 9H, Sn(CH3)3) ppm. 
13C NMR (101 MHz, CDCl3)  158.4 (C), 142.0 (C), 140.1 (C), 133.9 (C), 128.3 (CH), 
128.3 (CH), 125.8 (CH), 121.0 (CH), 120.3 (CH), 117.4 (CH), 107.9 (CH), 75.7 (CH), 
41.6 (CH2), 33.7 (CH2), 33.6 (CH2), 31.2 (CH2), 20.1 (CH2), 13.7 (CH3), −3.5 (CH3) ppm. 
HRMS (ESI) calculated for C23H33N2OSn [M+H]+ 473.1613, found 473.1613.   
IR (max/cm–1, neat) 2957.8, 2928.8, 2861.4, 1621.0, 1534.1 and 1455.4. 








1H-Benzo[1,2,3]triazol-1-yl 4-methylbenzenesulfonate (696) 
 
To a stirred solution of HOBt hydrate (695) (500 mg, 3.70 mmol, 1.00 equiv) in 
anhydrous DCM (0.25 M, 14.8 mL) under nitrogen atmosphere was added imidazole 
(256.7 mg, 3.77 mmol, 1.02 equiv). The resulting solution was cooled to 0 C (ice/ water) 
and a solution of freshly recrytallised tosyl chloride (712.8mg, 3.74 mmol 1.01 equiv) in 
anhydrous DCM (1.90 M, 1.97 mL) was added dropwise over 2 min. The reaction mixture 
was warmed to ambient temperature and stirred for 18 h. The reaction was then diluted 
with DCM (50 mL), dried (MgSO4), filtered and concentrated in vacuo to a colourless 
oil. This oil was purified by column chromatography (SiO2, pentane:Et2O 80:20) to yield 
696 (792.2 mg, 74%) as an amorphous white solid that was used as such. 
All data matched that reported in the literature.219 
1H NMR (400 MHz, CDCl3)  7.95 (m, 1H, ArH), 7.80−7.75 (m, 2H, ArH), 7.65 (m, 1H, 
ArH), 7.59 (m, 1H, ArH), 7.46−7.38 (m, 3H, ArH), 2.50 (s, 3H, CH3) ppm. 
13C NMR (125 MHz, CDCl3)  148.0 (C), 142.9 (C), 130.5 (CH), 129.8 (CH), 129.3 
(CH), 129.0 (C), 128.7 (C), 125.3 (CH), 120.3 (CH), 109.5 (CH), 22.0 (CH3) ppm. 
1-(3-Phenylpropoxy)-1H-benzo[1,2,3]triazole (697) 
 
To a stirred solution of 1H-benzo[1,2,3]triazol-1-yl 4-methylbenzenesulfonate 696 
(20  mg, 0.69 mmol, 1.00 equiv) in anhydrous THF (0.2 M, 3.45 mL) under a nitrogen 
atmosphere was added 3-phenyl propan-1-ol (0.11 mL, 0.82 mmol, 1.20 equiv) followed 
by the dropwise addition of DBU (0.12 mL, 0.83 mmol, 1.20 equiv). The reaction was 
stirred at ambient temperature for 48 h. The volatiles were removed under high vacuum 
and the residue was purified by column chromatography (SiO2, pentane:Et2O 90:10) to 





1H NMR (400 MHz, CDCl3)  8.02 (m, 1H, ArH), 7.58−7.48 (m, 2H, ArH), 7.39 (m, 1H, 
ArH), 7.35−7.29 (m, 2H, ArH), 7.25−7.20 (m, 3H, ArH), 4.57 (t, J = 6.5 Hz, 2H, OCH2), 
2.92 (t, J = 7.2 Hz, 2H, PhCH2), 2.25−2.16 (m, 2H, OCH2CH2) ppm. 
13C NMR (101 MHz, CDCl3)  143.5 (C), 140.5 (C), 128.6 (CH), 128.5 (CH), 127.9 
(CH), 127.3 (C), 126.3 (CH), 124.6 (CH), 120.3 (CH), 108.6 (CH), 79.8 (CH2), 31.7 
(CH2), 29.6 (CH2) ppm. 
HRMS (ESI) calculated for C15H16N3O [M+H]+ 254.1288, found 254.1294. 
IR (max/cm–1, neat) 3025.7, 1496.3, 1366.6, 1239.3. 
Rf 0.33 (7:3 pentane:Et2O) 
1-Isopropyl-1,4-dihydro-5H-tetrazol-5-one (698) 
 
Anhydrous AlCl3 (740.5 mg, 5.56 mmol, 1.10 equiv) was added to anhydrous DMF (0.5 
M, 10.1 mL) at 0 C (ice/ water) and was stirred for 15 min. NaN3 (328 mg, 5.05 mmol, 
1.00 equiv) was added and the resulting mixture stirred for a further 15 min. Isopropyl 
isocyanate (0.57 mL, 5.05 mmol, 1.00 equiv) was then added and the resulting solution 
stirred at 75 C (oil bath) for 3 h. The reaction mixture was cooled to ambient temperature 
and poured onto a stirring mixture of NaNO2 (500 mg), water (100 mL) and ice (2.00 g). 
The resulting mixture was acidified with HCl (10% aq, 100 mL) and diluted with EtOAc 
(100 mL) The phases were separated, and the aqueous phase was extracted with EtOAc 
(3 x 50 mL). The combined organics were washed with brine, dried (MgSO4) and 
concentrated in vacuo. The resulting crude residue was purified by column 
chromatography (SiO2, pentane:Et2O 88:12) to afford 698 (372.2 mg, 49 %) as a white 
foam. 
1H NMR (500 MHz, CDCl3) 4.96 (s(br), 1H, NH), 3.91 (hept, J = 6.7 Hz, 1H, CH), 1.17 
(d, J = 6.7 Hz, 6H, 2 x CH3). 
13C NMR (125 MHz, CDCl3)  155.5 (C), 43.4 (CH), 22.6 (CH3). 





IR (max/cm–1, neat) 3322.9, 2977.5, 2143.4, 1617.5, 1535.4, 1474.5 and 1339.6. 
Rf 0.45 (70:30 pentane:Et2O). 
1-Isopropyl-5-(3-phenylpropoxy)-1H-tetrazole (699) 
 
According to a modified literature procedure.185 To a stirred solution of PPh3 (390.8 mg, 
1.49 mmol, 1.10 equiv), 3-phenyl propan-1-ol (0.19 mL, 1.36 mmol, 1.00 equiv) and 
1-isopropyl-1,4-dihydro-5H-tetrazol-5-one (698) (200 mg, 1.56 mmol, 1.15 equiv) in 
anhydrous THF (0.66 M, 10.1 mL) under a nitrogen atmosphere was added DIAD (0.29 
mL, 1.49 mmol, 1.10 equiv) dropwise. The resulting reaction mixture was stirred at 
ambient temperature for 3 h before the volatiles were removed in vacuo. The crude 
residue was purified by column chromatography (Si2O, pentane:Et2O 4:1) to yield 699 
(106.4 mg, 32%) as a colourless oil. 
1H NMR (500 MHz, CDCl3) 7.33−7.28 (m, 2H, ArH), 7.23−7.19 (m, 3H, ArH), 4.10 
(t(br), J = 6.5 Hz, 2H, OCH2), 3.90−3.78 (m(br), 1H, CH), 2.71 (t, J = 7.8 Hz, 2H, PhCH2), 
2.00−1.92 (m(br), 2H, OCH2CH2), 1.18 (d, 6.5 Hz, 6H, 2xCH3) ppm. 
13C NMR (125 MHz, CDCl3)  155.8 (C), 141.5 (C), 128.4 (CH) 128.4 (CH), 125.9 (CH), 
64.0 (CH2), 43.0 (CH), 32.2 (CH2), 30.7 (CH2), 23.1 (CH3) ppm. 
HRMS (ESI) calculated for C13H18N4NaO [M+Na]+ 269.1373, found 269.1366. 
IR (max/cm–1, neat) 3324.1, 2972.6, 1681.5, 1527.9, 1454.7, 1256.1 and 1097.8.  
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